FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ornelas, AMM
   Xavier-de-Carvalho, C
   Alvarado-Arnez, L
   Ribeiro-Alves, M
   Tanuri, A
   Aguiar, RS
   Moraes, MO
   Cardoso, CC
AF Ornelas, A. M. M.
   Xavier-de-Carvalho, C.
   Alvarado-Arnez, L.
   Ribeiro-Alves, M.
   Tanuri, A.
   Aguiar, R. S.
   Moraes, M. O.
   Cardoso, C. C.
TI Association between MBL2 haplotypes and dengue severity in children from
   Rio de Janeiro, Brazil
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Meeting Abstract
CT 52nd Conference of the European-Society-of-Human-Genetics (ESHG)
CY JUN 15-18, 2019
CL Gothenburg, SWEDEN
SP European Soc Human Genet
C1 [Ornelas, A. M. M.; Tanuri, A.; Aguiar, R. S.; Cardoso, C. C.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Xavier-de-Carvalho, C.; Moraes, M. O.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Alvarado-Arnez, L.] Univ Privada Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
   [Ribeiro-Alves, M.] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RI Cardoso, Cynthia/K-5824-2012; Aguiar, Renato S/G-3542-2015
OI Cardoso, Cynthia/0000-0003-0565-7047; Aguiar, Renato
   S/0000-0001-5180-3717
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX CNPq, CAPES.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD OCT
PY 2019
VL 27
SU 2
MA P18.15C
BP 1749
EP 1749
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA JC5ID
UT WOS:000489313906063
DA 2020-10-22
ER

PT J
AU Hill, SC
   Vasconcelos, J
   Neto, Z
   Jandondo, D
   Ze-Ze, L
   Aguiar, RS
   Xavier, J
   Theze, J
   Mirandela, M
   Candido, ALM
   Vaz, F
   Sebastiao, CD
   Wu, CH
   Kraemer, MUG
   Melo, A
   Schamber-Reis, BLF
   de Azevedo, GS
   Tanuri, A
   Higa, LM
   Clemente, C
   da Silva, SP
   Candido, DD
   Claro, IM
   Quibuco, D
   Domingos, C
   Pocongo, B
   Watts, AG
   Khan, K
   Alcantara, LCJ
   Sabino, EC
   Lackritz, E
   Pybus, OG
   Alves, MJ
   Afonso, J
   Faria, NR
AF Hill, Sarah C.
   Vasconcelos, Jocelyne
   Neto, Zoraima
   Jandondo, Domingos
   Ze-Ze, Libia
   Aguiar, Renato Santana
   Xavier, Joilson
   Theze, Julien
   Mirandela, Marinela
   Micolo Candido, Ana Luisa
   Vaz, Filipa
   Sebastiao, Cruz dos Santos
   Wu, Chieh-Hsi
   Kraemer, Moritz U. G.
   Melo, Adriana
   Schamber-Reis, Bruno L. F.
   de Azevedo, Girlene S.
   Tanuri, Amilcar
   Higa, Luiza M.
   Clemente, Carina
   da Silva, Sara Pereira
   Candido, Darlan da Silva
   Claro, Ingra M.
   Quibuco, Domingos
   Domingos, Cristovao
   Pocongo, Barbara
   Watts, Alexander G.
   Khan, Kamran
   Junior Alcantara, Luiz Carlos
   Sabino, Ester C.
   Lackritz, Eve
   Pybus, Oliver G.
   Alves, Maria-Joao
   Afonso, Joana
   Faria, Nuno R.
TI Emergence of the Asian lineage of Zika virus in Angola: an outbreak
   investigation
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID TRANSMISSION; AFRICA
AB Background Zika virus infections and suspected microcephaly cases have been reported in Angola since late 2016, but no data are available about the origins, epidemiology, and diversity of the virus. We aimed to investigate the emergence and circulation of Zika virus in Angola.
   Methods Diagnostic samples collected by the Angolan Ministry of Health as part of routine arboviral surveillance were tested by real-time reverse transcription PCR by the Instituto Nacional de Investigacao em Saude (Ministry of Health, Luanda, Angola). To identify further samples positive for Zika virus and appropriate for genomic sequencing, we also tested samples from a 2017 study of people with HIV in Luanda. Portable sequencing was used to generate Angolan Zika virus genome sequences from three people positive for Zika virus infection by real-time reverse transcription PCR, including one neonate with microcephaly. Genetic and mobility data were analysed to investigate the date of introduction and geographical origin of Zika virus in Angola. Brain CT and MRI, and serological assays were done on a child with microcephaly to confirm microcephaly and assess previous Zika virus infection.
   Findings Serum samples from 54 people with suspected acute Zika virus infection, 76 infants with suspected microcephaly, 24 mothers of infants with suspected microcephaly, 336 patients with suspected dengue virus or chikungunya virus infection, and 349 samples from the HIV study were tested by real-time reverse transcription PCR. Four cases identified between December, 2016, and June, 2017, tested positive for Zika virus. Analyses of viral genomic and human mobility data suggest that Zika virus was probably introduced to Angola from Brazil between July, 2015, and June, 2016. This introduction probably initiated local circulation of Zika virus in Angola that continued until at least June, 2017. The infant with microcephaly in whom CT and MRI were done had brain abnormalities consistent with congenital Zika syndrome and serological evidence for Zika virus infection.
   Interpretation Our analyses show that autochthonous transmission of the Asian lineage of Zika virus has taken place in Africa. Zika virus surveillance and surveillance of associated cases of microcephaly throughout the continent is crucial.
C1 [Hill, Sarah C.; Theze, Julien; Kraemer, Moritz U. G.; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Wu, Chieh-Hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Vasconcelos, Jocelyne; Neto, Zoraima; Jandondo, Domingos; Mirandela, Marinela; Micolo Candido, Ana Luisa; Vaz, Filipa; Sebastiao, Cruz dos Santos; Afonso, Joana] Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
   [Ze-Ze, Libia; Alves, Maria-Joao] Inst Nacl Saude Doutor Ricardo Jorge, Aguas De Moura, Portugal.
   [Ze-Ze, Libia] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Aguiar, Renato Santana; Tanuri, Amilcar; Higa, Luiza M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato Santana; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Dept Genet Ecol & Evolucao, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Sebastiao, Cruz dos Santos] Univ Agostinho Neto, Inst Super Ciencias Saude, Luanda, Angola.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Med Sch, Boston, MA 02115 USA.
   [Melo, Adriana; de Azevedo, Girlene S.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
   [Schamber-Reis, Bruno L. F.] Ctr Univ Unifacisa, Dept Human Genet, Campina Grande, Brazil.
   [Clemente, Carina; da Silva, Sara Pereira] Cligest Clin, Luanda, Angola.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra M.; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Quibuco, Domingos] Hosp Pediat David Bernardino, Luanda, Angola.
   [Domingos, Cristovao; Pocongo, Barbara] Inst Nacl Luta SIDA, Luanda, Angola.
   [Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Junior Alcantara, Luiz Carlos] IOC Fundacao Oswaldo Cruz MS, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Lackritz, Eve] WHO, Geneva, Switzerland.
RP Faria, NR (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.; Afonso, J (corresponding author), Minist Hlth, Inst Nacl Invest Saude, Luanda, Angola.
EM jfm.morais9@gmail.com; nuno.faria@zoo.ox.ac.uk
RI Pybus, Oliver G/B-2640-2012; Higa, Luiza/W-2698-2019; Ze-Ze, Libia Maria
   Marques/U-5730-2017; Melo, Adriana S O/H-5650-2016; Faria, Nuno
   R/I-2975-2012; Sabino, Ester Cerdeira/F-7750-2010; Aguiar, Renato
   S/G-3542-2015
OI Pybus, Oliver G/0000-0002-8797-2667; Ze-Ze, Libia Maria
   Marques/0000-0001-7258-1439; Faria, Nuno R/0000-0001-8839-2798; Sabino,
   Ester Cerdeira/0000-0003-2623-5126; Aguiar, Renato
   S/0000-0001-5180-3717; da Silva Candido, Darlan/0000-0002-5080-3130;
   Theze, Julien/0000-0001-8188-9494; Sebastiao, Cruz/0000-0003-1232-0119;
   Alves, Maria Joao/0000-0003-0065-9000; Alcantara,
   Luiz/0000-0002-6769-9931; Hill, Sarah/0000-0002-2995-2596; Xavier,
   Joilson/0000-0003-3916-2018
FU Sir Henry Dale Fellowship [204311/Z/16/Z]; internal Higher Education
   Funding Council for England Global Challenges Research Fund [005073];
   Africa Oxford Initiative [AfiOx-48, AfiOx-60]; John Fell Research Fund
   [005166]; Medical Research CouncilMedical Research Council UK (MRC)
   [MR/S0195/1, 2018/14389-0]; O Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [440900/2016-6, 440685/2016-8];
   Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.130757/2016-01, 88887.130716/2016-00,
   88881.130728/2016-01]; European Research CouncilEuropean Research
   Council (ERC) [614725-PATHPHYLODYN]; Oxford Martin School; UK Medical
   Research CouncilMedical Research Council UK (MRC); Cancer Research
   UKCancer Research UK [ANR00310]
FX We thank the participants who participated in this study and the WHO
   Angolan country office for sharing information about suspected Zika and
   microcephaly cases. This research was supported by a Sir Henry Dale
   Fellowship (204311/Z/16/Z), internal Higher Education Funding Council
   for England Global Challenges Research Fund (005073), the Africa Oxford
   Initiative (AfiOx-48 and AfiOx-60), John Fell Research Fund (005166),
   and by the Medical Research Council (MR/S0195/1 and 2018/14389-0), O
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440900/2016-6 and 440685/2016-8), Fundacao Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (88881.130757/2016-01,
   88887.130716/2016-00, and 88881.130728/2016-01), the European Research
   Council (FP7 grant agreement 614725-PATHPHYLODYN), and the Oxford Martin
   School. C-HW is supported by the UK Medical Research Council and Cancer
   Research UK (ANR00310). We thank Patricia Alvarez Baptista and Antonio
   Gomes Pinto Ferreira (Fundacao Oswaldo Cruz, Instituto de Tecnologia em
   Imunobiologicos Bio-Manguinhos, Rio de Janeiro, Brazil) for donating
   Bio-Manguinhos reagents, and Jorge Munoz-Jordan and Gilberto Santiago
   (CDC) for donating real-time reverse transcription PCR reagents.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hill SC, 2019, EMERG INFECT DIS, V25, P784, DOI 10.3201/eid2504.180958
   Lourenco J, 2018, PLOS CURR OUTBREAKS
   Melo AS, 2016, JAMA NEUROL
   Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pan American Health Organization, 2018, DIG ZIK CAS INC RAT
   Pan American Health Organization WHO, 2018, ZIK CAS CONG SYNDR A
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Sharp TM, 2013, MMWR-MORBID MORTAL W, V62, P504
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Taiwan Centers for Disease Control, TRAV VIS RET ZIK AFF
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.101, 10.1016/j.chom.2018.04.017]
   WHO, 2017, WEEK, V48
   World Health Organisation [WHO], 2007, WHO CHILD GROWTH STA
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 32
TC 11
Z9 11
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2019
VL 19
IS 10
BP 1138
EP 1147
DI 10.1016/S1473-3099(19)30293-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA JA4ST
UT WOS:000487824300040
PM 31559967
OA Green Accepted, Other Gold, Green Published
DA 2020-10-22
ER

PT J
AU Dias, ASO
   Sacramento, PM
   Lopes, LM
   Sales, MC
   Castro, C
   Araujo, ACRA
   Ornelas, AMM
   Aguiar, RS
   Silva, RG
   Alvarenga, R
   Bento, CAM
AF Dias, Aleida S. O.
   Sacramento, Priscila M.
   Lopes, Lana Marcia
   Sales, Marisa C.
   Castro, Camilla
   Araujo, Ana Carolina R. A.
   Ornelas, Alice M. M.
   Aguiar, Renato S.
   Silva-Filho, Renato Geraldo
   Alvarenga, Regina
   Bento, Cleonice A. M.
TI TLR-2 and TLR-4 agonists favor expansion of CD4(+) T cell subsets
   implicated in the severity of neuromyelitis optica spectrum disorders
SO MULTIPLE SCLEROSIS AND RELATED DISORDERS
LA English
DT Article
DE NMOSD; TLR ligands; CD4(+) T cells; Cytokines; CD14
ID TOLL-LIKE RECEPTORS; NEUROLOGICAL DISABILITIES; MICROBIAL TRANSLOCATION;
   ACTIVATION; MECHANISMS; EXPRESSION; PROFILES
AB Background: High frequency of circulating Th17 cell subsets expressing TLR2, TLR4 and TLR9 was observed in Neuromyelitis optica spectrum disorder (NMOSD) patients, a severe humoral autoimmune disease of the central nervous system. Our objective was to evaluate the direct effects of different TLR ligands on CD4(+) T-cells form those patients.
   Methods: CD4(+) T-cell cultures from NMOSD and healthy individuals were stimulated with different TLR ligands and the cell proliferation and cytokine profile was analyzed by [H-3] TdR up take and ELISA/cytometry, respectively. The plasma levels of CD14 were determined by ELISA.
   Results: Here, Pam3C (TLR2) and LPS (TLR4) induced significant cell proliferation and IL-6, IL-17 and IL-21 production by CD4(+) T-cells from NMOSD. Additionally, while both TLR ligands were more potent in favoring the expansion of T-FH-like cells, Pam3C reduced the frequency of IL-10-secreting FoxP3(+) and FoxP3(-) CD4(+) T-cells. With regard to disease severity, the levels of IL-6, IL-17 and IL-21 produced by CD4(+) T-cells, as well as the frequency of T-FH-like cells, in response to TLR2 and TLR4 agonists were positively correlated with neurological disabilities and the occurrence of new acute relapses during follow up. Finally, circulating levels of CD14, an indirect marker of microbial translocation, were positively correlated with IL-6, IL-17 and IL-21 release by Pam3C- and LPS-activated CD4(+) T-cells.
   Conclusions: In summary, our data suggest that microbial antigens may affect NMOSD outcomes by favoring an imbalance between Th17 and TFH-like cells and regulatory T cell subsets.
C1 [Dias, Aleida S. O.; Sacramento, Priscila M.; Lopes, Lana Marcia; Castro, Camilla; Silva-Filho, Renato Geraldo; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, Brazil.
   [Dias, Aleida S. O.; Sacramento, Priscila M.; Lopes, Lana Marcia; Sales, Marisa C.; Bento, Cleonice A. M.] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, Brazil.
   [Araujo, Ana Carolina R. A.; Alvarenga, Regina; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Neurol, Rio De Janeiro, Brazil.
   [Ornelas, Alice M. M.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, RJ, Brazil.
RP Bento, CAM (corresponding author), Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, Brazil.
EM cbento@globo.com
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Papais-Alvarenga, Regina
   Maria/0000-0002-1141-8619
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/202.940/2017]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [301.780/2017-0]
FX This work was supported by Fundacao de Amparo a Pesquisa Carlos Chagas
   Filho (FAPERJ) (grant no. E-26/202.940/2017) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (grant no.
   301.780/2017-0).
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Barros PO, 2016, CLIN EXP IMMUNOL, V183, P480, DOI 10.1111/cei.12733
   Barros PO, 2017, J NEUROIMMUNOL, V307, P82, DOI 10.1016/j.jneuroim.2017.04.001
   Barros PO, 2013, HUM IMMUNOL, V74, P1080, DOI 10.1016/j.humimm.2013.06.016
   Brill L, 2019, MULT SCLER RELAT DIS, V30, P114, DOI 10.1016/j.msard.2019.01.047
   Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633
   Cree BAC, 2016, ANN NEUROL, V80, P443, DOI 10.1002/ana.24718
   Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024
   Fan X, 2016, MEDIAT INFLAMM, V2016
   Ferreira TB, 2018, IMMUNOLOGY, V154, P239, DOI 10.1111/imm.12872
   Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760
   Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103
   Gong JL, 2019, MULT SCLER J, V25, P1316, DOI 10.1177/1352458518790396
   Hackl D, 2011, EUR J IMMUNOL, V41, P1334, DOI 10.1002/eji.201041014
   Hernandez-Pedro Norma, 2016, Front Biosci (Schol Ed), V8, P13
   Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453
   Kira Jun-Ichi, 2011, Pathophysiology, V18, P69, DOI 10.1016/j.pathophys.2010.04.008
   Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565
   Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Leon A, 2015, AIDS, V29, P675, DOI 10.1097/QAD.0000000000000596
   Li YJ, 2015, J NEUROIMMUNOL, V278, P239, DOI 10.1016/j.jneuroim.2014.11.011
   Lin J, 2016, INT J NEUROSCI, V126, P1051, DOI 10.3109/00207454.2016.1163550
   Linhares UC, 2013, J CLIN IMMUNOL, V33, P179, DOI 10.1007/s10875-012-9780-2
   Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917
   Masuda S, 2015, J NEUROL NEUROSUR PS, V86, P1137, DOI 10.1136/jnnp-2014-308095
   Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095
   Monteiro C, 2019, J NEUROIMMUNOL, V330, P12, DOI 10.1016/j.jneuroim.2019.01.015
   Mori M, 2011, NEUROL SCI, V32, P795, DOI 10.1007/s10072-011-0564-x
   Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012
   Nyirenda MH, 2015, J IMMUNOL, V194, P5761, DOI 10.4049/jimmunol.1400472
   Olliver M, 2011, INFECT IMMUN, V79, P4210, DOI 10.1128/IAI.05286-11
   Opazo MC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00432
   Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231
   Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94
   Ranjan P, 2009, TRENDS MOL MED, V15, P359, DOI 10.1016/j.molmed.2009.06.003
   Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010
   Slyepchenko A, 2016, CURR PHARM DESIGN, V22, P6087, DOI 10.2174/1381612822666160922165706
   Smyk DS, 2014, WORLD J GASTROENTERO, V20, P613, DOI 10.3748/wjg.v20.i3.613
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447
   Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247
   Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651
   Verstrepen BE, 2016, J GEN VIROL, V97, P2599, DOI 10.1099/jgv.0.000577
   Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925
NR 48
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-0348
EI 2211-0356
J9 MULT SCLER RELAT DIS
JI Mult. Scler. Relat. Disord.
PD SEP
PY 2019
VL 34
BP 66
EP 76
DI 10.1016/j.msard.2019.06.018
PG 11
WC Clinical Neurology
SC Neurosciences & Neurology
GA IY8EY
UT WOS:000486628300012
PM 31229737
DA 2020-10-22
ER

PT J
AU Castro, FL
   Geddes, VEV
   Monteiro, FLL
   Goncalves, RMDT
   Campanati, L
   Pezzuto, P
   Paquin-Proulx, D
   Schamber-Reis, BL
   Azevedo, GS
   Goncalves, AL
   Cunha, DP
   Moreira, MEL
   Vasconcelos, ZFM
   Chimeli, L
   Melo, A
   Tanuri, A
   Nixon, DF
   Ribeiro-Alves, M
   Aguiar, RS
AF Castro, Fernanda L.
   Geddes, Victor E. V.
   Monteiro, Fabio L. L.
   Goncalves, Raphael M. D. T.
   Campanati, Loraine
   Pezzuto, Paula
   Paquin-Proulx, Dominic
   Schamber-Reis, Bruno L.
   Azevedo, Girlene S.
   Goncalves, Alessandro L.
   Cunha, Daniela P.
   Moreira, Maria Elisabeth L.
   Vasconcelos, Zilton F. M.
   Chimeli, Leila
   Melo, Adriana
   Tanuri, Amilcar
   Nixon, Douglas F.
   Ribeiro-Alves, Marcelo
   Aguiar, Renato S.
TI MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus
   Infection
SO ASN NEURO
LA English
DT Article
DE miRNAs; microcephaly; neuroblastoma; postmortem brain autopsies; Zika
ID INVASION; BRAIN; CELLS; MIGRATION; PATHOLOGY; MIR-148A; REVEALS;
   MITOSIS; GROWTH; MODEL
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) member of the Flaviviridae family, which has been associated with the development of the congenital Zika syndrome (CZS). RNA viruses, such as flaviviruses, have been reported to exert a profound impact on host microRNAs (miRNAs). Cellular miRNAs modulated by ZIKV may help identify cellular pathways of relevance to pathogenesis. Here, we screened 754 human cellular miRNAs modulated by ZIKV infection (Brazilian PE strain) in a neuroblastoma cell line. Seven miRNAs (miR-99a*, miR-126*, miR-190b, miR-361-3p, miR-522-3p, miR-299-5p, and miR-1267) were downregulated during ZIKV infection, while miR-145 was upregulated. Furthermore, 11 miRNAs were exclusively expressed in ZIKV-infected (miR-148a, miR-342-5p, miR-598, and miR-708-3p) or mock cells (miR-208, miR-329, miR-432-5p, miR-488, miR-518b, miR-520g, and miR-767-5p). Furthermore, in silico analysis indicated that some central nervous system, cellular migration, and adhesion function-related biological processes were overrepresented in the list of target genes of the miRNAs regulated in ZIKV-infected cells, especially for miR-145 and miR-148a. The induction of miR-145 and miR-148a was confirmed in postmortem brain samples from stillborn with severe CZS. Finally, we determined the expression regulation of microcephaly related genes through RNA interference pathway caused by ZIKV directly on neuron cells.
C1 [Castro, Fernanda L.; Geddes, Victor E. V.; Monteiro, Fabio L. L.; Goncalves, Raphael M. D. T.; Pezzuto, Paula; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Paquin-Proulx, Dominic] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [Schamber-Reis, Bruno L.; Melo, Adriana] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
   [Azevedo, Girlene S.; Melo, Adriana] Inst Pesquisa Prof Amor Neto, Campina Grande, Brazil.
   [Goncalves, Alessandro L.] Hosp Vera Cruz, Serv Neurol, Belo Horizonte, MG, Brazil.
   [Cunha, Daniela P.; Moreira, Maria Elisabeth L.; Vasconcelos, Zilton F. M.] Inst Fernandes Figueira FIOCRUZ, Rio De Janeiro, Brazil.
   [Chimeli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nixon, Douglas F.] Weill Cornell Med, Div Infect Dis, New York, NY USA.
   [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
RP Aguiar, RS (corresponding author), Lab Virol Mol, Av Carlos Chagas Filho 373,Predio CCS,Bloco A2, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM santanarnt@gmail.com
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Vasconcelos,
   Zilton/AAD-5784-2019; Aguiar, Renato S/G-3542-2015; Nixon,
   Douglas/AAU-5734-2020; Melo, Adriana S O/H-5650-2016
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Vasconcelos,
   Zilton/0000-0002-2193-2224; Aguiar, Renato S/0000-0001-5180-3717; Nixon,
   Douglas/0000-0002-2801-1786; Paquin Proulx, Dominic/0000-0003-1407-3414;
   Lima Monteiro, Fabio Luis/0000-0002-9107-6865; Ribeiro-Alves,
   Marcelo/0000-0002-8663-3364
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440900/2016-6]; council for the Improvement of Higher Education
   (CAPES) [88881.130757/2016-01]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-18/2015]; CAPESCAPES
   [001]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by National Council for Scientific and Technological
   Development (CNPq) grant 440900/2016-6, council for the Improvement of
   Higher Education (CAPES) grant 88881.130757/2016-01 and Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant E-18/2015.
   F.L.C. and V. E. V. G. are funded by CAPES (grant 001).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140
   [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Azouz F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020162
   Bhagat R, 2018, CELL DEATH DIFFER, V25, P1837, DOI 10.1038/s41418-018-0163-y
   Brasil P, 2016, OBSTET GYNECOL SURV, V71, P331, DOI 10.1097/01.ogx.0000483239.08585.8d
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034
   Chen ZT, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.572.6270
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Donzelli S, 2015, ONCOTARGET, V6, P35183, DOI 10.18632/oncotarget.5930
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ferreira RN, 2018, VIRAL IMMUNOL, V31, P583, DOI 10.1089/vim.2017.0186
   Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hu CW, 2013, J PROTEOME RES, V12, P3993, DOI 10.1021/pr400302w
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kakumani PK, 2016, GENE, V586, P7, DOI 10.1016/j.gene.2016.03.053
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumar M, 2014, VIROLOGY, V452, P143, DOI 10.1016/j.virol.2014.01.004
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054652
   Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McLean E, 2017, LIBYAN J MED, V12, DOI 10.1080/19932820.2017.1304505
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Muti P, 2014, CANCER EPIDEM BIOMAR, V23, P2471, DOI 10.1158/1055-9965.EPI-14-0398
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Romero DM, 2018, SEMIN CELL DEV BIOL, V76, P33, DOI 10.1016/j.semcdb.2017.09.031
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sachdeva M, 2010, AM J TRANSL RES, V2, P170
   Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511
   Shalev SA, 2014, PEDIATR DIABETES, V15, P252, DOI 10.1111/pedi.12086
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Zhang HJ, 2019, MOL NEUROBIOL, V56, P4072, DOI 10.1007/s12035-018-1358-4
   Zhang L, 2017, INT J CLIN EXP PATHO, V10, P8361
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
NR 62
TC 2
Z9 2
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1759-0914
J9 ASN NEURO
JI ASN Neuro
PD JUN
PY 2019
VL 11
AR 1759091419850983
DI 10.1177/1759091419850983
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA IE1TZ
UT WOS:000472170000001
PM 31213064
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Monteiro, C
   Fernandes, G
   Kasahara, TM
   Barros, PO
   Dias, ASO
   Araujo, ACRA
   Ornelas, AMM
   Aguiar, RS
   Alvarenga, R
   Bento, CAM
AF Monteiro, Clarice
   Fernandes, Gabriel
   Kasahara, Taissa M.
   Barros, Priscila O.
   Dias, Aleida S. O.
   Araujo, Ana Carolina R. A.
   Ornelas, Alice M. M.
   Aguiar, Renato S.
   Alvarenga, Regina
   Bento, Cleonice A. M.
TI The expansion of circulating IL-6 and IL-17-secreting follicular helper
   T cells is associated with neurological disabilities in neuromyelitis
   optica spectrum disorders
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Neuromyelitis optica spectrum disorders; Aquaporin-4; Folicular helper T
   cell; Cytokines
ID MULTIPLE-SCLEROSIS
AB Due to their function in assisting B cells, T-FH cells may be involved in the production of pathogenic IgG in neuromyelitis optica spectrum disorder (NMOSD). In the present study, the proportion of IL-6(+) and IL-17(+) T-FH cell subsets was higher in NMOSD patients than healthy individuals. The frequency of both T-FH cell subsets were directly associated with disease activity. By contrast, NMOSD patients with a higher proportion of IL-10(+) T-FH cell subsets showed a lower neurological disabilities score. In summary, all findings suggest that expansion of peripheral IL-6(+) and IL-17(+) T-FH cells may be involved in the severity of NMOSD.
C1 [Monteiro, Clarice; Fernandes, Gabriel; Kasahara, Taissa M.; Barros, Priscila O.; Dias, Aleida S. O.; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Monteiro, Clarice; Kasahara, Taissa M.; Dias, Aleida S. O.; Bento, Cleonice A. M.] Univ Estado Rio De Janeiro, Dept Microbiol Immunol & Parasitol, Rio De Janeiro, Brazil.
   [Araujo, Ana Carolina R. A.; Alvarenga, Regina; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Neurol, Rio De Janeiro, RJ, Brazil.
   [Ornelas, Alice M. M.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
RP Bento, CAM (corresponding author), Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
EM cbento@unirio.br
RI de Matos Kasahara, Taissa/AAC-9399-2020; Aguiar, Renato S/G-3542-2015;
   Barros, Priscila O./AAA-3188-2020
OI de Matos Kasahara, Taissa/0000-0002-1366-1049; Aguiar, Renato
   S/0000-0001-5180-3717; Barros, Priscila O./0000-0002-6173-0416
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by Fundacao de Amparo a Pesquisa Carlos Chagas
   Filho (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq).
CR Barros PO, 2016, CLIN EXP IMMUNOL, V183, P480, DOI 10.1111/cei.12733
   Che YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20963
   Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108
   Cobo-Calvo A, 2016, MULT SCLER J, V22, P312, DOI 10.1177/1352458515591071
   Fan X., 2016, MEDIAT INFLAMM, DOI [10.1155/2016/3678152.3678152104, DOI 10.1155/2016/3678152.3678152104]
   Hinson S. R., 2008, J IMMUNOL, V181, P5730
   Jarius S, 2014, CLIN EXP IMMUNOL, V176, P149, DOI 10.1111/cei.12271
   Jasiak-Zatonska M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030273
   Kessler RA, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-015-0387-9
   Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Li YJ, 2015, J NEUROIMMUNOL, V278, P239, DOI 10.1016/j.jneuroim.2014.11.011
   Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917
   Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012
   Onabajo OO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059758
   Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94
   Rasmussen T. K., 2008, IMMUNOLOGY, V181, P6038
   Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411
   Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101
   Sawaf M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5767106
   Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447
   Wang HH, 2011, J CLIN NEUROSCI, V18, P1313, DOI 10.1016/j.jocn.2011.01.031
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038
   Zhao C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00104
NR 25
TC 5
Z9 5
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD MAY 15
PY 2019
VL 330
BP 12
EP 18
DI 10.1016/j.jneuroim.2019.01.015
PG 7
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA HU1UK
UT WOS:000465057100003
PM 30769212
DA 2020-10-22
ER

PT J
AU Naveca, FG
   Claro, I
   Giovanetti, M
   de Jesus, JG
   Xavier, J
   Iani, FCD
   do Nascimento, VA
   de Souza, VC
   Silveira, PP
   Lourenco, J
   Santillana, M
   Kraemer, MUG
   Quick, J
   Hill, SC
   Theze, J
   Carvalho, RDD
   Azevedo, V
   Salles, FCD
   Nunes, MRT
   Lemos, PD
   Candido, DD
   Pereira, GD
   Oliveira, MAA
   Meneses, CAR
   Maito, RM
   Cunha, CRS
   Campos, DPD
   Castilho, MD
   Siqueira, TCD
   Terra, TM
   de Albuquerque, CFC
   da Cruz, LN
   de Abreu, AL
   Martins, DV
   Simoes, DSDV
   de Aguiar, RS
   Luz, SLB
   Loman, N
   Pybus, OG
   Sabino, EC
   Okumoto, O
   Alcantara, LCJ
   Faria, NR
AF Naveca, Felipe Gomes
   Claro, Ingra
   Giovanetti, Marta
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   de Melo Iani, Felipe Campos
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   Silveira, Paola Paz
   Lourenco, Jose
   Santillana, Mauricio
   Kraemer, Moritz U. G.
   Quick, Josh
   Hill, Sarah C.
   Theze, Julien
   de Oliveira Carvalho, Rodrigo Dias
   Azevedo, Vasco
   da Silva Salles, Flavia Cristina
   Teixeira Nunes, Marcio Roberto
   Lemos, Poliana da Silva
   Candido, Darlan da Silva
   Pereira, Glauco de Carvalho
   Assuncao Oliveira, Marluce Aparecida
   Ribeiro Meneses, Catia Alexandra
   Maito, Rodrigo Melo
   Santa Brigida Cunha, Claudeth Rocha
   de Sousa Campos, Daniela Palha
   Castilho, Marcia da Costa
   da Silva Siqueira, Thalita Caroline
   Terra, Tiza Matos
   Campelo de Albuquerque, Carlos F.
   da Cruz, Laura Nogueira
   de Abreu, Andre Luis
   Martins, Divino Valerio
   de Moraes Vanlume Simoes, Daniele Silva
   de Aguiar, Renato Santana
   Bessa Luz, Sergio Luiz
   Loman, Nicholas
   Pybus, Oliver G.
   Sabino, Ester C.
   Okumoto, Osnei
   Junior Alcantara, Luiz Carlos
   Faria, Nuno Rodrigues
TI Genomic, epidemiological and digital surveillance of Chikungunya virus
   in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; POPULATION-DYNAMICS; MATO-GROSSO; ZIKA VIRUS; OUTBREAK;
   INFERENCE; EMERGENCE; OROPOUCHE; DISEASE; ILLNESS
AB Background Since its first detection in the Caribbean in late 2013, chikungunya virus (CHIKV) has affected 51 countries in the Americas. The CHIKV epidemic in the Americas was caused by the CHIKV-Asian genotype. In August 2014, local transmission of the CHIKV-Asian genotype was detected in the Brazilian Amazon region. However, a distinct lineage, the CHIKV-East-Central-South-America (ECSA)-genotype, was detected nearly simultaneously in Feira de Santana, Bahia state, northeast Brazil. The genomic diversity and the dynamics of CHIKV in the Brazilian Amazon region remains poorly understood despite its importance to better understand the epidemiological spread and public health impact of CHIKV in the country.
   Methodology/Principal findings We report a large CHIKV outbreak (5,928 notified cases between August 2014 and August 2018) in Boa vista municipality, capital city of Roraima's state, located in the Brazilian Amazon region. We generated 20 novel CHIKV-ECSA genomes from the Brazilian Amazon region using MinION portable genome sequencing. Phylogenetic analyses revealed that despite an early introduction of the Asian genotype in 2015 in Roraima, the large CHIKV outbreak in 2017 in Boa Vista was caused by an ECSA-lineage most likely introduced from northeastern Brazil. Epidemiological analyses suggest a basic reproductive number of R-0 of 1.66, which translates in an estimated 39 (95% CI: 36 to 45) % of Roraima's population infected with CHIKV-ECSA. Finally, we find a strong association between Google search activity and the local laboratory-confirmed CHIKV cases in Roraima.
   Conclusions/Significance This study highlights the potential of combining traditional surveillance with portable genome sequencing technologies and digital epidemiology to inform public health surveillance in the Amazon region. Our data reveal a large CHIKV-ECSA outbreak in Boa Vista, limited potential for future CHIKV outbreaks, and indicate a replacement of the Asian genotype by the ECSA genotype in the Amazon region.
C1 [Naveca, Felipe Gomes; do Nascimento, Valdinete Alves; de Souza, Victor Costa; Bessa Luz, Sergio Luiz] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Claro, Ingra; da Silva Salles, Flavia Cristina; Sabino, Ester C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Giovanetti, Marta; de Jesus, Jaqueline Goes; Xavier, Joilson; Junior Alcantara, Luiz Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; de Melo Iani, Felipe Campos; de Oliveira Carvalho, Rodrigo Dias; Azevedo, Vasco; Pereira, Glauco de Carvalho; Assuncao Oliveira, Marluce Aparecida; Junior Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.
   [de Jesus, Jaqueline Goes; Xavier, Joilson] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol Expt, Salvador, BA, Brazil.
   [de Melo Iani, Felipe Campos] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Silveira, Paola Paz; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Lourenco, Jose; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Candido, Darlan da Silva; Pybus, Oliver G.; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
   [Santillana, Mauricio] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.
   [Santillana, Mauricio] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Quick, Josh; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Teixeira Nunes, Marcio Roberto; Lemos, Poliana da Silva] Brazilian Minist Hlth, Evandro Chagas Inst, Ananindeua, Brazil.
   [Ribeiro Meneses, Catia Alexandra; Maito, Rodrigo Melo; Santa Brigida Cunha, Claudeth Rocha] Lab Cent Saude Publ, Boa Vista, Roraima, Brazil.
   [de Sousa Campos, Daniela Palha; da Silva Siqueira, Thalita Caroline] Secretaria Municipal Saude Boa Vista, Superintendencia Vigilancia Saude, Roraima, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tiza Matos] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [da Cruz, Laura Nogueira; de Abreu, Andre Luis; Martins, Divino Valerio; de Moraes Vanlume Simoes, Daniele Silva; Okumoto, Osnei] MS, SVS, Brasilia, DF, Brazil.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Genet Celular & Mol, Belo Horizonte, MG, Brazil.; Faria, NR (corresponding author), Univ Oxford, Dept Zool, South Parks Rd, Oxford, England.
EM luiz.alcantara@ioc.fiocruz.br; nuno.faria@zoo.ox.ac.uk
RI Aguiar, Renato S/G-3542-2015; Giovanetti, Marta/AAK-7408-2020; Faria,
   Nuno R/I-2975-2012; Azevedo, Vasco A/B-1556-2019; Sabino, Ester
   Cerdeira/F-7750-2010; Pybus, Oliver G/B-2640-2012; Nascimento, Valdinete
   Alves do/AAV-1879-2020; Loman, Nicholas/Z-1573-2019
OI Aguiar, Renato S/0000-0001-5180-3717; Faria, Nuno R/0000-0001-8839-2798;
   Azevedo, Vasco A/0000-0002-4775-2280; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Pybus, Oliver G/0000-0002-8797-2667;
   Nascimento, Valdinete Alves do/0000-0002-7786-4718;
   /0000-0002-8529-4022; da Silva Candido, Darlan/0000-0002-5080-3130;
   Souza, Victor Costa de/0000-0002-3869-1519; Alcantara,
   Luiz/0000-0002-6769-9931; Iani, Felipe/0000-0002-3629-8529; Hill,
   Sarah/0000-0002-2995-2596; Xavier, Joilson/0000-0003-3916-2018;
   Lourenco, Jose/0000-0002-9318-2581; Luz, Sergio Luiz
   Bessa/0000-0001-5887-7372; Theze, Julien/0000-0001-8188-9494; Carvalho,
   Rodrigo/0000-0003-0216-7173; da Silva Sales, Flavia
   Cristina/0000-0002-9048-0030
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [440685/2016-8, 440856/2016-7]; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES [88887.130716/2016-00,
   88881.130825/2016-00, 88887.130823/2016-00]; EU's Horizon 2020 Programme
   through ZIKAlliance [PRES-005-FEX-17-4-2-33]; Royal SocietyRoyal Society
   of London; Wellcome Trust Sir Henry Dale Fellowship [204311/Z/16/Z];
   John Fell Research Fund [005166]; ERCEuropean Research Council (ERC)
   [614725-PATHPHYLODYN]; National Institute of General Medical Sciences of
   the NIH (USA) [R01GM130668]; internal GCRF grant [005073]
FX The ZIBRA-2 project is funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant 440685/2016-8) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (grant
   88887.130716/2016-00). FGN is funded by Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br, grant
   440856/2016-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (http://www.capes.gov.br, grants 88881.130825/2016-00 and
   88887.130823/2016-00). L.C.J.A. is supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant PRES-005-FEX-17-4-2-33). N.R.F. is
   funded by a Royal Society and Wellcome Trust Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN). MS was partially supported by the
   National Institute of General Medical Sciences of the NIH (USA) under
   award number R01GM130668. The funders had no role in study design, data
   collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2015, PUBMED, V7, pe141
   [Anonymous], 2017, EMERGING INFECTIOUS, V23, ps6
   [Anonymous], 2015, PUBMED, V31, P43
   [Anonymous], 2016, PLOS CURRENTS OUTBRE, V39, pS1, DOI 10.2337/dc16-S001
   [Anonymous], 2015, PUBMED, V4, pA1
   [Anonymous], 2010, EURO SURVEILLANCE, V15, pe1936
   [Anonymous], 2016, PUBMED, V44, pD7
   [Anonymous], 2016, EVOLUTION, V2, pA49
   [Anonymous], 2016, PUBMED, V21, piii
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Brunini S, 2017, EMERG INFECT DIS, V23, P1025, DOI 10.3201/eid2306.160929
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carrillo FB, 2019, J VIROL, V93, DOI 10.1128/JVI.01622-18
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Tanabe ELD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860019, 10.1590/s1678-9946201860019]
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Freitas Andre Ricardo Ribas, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.14608e586cd321d8d5088652d7a0d884
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Obolski U, 2018, MVSE R PACKAGE ESTIM, DOI [10.1101/360701, DOI 10.1101/360701]
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Organization PAWH, 2017, NUMB REP CAS CHIK FE
   Pauvolid-Correa A, 2015, MEM I OSWALDO CRUZ, V110, P125, DOI 10.1590/0074-02760140383
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Souza TM, 2017, PLOS CURRENTS, V9, DOI [10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727, DOI 10.1371/CURRENTS.OUTBREAKS.4200119978D62CCAA454599CD27357]
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Team RC, 2014, R LANG ENV COMP
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Vasconcelos PFC, 1992, CIENC CULT-SAO PAULO, V43, P117
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weiss DJ, 2018, NATURE, V553, P333, DOI 10.1038/nature25181
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 79
TC 13
Z9 13
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2019
VL 13
IS 3
AR e0007065
DI 10.1371/journal.pntd.0007065
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HS3YU
UT WOS:000463799300007
PM 30845267
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Rossi, AD
   Faucz, FR
   Melo, A
   Pezzuto, P
   de Azevedo, GS
   Schamber-Reis, BLF
   Tavares, JS
   Mattapallil, JJ
   Tanuri, A
   Aguiar, RS
   Cardoso, CC
   Stratakis, CA
AF Rossi, A. D.
   Faucz, F. R.
   Melo, A.
   Pezzuto, P.
   de Azevedo, G. S.
   Schamber-Reis, B. L. F.
   Tavares, J. S.
   Mattapallil, J. J.
   Tanuri, A.
   Aguiar, R. S.
   Cardoso, C. C.
   Stratakis, C. A.
TI Variations in maternal adenylate cyclase genes are associated with
   congenital Zika syndrome in a cohort from Northeast, Brazil
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE congenital malformations; gene polymorphism; infectious disease;
   virology; zika
ID VIRUS; PATHOGENICITY; ROUTES
AB Background. Vertical transmission of Zika virus (ZIKV) is associated with congenital malformations but the mechanism of pathogenesis remains unclear. Although host genetics appear to play a role, no genetic association study has yet been performed to evaluate this question. In order to investigate if maternal genetic variation is associated with Congenital Zika Syndrome (CZS), we conducted a case-control study in a cohort of Brazilian women infected with ZIKV during pregnancy.
   Methods. A total of 100 women who reported symptoms of zika during pregnancy were enrolled and tested for ZIKV. Among 52 women positive for ZIKV infection, 28 were classified as cases and 24 as controls based on the presence or absence of CZS in their infants. Variations in the coding region of 205 candidate genes involved in cAMP signaling or immune response were assessed by high throughput sequencing and tested for association with development of CZS.
   Results. From the 817 single nucleotide variations (SNVs) included in association analyses, 22 SNVs in 17 genes were associated with CZS under an additive model (alpha=0.05). Variations c.319T>C (rs11676272) and c.1297G>A, located at ADCY3 and ADCY7 genes showed the most prominent effect. The association of ADCY3 and ADCY7 genes was confirmed using a Sequence Kernel Association Test to assess the joint effect of common and rare variations, and results were statistically significant after adjustment for multiple comparisons (P<0.002).
   Conclusion. These results suggest that maternal ADCY genes contribute to ZIKV pathogenicity and influence the outcome of CZS, being promising candidates for further replication studies and functional analysis.
C1 [Rossi, A. D.; Pezzuto, P.; Tanuri, A.; Aguiar, R. S.; Cardoso, C. C.] Univ Fed Rio de Janeiro, Inst Biol, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Faucz, F. R.; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.
   [Melo, A.; de Azevedo, G. S.; Tavares, J. S.] Ctr Univ UniFacisa, Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Schamber-Reis, B. L. F.] Ctr Univ UniFacisa, Fac Ciencias Med Campina Grande, Nucleo Genet Med, Campina Grande, Brazil.
   [Mattapallil, J. J.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD USA.
RP Stratakis, CA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.; Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Lab Virol Mol, Inst Biol, CCS, Av Carlos Chagas Filho 373,Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
EM stratakc@cc1.nichd.nih.gov; stratake@ccl.nichd.nih.gov
RI Rossi, Atila Duque/AAV-6079-2020; Aguiar, Renato S/G-3542-2015; Cardoso,
   Cynthia/K-5824-2012; Stratakis, Constantine A./AAP-4745-2020; Melo,
   Adriana S O/H-5650-2016; Faucz, Fabio R/C-1607-2009
OI Rossi, Atila Duque/0000-0001-6235-8807; Aguiar, Renato
   S/0000-0001-5180-3717; Cardoso, Cynthia/0000-0003-0565-7047; 
FU Intramural Research Program (IRP) of the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development (NICHD) [Z1A HD008920];
   Uniformed Services University (USU) [R0739273]; National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [440900/2016-6];
   National Council for the Improvement of Higher Education (CAPES)CAPES
   [88881.130757/2016-01]
FX This work was supported by the following funds: Intramural Research
   Program (IRP) of the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD) to CAS (Project# Z1A HD008920),
   Uniformed Services University (USU) to JJM (grant# R0739273), National
   Council for Scientific and Technological Development (CNPq -grant #
   440900/2016-6) and National Council for the Improvement of Higher
   Education (CAPES -grant # 88881.130757/2016-01). The authors are
   indebted to the NICHD's IRP Molecular Genomics Core (Dr. Steven Coon,
   Dr. James Iben, and Dr. Li Tianwei). We also thank Biometrix Diagnostica
   for donating kits for serology tests.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08
   FREIREMAIA N, 1957, AM J HUM GENET, V9, P284
   Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045
   Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436
   Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892
   Klein M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00315
   Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007
   Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812
   McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688
   Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162
   Moretti C, 2002, TRENDS ENDOCRIN MET, V13, P428, DOI 10.1016/S1043-2760(02)00632-X
   Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicol X, 2014, EUR J NEUROSCI, V39, P1742, DOI 10.1111/ejn.12543
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Olmos-Ortiz A, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12841
   Price AL, 2012, NATURE REV GENETICS, V11, P1
   Pulliainen AT, 2012, P NATL ACAD SCI USA, V109, P9581, DOI 10.1073/pnas.1117651109
   Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703
   Riva L, 2018, J VIROL, V92, DOI 10.1128/JVI.01982-17
   Santos S, 2014, J COMMUN GENET, V5, P199, DOI 10.1007/s12687-013-0174-9
   Schanton M, 2018, REPRODUCTION, V155, pR1, DOI 10.1530/REP-17-0512
   Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890
   Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Truttmann MC, 2017, TRENDS CELL BIOL, V27, P608, DOI 10.1016/j.tcb.2017.03.004
   Vaser R, 2009, NAT PROTOC, V4, P1073
   Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weedon-Fekjraer MS, 2012, PLACENTA, V33, pS87, DOI 10.1016/j.placenta.2011.11.003
   Weller M, 2012, AM J HUM BIOL, V24, P835, DOI 10.1002/ajhb.22328
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19361
NR 47
TC 5
Z9 5
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2019
VL 285
IS 2
BP 215
EP 222
DI 10.1111/joim.12829
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA HM6IK
UT WOS:000459577200006
PM 30222212
OA Bronze, Green Accepted
DA 2020-10-22
ER

PT J
AU Maniero, VC
   Rangel, PSC
   Coelho, LMC
   Silva, CSB
   Aguiar, RS
   Lamas, CC
   Cardozo, SV
AF Maniero, V. C.
   Rangel, P. S. C.
   Coelho, L. M. C.
   Silva, C. S. B.
   Aguiar, R. S.
   Lamas, C. C.
   Cardozo, S., V
TI Identification of Zika virus in immature phases of Aedes aegypti and
   Aedes albopictus: a surveillance strategy for outbreak anticipation
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Zika virus; Aedes aegypti; Aedes albopictus; Arbovirus; Georeferencing;
   Xenomonitoring
ID DENGUE VIRUSES; VERTICAL TRANSMISSION; MOSQUITOS; CHIKUNGUNYA;
   INFECTION; BRAZIL
AB A progressive increase in the circulation of arboviruses in tropical countries has been observed, accounting for 700,000 yearly deaths in the world. The main objective of this article was to identify the presence of Zika (ZIKV), dengue (DENV), and Chikungunya (CHIKV) viruses in immature stages of Aedes aegypti and Ae. albopictus. Household collections of immature phases of the vectors were carried out in the years 2015 and 2016. A total of 2902 dwellings were visited and the rate of infestation with larvae and pupae of Aedes mosquitoes was 283/1462 (19.4%) in March 2015 and 55/1440 (3.8%) in June 2015. In March 2015, 907 larvae/pupae were collected (583 or 64.3% of Ae. aegypti and 324 or 35.7% of Ae. albopictus) while in June 2015 there was a reduction in the number of immature forms found: 197 larvae/pupae (121 or 61.4% of Ae. aegypti and 76 or 38.6% of Ae. albopictus). This reduction was accompanied by a decrease in suspected human ZIKV cases from March to June 2015. The RT-qPCR performed in 18 pools identified that three (two of Ae. aegypti and one of Ae. albopictus) were positive for ZIKV, and none were positive for DENV or CHIKV. Our findings demonstrated that ZIKV was present in immature stages of insect vectors in the study region at least five months prior to the peak of ZIKV associated cases. Xenomonitoring of immature phases of the vectors may prove useful for predicting outbreaks.
C1 [Maniero, V. C.; Lamas, C. C.; Cardozo, S., V] Univ Grande Rio, Dept Saude, Programa Posgrad Biomed Translac, Duque De Caxias, RJ, Brazil.
   [Rangel, P. S. C.] Univ Grande Rio, Fac Med Vet, Dept Saude, Duque De Caxias, RJ, Brazil.
   [Coelho, L. M. C.] Univ Grande Rio, Fac Med, Dept Saude, Duque De Caxias, RJ, Brazil.
   [Silva, C. S. B.; Aguiar, R. S.] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [Lamas, C. C.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Lamas, C. C.] Inst Nacl Cardiol, Rio De Janeiro, RJ, Brazil.
RP Cardozo, SV (corresponding author), Univ Grande Rio, Dept Saude, Programa Posgrad Biomed Translac, Duque De Caxias, RJ, Brazil.
EM sergianvc@unigranrio.edu.br
RI Lamas, Cristiane/AAV-4157-2020; Aguiar, Renato S/G-3542-2015
OI Lamas, Cristiane/0000-0002-5561-999X; Aguiar, Renato
   S/0000-0001-5180-3717; Cardozo, Sergian/0000-0003-2990-7936; Salgado
   Benvindo da Silva, Clarisse/0000-0002-2244-7992
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [114133/2016-6, 124429/2017-3]; Fundacao de Amparo a Pesquisa no
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
   [E26/201.772/2015]
FX We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Grant Nos. 114133/2016-6 and 124429/2017-3) and Fundacao de
   Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ, Grant No.
   E26/201.772/2015). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2013, LEV RAP IND AED AEG
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Consoli RAG., 1994, PRINCIPAIS MOSQUITOS
   Cruz LCTA, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   da Costa CA, 2009, REV SOC BRAS MED TRO, V42, P677, DOI 10.1590/S0037-86822009000600013
   da Silva NM, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300003, 10.5123/s1679-49742018000300003]
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Joyce AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3226-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   MULLA MS, 1982, APPL ENVIRON MICROB, V43, P1288, DOI 10.1128/AEM.43.6.1288-1293.1982
   PAHO/WHO (Pan American Health Organization/World Health Organization), 2016, ZIK VIR DET AED ALB
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Romero-Vivas CME, 1998, MED VET ENTOMOL, V12, P284, DOI 10.1046/j.1365-2915.1998.00117.x
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   WHO, 2017, INT NEGL TROP DIS GL
   Zeidler Julianna Dias, 2008, Rev. Saúde Pública, V42, P986, DOI 10.1590/s0034-89102008000600002
NR 37
TC 1
Z9 1
U1 2
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2019
VL 52
IS 11
AR e8339
DI 10.1590/1414-431X20198339
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA JO0ZR
UT WOS:000497315700001
PM 31721902
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Ornelas, AMD
   Xavier-de-Carvalho, C
   Alvarado-Arnez, LE
   Ribeiro-Alves, M
   Rossi, AD
   Tanuri, A
   de Aguiar, RS
   Moraes, MO
   Cardoso, CC
AF de Magalhaes Ornelas, Alice Maria
   Xavier-de-Carvalho, Caroline
   Alvarado-Arnez, Lucia Elena
   Ribeiro-Alves, Marcelo
   Rossi, Atila Duque
   Tanuri, Amilcar
   de Aguiar, Renato Santana
   Moraes, Milton Ozorio
   Cardoso, Cynthia Chester
TI Association between MBL2 haplotypes and dengue severity in children from
   Rio de Janeiro, Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE dengue; Polymorphisms; MBL2; CCR5; ITGB3; CLEC5A
ID MANNOSE-BINDING LECTIN; VITAMIN-D; POLYMORPHISMS; RECEPTOR; GENE;
   SUSCEPTIBILITY; CLEC5A
AB BACKGROUND Dengue is an arthropod-borne viral disease with a majority of asymptomatic individuals and clinical manifestations varying from mild fever to severe and potentially lethal forms. An increasing number of genetic studies have outlined the association between host genetic variations and dengue severity. Genes associated to viral recognition and entry, as well as those encoding mediators of the immune response against infection are strong candidates for association studies.
   OBJECTIVES The aim of this study was to investigate the association between MBL2, CLEC5A, ITGB3 and CCR5 genes and dengue severity in children.
   METHODS A matched case-control study was conducted and 19 single nucleotide polymorphisms (SNPs) were investigated.
   FINDINGS No associations were observed in single SNP analysis. However, when MBL2 SNPs were combined in haplotypes, the allele rs7095891G/rs1800450C/ rs1800451C/rs4935047A/rs930509G/rs2120131G/rs2099902C was significantly associated to risk of severe dengue under alpha = 0.05 (aOR = 4.02; p = 0.02). A second haplotype carrying rs4935047G and rs7095891G alleles was also associated to risk (aOR = 1.91; p = 0.04).
   MAIN CONCLUSIONS This is the first study to demonstrate the association between MBL2 haplotypes and dengue severity in Brazilians including adjustment for genetic ancestry. These results reinforce the role of mannose binding lectin in immune response to DENV.
C1 [de Magalhaes Ornelas, Alice Maria; Rossi, Atila Duque; Tanuri, Amilcar; de Aguiar, Renato Santana; Cardoso, Cynthia Chester] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [Xavier-de-Carvalho, Caroline; Alvarado-Arnez, Lucia Elena; Moraes, Milton Ozorio] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST AIDS, Rio De Janeiro, RJ, Brazil.
   [de Magalhaes Ornelas, Alice Maria; Alvarado-Arnez, Lucia Elena] Univ Franz Tamayo, Coordinac Invest, Cochabamba, Bolivia.
RP Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
EM cynthiac@biologia.ufrj.br
RI Arnez, Lucia Elena Alvarado/D-4690-2016; Aguiar, Renato S/G-3542-2015;
   Moraes, Milton Ozorio/G-9753-2011; Rossi, Atila Duque/AAV-6079-2020;
   Cardoso, Cynthia/K-5824-2012
OI Arnez, Lucia Elena Alvarado/0000-0002-3537-6361; Aguiar, Renato
   S/0000-0001-5180-3717; Moraes, Milton Ozorio/0000-0003-2653-0037; Rossi,
   Atila Duque/0000-0001-6235-8807; Cardoso, Cynthia/0000-0003-0565-7047;
   Ribeiro-Alves, Marcelo/0000-0002-8663-3364
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [404241/2012-3]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/010.001562/2014];
   CAPESCAPES [001]
FX CNPq (404241/2012-3), FAPERJ (E-26/010.001562/2014). This study was also
   financed in part by the CAPES (Finance Code 001).
CR Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005
   Adamek M, 2013, TISSUE ANTIGENS, V82, P410, DOI 10.1111/tan.12232
   Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
   Alagarasu K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-86
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brestovac B, 2014, MICROBES INFECT, V16, P518, DOI 10.1016/j.micinf.2014.02.007
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   de Almeida TB, 2018, J ANTIMICROB CHEMOTH, V73, P2460, DOI 10.1093/jac/dky190
   Figueiredo GG, 2016, HUM IMMUNOL, V77, P571, DOI 10.1016/j.humimm.2016.05.006
   Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x
   Kalia N, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2543-4
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lee PH, 2018, HUM GENET, V137, P15, DOI 10.1007/s00439-017-1861-0
   Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102
   Marques RE, 2015, IMMUNOLOGY, V145, P583, DOI 10.1111/imm.12476
   Salles TS, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2830-8
   SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019
   WHO, 2009, DENG GUID DIAGN TREA
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Xavier-Carvalho C, 2017, INFECT GENET EVOL, V56, P99, DOI 10.1016/j.meegid.2017.11.009
   Xavier-Carvalho C, 2017, HUM IMMUNOL, V78, P649, DOI 10.1016/j.humimm.2017.07.013
   Xavier-Carvalho C, 2013, INFECT GENET EVOL, V20, P197, DOI 10.1016/j.meegid.2013.08.017
   Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051
NR 30
TC 4
Z9 4
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e190004
DI 10.1590/0074-02760190004
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IA7UQ
UT WOS:000469763300001
PM 31141020
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Rockstroh, A
   Barzon, L
   Kumbukgolla, W
   Su, HX
   Lizarazo, E
   Vincenti-Gonzalez, MF
   Tami, A
   Ornelas, AMM
   Aguiar, RS
   Cadar, D
   Schmidt-Chanasit, J
   Ulbert, S
AF Rockstroh, Alexandra
   Barzon, Luisa
   Kumbukgolla, Widuranga
   Su, Hoang Xuan
   Lizarazo, Erley
   Vincenti-Gonzalez, Maria Fernanda
   Tami, Adriana
   Ornelas, Alice M. M.
   Aguiar, Renato Santana
   Cadar, Daniel
   Schmidt-Chanasit, Jonas
   Ulbert, Sebastian
TI Dengue Virus IgM Serotyping by ELISA with Recombinant Mutant Envelope
   Proteins
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TESTS
AB We developed an IgM-based ELISA that identifies the dengue virus serotype of recent infections. Dominant serotypes were detectable in 91.1% of samples from travelers and 86.5% of samples from residents of endemic regions; 97.1% corresponded to the serotype identified by PCR. This ELISA enables more accurate reporting of epidemiologic findings.
C1 [Rockstroh, Alexandra] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany.
   [Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
   [Barzon, Luisa] Univ Padua, Padua, Italy.
   [Kumbukgolla, Widuranga] Rajarata Univ Sri Lanka, Mihinthale, Sri Lanka.
   [Su, Hoang Xuan] Vietnam Mil Med Univ, Hanoi, Vietnam.
   [Lizarazo, Erley; Vincenti-Gonzalez, Maria Fernanda; Tami, Adriana] Univ Med Ctr Groningen, Groningen, Netherlands.
   [Ornelas, Alice M. M.; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Cadar, Daniel; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res, Hamburg, Germany.
RP Ulbert, S (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Perlickstr 1, D-04103 Leipzig, Germany.
EM sebastian.ulbert@izi.fraunhofer.de
RI Aguiar, Renato S/G-3542-2015; Barzon, Luisa/K-7961-2016; Lizarazo,
   Erley/AAF-8338-2019
OI Aguiar, Renato S/0000-0001-5180-3717; Barzon, Luisa/0000-0003-0720-8456;
   Lizarazo, Erley/0000-0003-2749-9780; Tami, Adriana/0000-0002-1918-9144;
   Cadar, Daniel/0000-0002-8063-2766
FU European Union (European Funds for Regional Development) [100216415]
FX Parts of this work were supported by the European Union (European Funds
   for Regional Development grant 100216415). S.U. and A.R. are on a patent
   application that includes the proteins described in this study. This
   does not alter their adherence to policies on sharing data and
   materials.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Chabierski S, 2014, DD, V14, P246
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hunsperger EA, 2014, DS, V8, pe3171
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Nawa M, 2000, CLIN DIAGN LAB IMMUN, V7, P774, DOI 10.1128/CDLI.7.5.774-777.2000
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Shu PY, 2004, J CLIN MICROBIOL, V42, P2489, DOI 10.1128/JCM.42.6.2489-2494.2004
   Zidane N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-302
NR 17
TC 3
Z9 4
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2019
VL 25
IS 1
BP 112
EP 115
DI 10.3201/eid2501.180605
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HE6TK
UT WOS:000453546600013
PM 30387417
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Belloto, AC
   Souza, GK
   Perin, PC
   Schuquel, ITA
   Santin, SMO
   Chiavelli, LUR
   Garcia, FP
   Kaplum, V
   Rodrigues, JHS
   Scariot, DB
   Delvecchio, R
   Machado-Ferreira, E
   Aguiar, RS
   Soares, CAG
   Nakamura, CV
   Pomini, AM
AF Belloto, Andrezza C.
   Souza, Gredson K.
   Perin, Paula C.
   Schuquel, Ivania T. A.
   Santin, Silvana M. O.
   Chiavelli, Lucas U. R.
   Garcia, Francielle P.
   Kaplum, Vanessa
   Rodrigues, Jean H. S.
   Scariot, Debora B.
   Delvecchio, Rodrigo
   Machado-Ferreira, Erik
   Aguiar, Renato Santana
   Soares, Carlos A. G.
   Nakamura, Celso V.
   Pomini, Armando M.
TI Crispoic acid, a new compound from Laelia marginata (Orchidaceae), and
   biological evaluations against parasites, human cancer cell lines and
   Zika virus
SO NATURAL PRODUCT RESEARCH
LA English
DT Article
DE Laelia marginata; Leishmania (Leishmania) amazonensis; bioactive
   metabolites; cytotoxicity; Trypanosoma cruzi; Zika virus; Orchidaceae
ID CONSTITUENTS
AB The phytochemical study of Laelia marginata (Lindl.) L. O. Williams (Orchidaceae) led to the isolation of a new natural product named crispoic acid (1), together with six other known compounds (2-7). The new natural product was identified as a dimer of eucomic acid and was structurally characterised based upon 1D and 2D NMR and HRMS data. Biological assays with plant crude extract, fractions and isolated compounds were performed against two human cancer cell lines (Hela and Siha), and the tropical parasites Trypanosoma cruzi and Leishmania (Leishmania) amazonensis. The phenantrenoid 9,10-dihydro-4-methoxyphenanthren-2,7-diol 2 was active against Hela and Siha cells (CC50 5.86 +/- 0.19 and 20.78 +/- 2.72 mu g/mL, respectively). Sub-lethal concentrations of the flavone rhamnazin 4 were not able to rescue the viability of the Vero cells infected by Zika virus.
   [GRAPHICS]
   .
C1 [Belloto, Andrezza C.; Souza, Gredson K.; Perin, Paula C.; Schuquel, Ivania T. A.; Santin, Silvana M. O.; Chiavelli, Lucas U. R.; Pomini, Armando M.] Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil.
   [Garcia, Francielle P.; Kaplum, Vanessa; Rodrigues, Jean H. S.; Scariot, Debora B.; Nakamura, Celso V.] Univ Estadual Maringa, Dept Ciencias Basicas Saude, Maringa, Parana, Brazil.
   [Delvecchio, Rodrigo; Machado-Ferreira, Erik; Aguiar, Renato Santana; Soares, Carlos A. G.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
RP Pomini, AM (corresponding author), Univ Estadual Maringa, Dept Quim, Maringa, Parana, Brazil.
EM ampomini@uem.br
RI Garcia, Francielle Pelegrin/L-7691-2018; Souza, Gredson
   Keiff/G-2558-2016; Nakamura, Celso Vataru/AAA-5620-2019; Soares, Carlos
   A G/H-9464-2016; Pomini, Armando M/P-1277-2018; Aguiar, Renato
   S/G-3542-2015; Garcia, Francielle Pelegrin/AAY-5608-2020; de Oliveira
   Santin, Silvana Maria/AAD-8707-2019
OI Garcia, Francielle Pelegrin/0000-0001-8966-9154; Souza, Gredson
   Keiff/0000-0001-9724-1131; Soares, Carlos A G/0000-0001-9058-9266;
   Aguiar, Renato S/0000-0001-5180-3717; Garcia, Francielle
   Pelegrin/0000-0001-8966-9154; Botura Scariot,
   Debora/0000-0002-8681-0172; Perin, Paula Cristina/0000-0002-1494-0664
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao
   AraucariaFundacao Araucaria
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior and Fundacao Araucaria.
CR Almeida TL, 2014, QUIM NOVA, V37, P1151
   Brener Z., 1962, REV INST MED TROP SP, V4, P386
   Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0
   CALVERT DJ, 1979, ORG MAGN RESONANCE, V12, P583, DOI 10.1002/mrc.1270121008
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   JONES HG, 1976, B TORREY BOT CLUB, V103, P117, DOI 10.2307/2484886
   Monteiro JA, 2014, PHYTOCHEM LETT, V9, P141, DOI 10.1016/j.phytol.2014.06.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okada M, 2009, TETRAHEDRON, V65, P2136, DOI 10.1016/j.tet.2008.11.097
   Paula VF, 2006, QUIM NOVA, V29, P213, DOI 10.1590/S0100-40422006000200007
   Peraza-Flores LN, 2016, TAXON, V65, P1249, DOI 10.12705/656.3
   Philchenkov A A, 2015, Ukr Biochem J, V87, P122
   Pomini AM, 2012, PLANTA MED, V78, P1169
   Simmler C, 2011, J NAT PROD, V74, P949, DOI 10.1021/np1006636
   Suttleworth FS, 1994, ORQUIDEAS
   Tenorio-Neto ET, 2015, COLLOID POLYM SCI, V293, P3611, DOI 10.1007/s00396-015-3744-z
   TUCHINDA P, 1988, PHYTOCHEMISTRY, V27, P3267, DOI 10.1016/0031-9422(88)80040-2
   Woo Kyeong Wan, 2014, Natural Product Sciences, V20, P91
NR 18
TC 0
Z9 0
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-6419
EI 1478-6427
J9 NAT PROD RES
JI Nat. Prod. Res.
PD DEC 17
PY 2018
VL 32
IS 24
BP 2916
EP 2921
DI 10.1080/14786419.2017.1395428
PG 6
WC Chemistry, Applied; Chemistry, Medicinal
SC Chemistry; Pharmacology & Pharmacy
GA HN0NE
UT WOS:000459884600007
PM 29117727
DA 2020-10-22
ER

PT J
AU Arumugasaamy, N
   Ettehadieh, LE
   Kuo, CY
   Paquin-Proulx, D
   Kitchen, SM
   Santoro, M
   Placone, JK
   Silveira, PP
   Aguiar, RS
   Nixon, DF
   Fisher, JP
   Kim, PCW
AF Arumugasaamy, Navein
   Ettehadieh, Leila E.
   Kuo, Che-Ying
   Paquin-Proulx, Dominic
   Kitchen, Shannon M.
   Santoro, Marco
   Placone, Jesse K.
   Silveira, Paola P.
   Aguiar, Renato S.
   Nixon, Douglas F.
   Fisher, John P.
   Kim, Peter C. W.
TI Biomimetic Placenta-Fetus Model Demonstrating Maternal-Fetal
   Transmission and Fetal Neural Toxicity of Zika Virus
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Hydrogels; Tissue engineering; Placental transport; Zika virus; Tissue
   model
ID IN-VITRO SIMULATION; BIRTH-DEFECTS; CELLS; INFECTION; TRANSPORT;
   ESTABLISHMENT; PROTECTION; ANTIBODIES; BARRIER; WOMEN
AB Recent global epidemics of viral infection such as Zika virus (ZIKV) and associated birth defects from maternal-fetal viral transmission highlights the critical unmet need for experimental models that adequately recapitulates the biology of the human maternal-fetal interface and downstream fetal development. Herein, we report an in vitro biomimetic placenta-fetus model of the maternal-fetal interface and downstream fetal cells. Using a tissue engineering approach, we built a 3D model incorporating placental trophoblast and endothelial cells into an extracellular matrix environment and validated formation of the maternal-fetal interface. We utilized this model to study ZIKV exposure to the placenta and neural progenitor cells. Our results indicated ZIKV infects both trophoblast and endothelial cells, leading to a higher viral load exposed to fetal cells downstream of the barrier. Viral inhibition by chloroquine reduced the amount of virus both in the placenta and transmitted to fetal cells. A sustained downstream neural cell viability in contrast to significantly reduced viability in an acellular model indicates that the placenta sequesters ZIKV consistent with clinical observations. These findings suggest that the placenta can modulate ZIKV exposure-induced fetal damage. Moreover, such tissue models can enable rigorous assessment of potential therapeutics for maternal-fetal medicine.
C1 [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Santoro, Marco; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Santoro, Marco; Fisher, John P.] Univ Maryland, Ctr Engn Complex Tissues, College Pk, MD 20742 USA.
   [Arumugasaamy, Navein; Ettehadieh, Leila E.; Kuo, Che-Ying; Fisher, John P.; Kim, Peter C. W.] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [Paquin-Proulx, Dominic; Kitchen, Shannon M.; Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.
   [Placone, Jesse K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Silveira, Paola P.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.
   [Kim, Peter C. W.] George Washington Univ, Dept Surg, Washington, DC USA.
RP Kim, PCW (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM pcwkim@email.gwu.edu
RI Aguiar, Renato S/G-3542-2015; Nixon, Douglas/AAU-5734-2020; Placone,
   Jesse K/M-6388-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Nixon,
   Douglas/0000-0002-2801-1786; Placone, Jesse K/0000-0002-3464-8177;
   Kitchen, Shannon/0000-0002-1177-8825; Arumugasaamy,
   Navein/0000-0001-5688-0236; Paquin Proulx, Dominic/0000-0003-1407-3414
CR Baba UA, 2014, ANN MED HEALTH SCI R, V4, P298, DOI 10.4103/2141-9248.141975
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003
   Blundell C, 2016, LAB CHIP, V16, P3065, DOI 10.1039/c6lc00259e
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Costa MA, 2016, REPROD BIOMED ONLINE, V32, P14, DOI 10.1016/j.rbmo.2015.10.005
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Elad D, 2014, TRAFFIC, V15, P122, DOI 10.1111/tra.12130
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gedeon C, 2006, PLACENTA, V27, P861, DOI 10.1016/j.placenta.2005.09.001
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang X, 2016, MOL HUM REPROD, V22, P442, DOI 10.1093/molehr/gaw018
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8
   Kuo CY, 2016, ACS BIOMATER SCI ENG, V2, P1817, DOI 10.1021/acsbiomaterials.6b00031
   Leach L, 2002, J ANAT, V200, P599, DOI 10.1046/j.1469-7580.2002.00062.x
   Levkovitz R, 2013, PLACENTA, V34, P699, DOI 10.1016/j.placenta.2013.03.014
   Levkovitz R, 2013, PLACENTA, V34, P708, DOI 10.1016/j.placenta.2013.05.006
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   PATTILLO RA, 1968, CANCER RES, V28, P1231
   Poulsen MS, 2009, TOXICOL IN VITRO, V23, P1380, DOI 10.1016/j.tiv.2009.07.028
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sastry BVR, 1999, ADV DRUG DELIVER REV, V38, P17, DOI 10.1016/S0169-409X(99)00004-6
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 39
TC 13
Z9 13
U1 1
U2 58
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2018
VL 46
IS 12
BP 1963
EP 1974
DI 10.1007/s10439-018-2090-y
PG 12
WC Engineering, Biomedical
SC Engineering
GA HC7QU
UT WOS:000451997300001
PM 30003503
DA 2020-10-22
ER

PT J
AU Valadao, ALC
   Pezzuto, P
   Silva, VAO
   Goncalves, BS
   Rossi, AD
   da Cunha, RD
   Siani, AC
   Tostes, JBD
   Trovo, M
   Damasco, P
   Goncalves, G
   Reis, RM
   Aguiar, RS
   Bento, CAD
   Tanuri, A
AF Chaves Valadao, Ana Luiza
   Pezzuto, Paula
   Oliveira Silva, Viviane A.
   Goncalves, Barbara Simonson
   Rossi, Atila Duque
   da Cunha, Rodrigo Delvecchio
   Siani, Antonio Carlos
   de Freitas Tostes, Joao Batista
   Trovo, Marcelo
   Damasco, Paulo
   Goncalves, Gabriel
   Reis, Rui Manuel
   Aguiar, Renato Santana
   de Melo Bento, Cleonice Alves
   Tanuri, Amilcar
TI Reactivation of latent HIV-1 in vitro using an ethanolic extract from
   Euphorbia umbellata (Euphorbiaceae) latex
SO PLOS ONE
LA English
DT Article
ID PROTEIN-KINASE-C; PHORBOL ESTERS; T-CELLS; INFECTION; GRANTII;
   TIRUCALLI; THERAPY; PHASE
AB Euphorbia umbellata (E. umbellata) belongs to Euphorbiaceae family, popularly known as Janauba, and its latex contains a combination of phorbol esters with biological activities described to different cellular protein kinase C (PKC) isoforms. Here, we identified deoxiphorbol esters present in E. umbellata latex alcoholic extract that are able to increase HIV transcription and reactivate virus from latency models. This activity is probably mediated by NF-kB activation followed by nuclear translocation and binding to the HIV LTR promoter. In addition, E. umbellata latex extract induced the production of pro inflammatory cytokines in vitro in human PBMC cultures. This latex extract also activates latent virus in human PBMCs isolated from HIV positive patients as well as latent SIV in non-human primate primary CD4(+) T lymphocytes. Together, these results indicate that the phorbol esters present in E. umbellata latex are promising candidate compounds for future clinical trials for shock and kill therapies to promote HIV cure and eradication.
C1 [Chaves Valadao, Ana Luiza; Pezzuto, Paula; Rossi, Atila Duque; da Cunha, Rodrigo Delvecchio; Goncalves, Gabriel; Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
   [Oliveira Silva, Viviane A.] Hosp Canc Barretos, Ctr Pesquisa Oncol Mol, Barretos, Brazil.
   [Goncalves, Barbara Simonson; Damasco, Paulo; de Melo Bento, Cleonice Alves] Univ Fed Estado Rio de Janeiro, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil.
   [Siani, Antonio Carlos; de Freitas Tostes, Joao Batista] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Dept Prod Nat, Rio De Janeiro, Brazil.
   [Trovo, Marcelo] Univ Fed Rio de Janeiro, Inst Biol, Dept Bot, Rio De Janeiro, Brazil.
   [Reis, Rui Manuel] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Reis, Rui Manuel] 3Bs PT Govt Associate Lab, ICVS, Braga, Portugal.
   [Chaves Valadao, Ana Luiza] Inst Human Genet, Dept Mol Basis Humans Dis, Mol Basis Inflammat Lab, Montpellier, France.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Mol, Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Silva, Viviane A O/O-1772-2015; /AAD-2097-2020; Siani, Antonio
   C/L-3868-2014; Rossi, Atila Duque/AAV-6079-2020; Aguiar, Renato
   S/G-3542-2015; Trovo, Marcelo/A-1763-2014; Reis, Rui/AAD-6470-2020;
   Tostes, Joao B.F./P-2514-2017; Reis, Rui Manuel/B-1744-2018
OI Rossi, Atila Duque/0000-0001-6235-8807; Aguiar, Renato
   S/0000-0001-5180-3717; Trovo, Marcelo/0000-0002-0478-2332; Reis,
   Rui/0000-0002-9639-7940; Tostes, Joao B.F./0000-0002-6085-365X; Reis,
   Rui Manuel/0000-0002-9639-7940; Silva, Viviane A O/0000-0001-5919-5242;
   Siani, Antonio Carlos/0000-0001-8108-2500
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E26/2015064289];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX Postdoc fellowships and PhD stipends were supported by CNPq and CAPES
   during this work. Research and experimental expenses were funded by the
   grant E26/2015064289 from FAPERJ.; We thank Dr. Thomas Friedrich from
   Virology Services Unit at the Wisconsin National Primate Research
   Center, Wisconsin, USA for QVOA assay using SIVmac239 in NHP
   CD4<SUP>+</SUP> Lymphocytes. We are also grateful to Mr. Wilson Camargo
   Barros Filho and Mr. Luis Antonio Nogueira for providing E. umbellata's
   latex used in this work. This work was sponsored by CNPq, CAPES and
   FAPERJ.
CR Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158
   BAGAVATHI R, 1988, Planta Medica, V54, P506, DOI 10.1055/s-2006-962531
   BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Blackhall FH, 2001, BRIT J CANCER, V84, P465, DOI 10.1054/bjoc.2000.1624
   Campos A, 2016, INT J TOXICOL, V35, P666, DOI 10.1177/1091581816659660
   Coffin J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012526
   Costa LLG, 2012, REV BRAS FARMACOGN, V22, P1070, DOI 10.1590/S0102-695X2012005000050
   Cunha LC, 2009, BRAZILIAN J PHARMACO, V19, P403
   Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109
   Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7
   Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a
   Dutra RC, 2016, PHARMACOL RES, V112, P4, DOI 10.1016/j.phrs.2016.01.021
   El-Mekkawy S, 1998, PHYTOCHEMISTRY, V49, P1651, DOI 10.1016/S0031-9422(98)00254-4
   Fatope MO, 1996, J MED CHEM, V39, P1005, DOI 10.1021/jm950509i
   Franco-Salla GB, 2016, BMC COMPLEM ALTERN M, V16, P1, DOI [10.1186/s12906-015-0973-0, DOI 10.1186/S12906-015-0973-0]
   Gallo RC, 1984, SCIENCE, V224, P3769
   Hartmann D. B., 2011, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V14, P5
   Hassan EM, 2012, REC NAT PROD, V6, P255
   Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807
   Jiang G, 2017, AIDS RES HUM RETROV, P1
   Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188
   Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033
   Kared H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003422
   Kashiwada Y, 1998, J NAT PROD, V61, P1090, DOI 10.1021/np9800710
   Kim HJ, 2011, AM J TRANSL RES, V3, P166
   KINGHORN AD, 1980, J PHARM SCI-US, V69, P1446, DOI 10.1002/jps.2600691228
   Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398
   Levy J A, 2011, Adv Dent Res, V23, P13, DOI 10.1177/0022034511398874
   Lin MW, 2012, FOOD CHEM TOXICOL, V50, P4333, DOI 10.1016/j.fct.2012.05.029
   Loya S, 1999, BIOCHEM J, V344, P85, DOI 10.1042/0264-6021:3440085
   Martiny-Baron G, 1999, J BIOL CHEM, V274, P15320, DOI [10.1074/jbc.274.22.15320, DOI 10.1074/JBC.274.22.15320]
   McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551
   Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160
   Mochly-Rosen D, 1998, FASEB J, V12, P35
   Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197
   Ohtake N, 2004, J CHROMATOGR B, V812, P135, DOI 10.1016/j.jchromb.2004.06.051
   OLIVIER GWJ, 1992, J CHEM SOC PERK T 1, P1831, DOI 10.1039/p19920001831
   Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079
   Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058
   PRAKASH E, 2013, UNI J PLANT SCI, V1, P113, DOI DOI 10.13189/UJPS.2013.010401
   Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52
   Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005
   Siliciano RF, 2018, HIV LATENCY, P1, DOI [10.1101/cshperspect.a007096, DOI 10.1101/CSHPERSPECT.A007096]
   Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097
   Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007
   Tanaka M, 2001, BIOORG MED CHEM LETT, V11, P719, DOI 10.1016/S0960-894X(01)00045-2
   Trushin SA, 2005, J VIROL, V79, P9821, DOI 10.1128/JVI.79.15.9821-9830.2005
   UNAIDS, 2017, GLOB HIV STAT, P1
   UZABAKILIHO B, 1987, PHYTOCHEMISTRY, V26, P3041, DOI 10.1016/S0031-9422(00)84589-6
   Valentine LE, 2009, J VIROL, V83, P11514, DOI 10.1128/JVI.01298-09
   Wang L, 2013, MOL MED REP, V8, P1279, DOI 10.3892/mmr.2013.1650
   Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071
   Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200
   Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003
NR 54
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 27
PY 2018
VL 13
IS 11
AR e0207664
DI 10.1371/journal.pone.0207664
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HB9UV
UT WOS:000451440000018
PM 30481211
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Faria, NR
   Kraemer, MUG
   Hill, SC
   de Jesus, JG
   Aguiar, RS
   Iani, FCM
   Xavier, J
   Quick, J
   du Plessis, L
   Dellicour, S
   Theze, J
   Carvalho, RDO
   Baele, G
   Wu, CH
   Silveira, PP
   Arruda, MB
   Pereira, MA
   Pereira, GC
   Lourenco, J
   Obolski, U
   Abade, L
   Vasylyeva, TI
   Giovanetti, M
   Yi, D
   Weiss, DJ
   Wint, GRW
   Shearer, FM
   Funk, S
   Nikolay, B
   Fonseca, V
   Adelino, TER
   Oliveira, MAA
   Silva, MVF
   Sacchetto, L
   Figueiredo, PO
   Rezende, IM
   Mello, EM
   Said, RFC
   Santos, DA
   Ferraz, ML
   Brito, MG
   Santana, LF
   Menezes, MT
   Brindeiro, RM
   Tanuri, A
   dos Santos, FCP
   Cunha, MS
   Nogueira, JS
   Rocco, IM
   da Costa, AC
   Komninakis, SCV
   Azevedo, V
   Chieppe, AO
   Araujo, ESM
   Mendonca, MCL
   dos Santos, CC
   dos Santos, CD
   Mares-Guia, AM
   Nogueira, RMR
   Sequeira, PC
   Abreu, RG
   Garcia, MHO
   Abreu, AL
   Okumoto, O
   Kroon, EG
   de Albuquerque, CFC
   Lewandowski, K
   Pullan, ST
   Carroll, M
   de Oliveira, T
   Sabino, EC
   Souza, RP
   Suchard, MA
   Lemey, P
   Trindade, GS
   Drumond, BP
   Filippis, AMB
   Loman, NJ
   Cauchemez, S
   Alcantara, LCJ
   Pybus, OG
AF Faria, N. R.
   Kraemer, M. U. G.
   Hill, S. C.
   de Jesus, J. Goes
   Aguiar, R. S.
   Iani, F. C. M.
   Xavier, J.
   Quick, J.
   du Plessis, L.
   Dellicour, S.
   Theze, J.
   Carvalho, R. D. O.
   Baele, G.
   Wu, C. -H.
   Silveira, P. P.
   Arruda, M. B.
   Pereira, M. A.
   Pereira, G. C.
   Lourenco, J.
   Obolski, U.
   Abade, L.
   Vasylyeva, T. I.
   Giovanetti, M.
   Yi, D.
   Weiss, D. J.
   Wint, G. R. W.
   Shearer, F. M.
   Funk, S.
   Nikolay, B.
   Fonseca, V.
   Adelino, T. E. R.
   Oliveira, M. A. A.
   Silva, M. V. F.
   Sacchetto, L.
   Figueiredo, P. O.
   Rezende, I. M.
   Mello, E. M.
   Said, R. F. C.
   Santos, D. A.
   Ferraz, M. L.
   Brito, M. G.
   Santana, L. F.
   Menezes, M. T.
   Brindeiro, R. M.
   Tanuri, A.
   dos Santos, F. C. P.
   Cunha, M. S.
   Nogueira, J. S.
   Rocco, I. M.
   da Costa, A. C.
   Komninakis, S. C. V.
   Azevedo, V.
   Chieppe, A. O.
   Araujo, E. S. M.
   Mendonca, M. C. L.
   dos Santos, C. C.
   dos Santos, C. D.
   Mares-Guia, A. M.
   Nogueira, R. M. R.
   Sequeira, P. C.
   Abreu, R. G.
   Garcia, M. H. O.
   Abreu, A. L.
   Okumoto, O.
   Kroon, E. G.
   de Albuquerque, C. F. C.
   Lewandowski, K.
   Pullan, S. T.
   Carroll, M.
   de Oliveira, T.
   Sabino, E. C.
   Souza, R. P.
   Suchard, M. A.
   Lemey, P.
   Trindade, G. S.
   Drumond, B. P.
   Filippis, A. M. B.
   Loman, N. J.
   Cauchemez, S.
   Alcantara, L. C. J.
   Pybus, O. G.
TI Genomic and epidemiological monitoring of yellow fever virus
   transmission potential
SO SCIENCE
LA English
DT Article
ID SPREAD; BRAZIL; ANGOLA
AB The yellow fever virus (YFV) epidemic in Brazil is the largest in decades. The recent discovery of YFV in Brazilian Aedes species mosquitos highlights a need to monitor the risk of reestablishment of urban YFV transmission in the Americas. We use a suite of epidemiological, spatial, and genomic approaches to characterize YFV transmission. We show that the age and sex distribution of human cases is characteristic of sylvatic transmission. Analysis of YFV cases combined with genomes generated locally reveals an early phase of sylvatic YFV transmission and spatial expansion toward previously YFV-free areas, followed by a rise in viral spillover to humans in late 2016. Our results establish a framework for monitoring YFV transmission in real time that will contribute to a global strategy to eliminate future YFV epidemics.
C1 [Faria, N. R.; Kraemer, M. U. G.; Hill, S. C.; du Plessis, L.; Theze, J.; Lourenco, J.; Obolski, U.; Abade, L.; Vasylyeva, T. I.; Wint, G. R. W.; Pybus, O. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Kraemer, M. U. G.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA.
   [Kraemer, M. U. G.] Harvard Med Sch, Dept Pediat, Boston, MA USA.
   [de Jesus, J. Goes; Xavier, J.; Giovanetti, M.; Araujo, E. S. M.; Mendonca, M. C. L.; dos Santos, C. C.; dos Santos, C. D.; Mares-Guia, A. M.; Nogueira, R. M. R.; Sequeira, P. C.; de Oliveira, T.; Filippis, A. M. B.; Alcantara, L. C. J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Aguiar, R. S.; Silveira, P. P.; Arruda, M. B.; Menezes, M. T.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Iani, F. C. M.; Pereira, M. A.; Pereira, G. C.; Adelino, T. E. R.; Oliveira, M. A. A.; Silva, M. V. F.] FUNED, Inst Octavio Magalhaes, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Iani, F. C. M.; Carvalho, R. D. O.; Giovanetti, M.; Fonseca, V.; Sacchetto, L.; Figueiredo, P. O.; Rezende, I. M.; Mello, E. M.; Azevedo, V.; Kroon, E. G.; Trindade, G. S.; Drumond, B. P.; Alcantara, L. C. J.] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Quick, J.; Loman, N. J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [Dellicour, S.; Baele, G.; Lemey, P.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Leuven, Belgium.
   [Wu, C. -H.] Univ Oxford, Dept Stat, Oxford, England.
   [Abade, L.] Univ Oxford, Global Hlth Network, Oxford, England.
   [Yi, D.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
   [Weiss, D. J.; Shearer, F. M.] Univ Oxford, Nuffield Dept Med, Big Data Inst, Malaria Atlas Project, Oxford, England.
   [Funk, S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, Ctr Bioinformat, Paris, France.
   [Nikolay, B.; Cauchemez, S.] Inst Pasteur, CNRS, Genom Evolut Modelisat & Sante UMR2000, Paris, France.
   [Fonseca, V.; de Oliveira, T.] Univ KwaZulu Natal, KwaZulu Natal Res Innovat & Sequencing Platform K, Sch Lab Med & Med Sci, Durban, South Africa.
   [Said, R. F. C.; Santos, D. A.; Ferraz, M. L.; Brito, M. G.; Santana, L. F.] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil.
   [dos Santos, F. C. P.; Cunha, M. S.; Nogueira, J. S.; Rocco, I. M.; Souza, R. P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
   [Komninakis, S. C. V.] Sch Med ABC FMABC, Clin Immunol Lab, Santo Andre, SP, Brazil.
   [Chieppe, A. O.] Coordenacao Vigilancia Epidemiol Estado Rio de Ja, Rio De Janeiro, Brazil.
   [Abreu, R. G.; Garcia, M. H. O.] Minist Saude, Dept Vigilancia Doencas Transmissiveis, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Abreu, A. L.; Okumoto, O.] Minist Saude, Secretaria Vigilancia Saude, Coordenacao Geral Labs Saude Publ, Brasilia, DF, Brazil.
   [de Albuquerque, C. F. C.] OMS, OPAS, Brasilia, DF, Brazil.
   [Lewandowski, K.; Pullan, S. T.] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Carroll, M.] Publ Hlth England, NIHR HPRU Emerging & Zoonot Infect, London, England.
   [de Oliveira, T.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.
   [Suchard, M. A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA.
   [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Human Genet, Los Angeles, CA 90095 USA.
RP Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Alcantara, LCJ (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Alcantara, LCJ (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
EM nuno.faria@zoo.ox.ac.uk; luiz.alcantara@ioc.fiocruz.br;
   oliver.pybus@zoo.ox.ac.uk
RI Azevedo, Vasco A.C/F-4315-2011; Sacchetto, Livia/B-8841-2019;
   Komninakis, Shirley V/B-2915-2010; Fonseca, Vagner/R-5813-2019; Faria,
   Nuno R/I-2975-2012; Giovanetti, Marta/AAK-7408-2020; Funk,
   Stefan/B-7629-2015; Azevedo, Vasco A/B-1556-2019; da-Costa, Antonio
   Charlys/G-1548-2010; Pybus, Oliver G/B-2640-2012; Rezende, Izabela
   Mauricio/AAL-5766-2020; Sabino, Ester Cerdeira/F-7750-2010; Dellicour,
   Simon/AAE-9054-2020; Loman, Nicholas/Z-1573-2019; Kroon,
   Erna/V-5444-2019; Aguiar, Renato S/G-3542-2015; Baele, Guy/R-8157-2017;
   du Plessis, Louis/K-1667-2013
OI Azevedo, Vasco A.C/0000-0002-4775-2280; Sacchetto,
   Livia/0000-0001-9716-6899; Komninakis, Shirley V/0000-0001-7784-3418;
   Fonseca, Vagner/0000-0001-5521-6448; Faria, Nuno R/0000-0001-8839-2798;
   Funk, Stefan/0000-0002-2012-0080; Azevedo, Vasco A/0000-0002-4775-2280;
   da-Costa, Antonio Charlys/0000-0001-5516-5177; Pybus, Oliver
   G/0000-0002-8797-2667; Rezende, Izabela Mauricio/0000-0003-2616-6300;
   Sabino, Ester Cerdeira/0000-0003-2623-5126; Dellicour,
   Simon/0000-0001-9558-1052; Aguiar, Renato S/0000-0001-5180-3717; Pullan,
   Steven/0000-0002-8983-599X; Vasylyeva, Tetyana/0000-0002-9736-7022;
   Theze, Julien/0000-0001-8188-9494; Wu, Chieh-Hsi/0000-0001-9386-725X;
   Alcantara, Luiz/0000-0002-6769-9931; Baele, Guy/0000-0002-1915-7732;
   Xavier, Joilson/0000-0003-3916-2018; De Jesus,
   Jaqueline/0000-0002-5404-272X; Carvalho, Rodrigo/0000-0003-0216-7173;
   Hill, Sarah/0000-0002-2995-2596; du Plessis, Louis/0000-0003-0352-6289;
   Pereira de Souza, Renato/0000-0003-1315-7085; Iani,
   Felipe/0000-0002-3629-8529; Funk, Sebastian/0000-0002-2842-3406
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [400354/2016-0]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2016/01735-2, 2017/00021-9]; Sir Henry Dale Fellowship
   [204311/Z/16/Z]; internal GCRF grant [005073]; John Fell Research Fund
   [005166]; ERCEuropean Research Council (ERC) [614725-PATHPHYLODYN];
   Oxford Martin School; Branco Weiss Fellowship; National Institute of
   Child Health and Human DevelopmentUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Eunice
   Kennedy Shriver National Institute of Child Health & Human Development
   (NICHD) [T32HD040128]; National Library of Medicine of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [R01LM010812, R01LM011965]; Fonds Wetenschappelijk
   Onderzoek (FWO, Flanders, Belgium)FWO; Interne Fondsen KU
   Leuven/Internal Funds KU Leuven; EU's Horizon 2020 Programme through
   ZIKAlliance [734548]; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; AXA Research Fund; Association Robert Debre; European
   Research CouncilEuropean Research Council (ERC) [725422-ReservoirDOCS];
   Wellcome TrustWellcome Trust [206298/Z/17/Z]; Research Foundation,
   Flanders (Fonds voor Wetenschappelijk Onderzoek, Vlaanderen)FWO
   [G066215N, G0D5117N, G0B9317N]
FX This work was supported in part by CNPq 400354/2016-0 and FAPESP
   2016/01735-2. N.R.F. is supported by a Sir Henry Dale Fellowship
   (204311/Z/16/Z), internal GCRF grant 005073, and John Fell Research Fund
   grant 005166. This research received funding from the ERC (grant
   agreement 614725-PATHPHYLODYN) and from the Oxford Martin School.
   M.U.G.K. acknowledges funding from a Branco Weiss Fellowship,
   administered by ETH Zurich, a Training Grant from the National Institute
   of Child Health and Human Development (T32HD040128), and the National
   Library of Medicine of the National Institutes of Health (R01LM010812
   and R01LM011965). S.D. is funded by the Fonds Wetenschappelijk Onderzoek
   (FWO, Flanders, Belgium). G.B. acknowledges support from the Interne
   Fondsen KU Leuven/Internal Funds KU Leuven. A.C.d.C. is funded by FAPESP
   2017/00021-9. B.B.N. and S.C. are supported by the EU's Horizon 2020
   Programme through ZIKAlliance (grant 734548), the Investissement
   d'Avenir program, the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, the AXA Research Fund, and the Association
   Robert Debre. P.L. and M.A.S. acknowledge funding from the European
   Research Council (grant agreement 725422-ReservoirDOCS) and from the
   Wellcome Trust Collaborative Award 206298/Z/17/Z. P.L. acknowledges
   support from the Research Foundation, Flanders (Fonds voor
   Wetenschappelijk Onderzoek, Vlaanderen, G066215N, G0D5117N, and
   G0B9317N).
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Camara FP, 2011, REV SOC BRAS MED TRO, V44, P297, DOI [10.1590/S0037-86822011005000024, 10.1590/s0037-86822011005000024]
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   CHANG GJJ, 1995, J VIROL, V69, P5773, DOI 10.1128/JVI.69.9.5773-5780.1995
   Consoli RAG., 1994, PRINCIPAIS MOSQUITOS
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   do Nascimento Rafaela Almeida, 2013, Neotropical Biology and Conservation, V8, P79, DOI 10.4013/nbc.2013.82.03
   Dudas G, 2018, ELIFE, V7, DOI [10.7554/elife.37324, 10.7554/eLife.31257, 10.7554/eLife.37324]
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3
   Franco O., 1969, HIST FEBRE AMARELA B
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gill MS, 2016, SYST BIOL, V65, P1041, DOI 10.1093/sysbio/syw050
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Jung L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129789
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067
   Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   Nunes MRT, 2012, J VIROL, V86, P13263, DOI 10.1128/JVI.00565-12
   PAHO, 2009, OUTBR YELL FEV PAR
   Pan American Health Organization/World Health Organization, 2018, EP UPD YELL FEV 16 F
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Segura M. N. O., 2007, ATLAS CULICIDEOS AMA, V167
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stephens PR, 2017, ECOLOGY, V98, P1476, DOI 10.1002/ecy.1799
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vainio J., 1998, YELLOW FEVER
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vaughan TG, 2014, BIOINFORMATICS, V30, P2272, DOI 10.1093/bioinformatics/btu201
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81236-0
   Wang E, 1996, VIROLOGY, V225, P274, DOI 10.1006/viro.1996.0601
NR 49
TC 74
Z9 75
U1 1
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 31
PY 2018
VL 361
IS 6405
BP 894
EP +
DI 10.1126/science.aat7115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3UB
UT WOS:000443547000033
PM 30139911
OA Green Accepted, Bronze
DA 2020-10-22
ER

PT J
AU Geddes, VEV
   de Oliveira, AS
   Tanuri, A
   Arruda, E
   Ribeiro-Alves, M
   Aguiar, RS
AF Viana Geddes, Victor Emmanuel
   de Oliveira, Anibal Silva
   Tanuri, Amilcar
   Arruda, Eurico
   Ribeiro-Alves, Marcelo
   Aguiar, Renato Santana
TI MicroRNA and cellular targets profiling reveal miR-217 and miR-576-3p as
   proviral factors during Oropouche infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; TRANSPORTER EXPRESSION; VIRUS-INFECTION;
   THP-1 CELLS; HELA-CELLS; GENES; TRANSLATION; IDENTIFICATION; APOPTOSIS;
   HIV-1
AB Oropouche Virus is the etiological agent of an arbovirus febrile disease that affects thousands of people and is widespread throughout Central and South American countries. Although isolated in 1950's, still there is scarce information regarding the virus biology and its prevalence is likely underestimated. In order to identify and elucidate interactions with host cells factors and increase the understanding about the Oropouche Virus biology, we performed microRNA (miRNA) and target genes screening in human hepatocarcinoma cell line HuH-7. Cellular miRNAs are short non-coding RNAs that regulates gene expression post-transcriptionally and play key roles in several steps of viral infections. The large scale RT-qPCR based screening found 13 differentially expressed miRNAs in Oropouche infected cells. Further validation confirmed that miR-217 and miR-576-3p were 5.5 fold up-regulated at early stages of virus infection (6 hours post-infection). Using bioinformatics and pathway enrichment analysis, we predicted the cellular targets genes for miR-217 and miR-576-3p. Differential expression analysis of RNA from 95 selected targets revealed genes involved in innate immunity modulation, viral release and neurological disorder outcomes. Further analysis revealed the gene of decapping protein 2 (DCP2), a previous known restriction factor for bunyaviruses transcription, as a miR-217 candidate target that is progressively down-regulated during Oropouche infection. Our analysis also showed that activators genes involved in innate immune response through IFN-beta pathway, as STING (Stimulator of Interferon Genes) and TRAF3 (TNF-Receptor Associated Factor 3), were down-regulated as the infection progress. Inhibition of miR-217 or miR-576-3p restricts OROV replication, decreasing viral RNA (to up 8.3 fold) and virus titer (3 fold). Finally, we showed that virus escape IFN-beta mediated immune response increasing the levels of cellular miR-576-3p resulting in a decreasing of its partners STING and TRAF3. We concluded stating that the present study, the first for a Peribunyaviridae member, gives insights in its prospective pathways that could help to understand virus biology, interactions with host cells and pathogenesis, suggesting that the virus escapes the antiviral cellular pathways increasing the expression of cognates miRNAs.
C1 [Viana Geddes, Victor Emmanuel; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Oliveira, Anibal Silva; Arruda, Eurico] Univ Sao Paulo, Dept Biol Celular & Mol, Ctr Pesquisa Virol, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Ribeiro-Alves, Marcelo] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
EM santana@biologia.ufrj.br
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Ribeiro-Alves,
   Marcelo/0000-0002-8663-3364
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJCarlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [E-26/010.001562/2014, 210.022/2014]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPESCAPES [1545985]
FX This work was supported by funding from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro - FAPERJ (www.faperj.br) under the grant
   number: E-26/010.001562/2014, Ref.: 210.022/2014. RSA and AT were
   recipient of that funding. VEVG was recipient of a fellowship granted by
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES
   (www.capes.gov.br) under the grant number: 1545985. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013
   Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   [Anonymous], 2016, ICTV VIRUS TAXONOMY
   Araujo R, 1978, Rev Inst Med Trop Sao Paulo, V20, P45
   Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710
   Basso D, 2009, STATISTICS, V194, P1
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783
   Bourens M, 2017, J BIOL CHEM
   Cao MW, 2017, J IMMUNOL, V198, P1887, DOI 10.4049/jimmunol.1600622
   Chen J, 2017, J VIROL, V91, DOI 10.1128/JVI.01311-16
   Luna LKD, 2017, J MED VIROL, V89, P1108, DOI 10.1002/jmv.24722
   Demir ZC, 2017, J MED VIROL, V89, P417, DOI 10.1002/jmv.24667
   Deng SC, 2014, CANCER LETT, V355, P184, DOI 10.1016/j.canlet.2014.08.007
   Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049
   Ding SW, 2011, CURR OPIN VIROL, V1, P533, DOI 10.1016/j.coviro.2011.10.028
   DIXON KE, 1981, AM J TROP MED HYG, V30, P161, DOI 10.4269/ajtmh.1981.30.161
   Elliott RM, 2013, FIELDS VIROLOGY, P2664
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Fotheringham J, 2008, J NEUROIMMUNE PHARM, V3, P105, DOI 10.1007/s11481-007-9084-0
   Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023
   Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002
   He J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21663
   Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244
   Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113
   Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639
   Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102
   Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10
   Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kapinas K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3325
   Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lin CH, 2016, ONCOTARGET, V7, P49498, DOI 10.18632/oncotarget.10374
   Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11
   Martin HC, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r51
   Meier R, 2014, J VIROL, V88, P8565, DOI 10.1128/JVI.00388-14
   Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Najimi M, 2014, WORLD J GASTROENTERO, V20, P1554, DOI 10.3748/wjg.v20.i6.1554
   Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nayak TK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010003
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Paschou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046773
   Pepini T, 2010, J VIROL, V84, P11929, DOI 10.1128/JVI.01658-10
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P172, DOI 10.4269/ajtmh.1981.30.172
   PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036
   Proenca-Modena JL, 2015, J VIROL, V89, P4720, DOI 10.1128/JVI.00077-15
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227
   Rodrigues AH, 2011, VIRUS RES, V155, P35, DOI 10.1016/j.virusres.2010.08.009
   Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704
   Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104
   Santos RI, 2012, VIRUS RES, V170, P25, DOI 10.1016/j.virusres.2012.07.006
   Santos RIM, 2008, VIRUS RES, V138, P139, DOI 10.1016/j.virusres.2008.08.016
   Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210
   Schoen A, 2015, EUR J CELL BIOL, V94, P384, DOI 10.1016/j.ejcb.2015.06.001
   Shao Y, 2016, DIABETES-METAB RES, V32, P534, DOI 10.1002/dmrr.2788
   Shin OS, 2013, VIROLOGY, V446, P217, DOI 10.1016/j.virol.2013.07.036
   Shin OS, 2012, VIROLOGY, V434, P43, DOI 10.1016/j.virol.2012.08.004
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Spano A, 2013, CELL PROLIFERAT, V46, P328, DOI 10.1111/cpr.12030
   Tan SM, 2014, CELL REP, V8, P1225, DOI 10.1016/j.celrep.2014.07.023
   Tilston-Lunel NL, 2016, J VIROL, V90, P2616, DOI 10.1128/JVI.02849-15
   Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8
   Watts DM, 1997, AM J TROP MED HYG, V56, P661, DOI 10.4269/ajtmh.1997.56.661
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Xu HS, 2017, BIOMED PHARMACOTHER, V87, P405, DOI 10.1016/j.biopha.2016.12.100
   Yarbrough ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5963
   Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
   Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582
   Zhang HS, 2012, BBA-MOL CELL RES, V1823, P1017, DOI 10.1016/j.bbamcr.2012.02.014
   Zhang Li, ONCOLOGY REPORTS, P1772
   Zhang N, 2016, ONCOL LETT, V12, P4589, DOI 10.3892/ol.2016.5249
   Zhou WH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176395
NR 89
TC 2
Z9 2
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006508
DI 10.1371/journal.pntd.0006508
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900053
PM 29813068
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Hobbins, JC
   Platt, LD
   Copel, JA
   Euser, AG
   Afshar, Y
   Irani, RA
   Levine, D
   Cortes, MS
   Abuhamad, A
   Gaw, SL
   Harris, K
   Herrera, M
   Lynch, L
   Melo, A
   Noguchi, L
   Aguiar, R
   Sheffield, JS
   Minton, KK
AF Hobbins, John C.
   Platt, Lawrence D.
   Copel, Joshua A.
   Euser, Anna G.
   Afshar, Yalda
   Irani, Roxanna A.
   Levine, Deborah
   Cortes, Magda Sanz
   Abuhamad, Alfred
   Gaw, Stephanie L.
   Harris, Karen
   Herrera, Mauricio
   Lynch, Lauren
   Melo, Adriana
   Noguchi, Lisa
   Aguiar, Renato
   Sheffield, Jeanne S.
   Minton, Katherine K.
TI Gottesfeld-Hohler Memorial Foundation Zika Virus Think Tank Summary
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID PROTECTION; INFECTION; FETUSES; WOMEN
AB At a think tank bringing together experts on fetal neuroimaging, obstetric infectious diseases, and public health, we discussed trends in all of these areas for Zika virus. There is a wide variety of imaging findings in affected fetuses, influenced by timing of infection and probably host factors. The resources for diagnosis and interventions also vary by location with the hardest hit areas often having the fewest resources. We identified potential areas for both research and clinical collaboration as the Zika virus epidemic continues to evolve.
C1 Univ Colorado Denver, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA.
   Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
   Yale Sch Med, Dept Pediat, New Haven, CT USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA.
   Texas Childrens Hosp, Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   Eastern Virginia Med Sch, Maternal Fetal Med, Norfolk, VA 23501 USA.
   Univ Calif San Francisco, Obstet & Gynecol, San Francisco, CA 94143 USA.
   North Florida Womens Phys, Gainesville, FL USA.
   Columbia Univ Clin, Maternal Fetal Med Dept, Colsanitas Clin, Bogota, Colombia.
   Prof Joaquim Amorim Neto Res Inst, Campina Grande, Brazil.
   Johns Hopkins Univ Jhpiego, Baltimore, MD USA.
   Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA.
   Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   Amer Inst Ultrasound Med, Laurel, MD USA.
RP Hobbins, JC (corresponding author), Platte River Perinatal Ctr, 1772 Platte St, Denver, CO 80202 USA.
EM john.hobbins@ucdenver.edu
RI Gaw, Stephanie/K-4592-2019; Aguiar, Renato S/G-3542-2015; Melo, Adriana
   S O/H-5650-2016
OI Gaw, Stephanie/0000-0003-0891-6964; Aguiar, Renato
   S/0000-0001-5180-3717; Afshar, Yalda/0000-0003-3807-7022
FU Gottesfeld-Hohler Memorial Foundation
FX The manuscript was produced from a Think Tank organized by The
   Gottesfeld-Hohler Memorial Foundation and held in Ft. Lauderdale,
   Florida, June 2- 4, 2017. Costs of the meeting were underwritten by the
   Foundation with no commercial support.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR CAS COUNTS 2
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Levine D, 2003, RADIOLOGY, V229, P51, DOI 10.1148/radiol.2291020770
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G., 2017, N ENGL J MED
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Timor-Tritsch IE, 2012, ULTRASONOGRAPHY PREN
   World Health Organization, 2017, ZIK SIT REP
NR 23
TC 1
Z9 1
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2018
VL 131
IS 4
BP 661
EP 665
DI 10.1097/AOG.0000000000002538
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GQ0YP
UT WOS:000441347800010
PM 29528928
DA 2020-10-22
ER

PT J
AU Papa, MP
   Meuren, LM
   Coelho, SVA
   Lucas, CGD
   Mustafa, YM
   Matassoli, FL
   Silveira, PP
   Frost, PS
   Pezzuto, P
   Ribeiro, MR
   Tanuri, A
   Nogueira, ML
   Campanati, L
   Bozza, MT
   Neto, HAP
   Pimentel-Coelho, PM
   Figueiredo, CP
   de Aguiar, RS
   de Arruda, LB
AF Papa, Michelle P.
   Meuren, Lana M.
   Coelho, Sharton V. A.
   de Oliveira Lucas, Carolina G.
   Mustafa, Yasmin M.
   Matassoli, Flavio Lemos
   Silveira, Paola P.
   Frost, Paula S.
   Pezzuto, Paula
   Ribeiro, Milene R.
   Tanuri, Amilcar
   Nogueira, Mauricio L.
   Campanati, Loraine
   Bozza, Marcelo T.
   Paula Neto, Heitor A.
   Pimentel-Coelho, Pedro M.
   Figueiredo, Claudia P.
   de Aguiar, Renato S.
   de Arruda, Luciana B.
TI Zika Virus Infects, Activates, and Crosses Brain Microvascular
   Endothelial Cells, without Barrier Disruption
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; endothelial cells; blood brain barrier; transcytosis; mouse
   experimental model
ID JAPANESE ENCEPHALITIS-VIRUS; IN-VITRO; NERVOUS-SYSTEM; MODEL;
   TRANSCYTOSIS; ENDOCYTOSIS; INTEGRITY; TRANSPORT; PROTEINS; COMPLEX
AB Zika virus (ZIKV) has been associated to central nervous system (CNS) harm, and virus was detected in the brain and cerebrospinal fluids of microcephaly and meningoencephalitis cases. However, the mechanism by which the virus reaches the CNS is unclear. Here, we addressed the effects of ZIKV replication in human brain microvascular endothelial cells (HBMECs), as an in vitro model of blood brain barrier (BBB), and evaluated virus extravasation and BBB integrity in an in vivo mouse experimental model. HBMECs were productively infected by African and Brazilian ZIKV strains (ZIKV(MR766) and ZIKV(PE243)), which induce increased production of type I and type III IFN, inflammatory cytokines and chemokines. Infection with ZIKV(MR766) promoted earlier cellular death, in comparison to ZIKV(PE243), but infection with either strain did not result in enhanced endothelial permeability. Despite the maintenance of endothelial integrity, infectious virus particles crossed the monolayer by endocytosis/exocytosis-dependent replication pathway or by transcytosis. Remarkably, both viruses' strains infected IFNAR deficient mice, with high viral load being detected in the brains, without BBB disruption, which was only detected at later time points after infection. These data suggest that ZIKV infects and activates endothelial cells, and might reach the CNS through basolateral release, transcytosis or transinfection processes. These findings further improve the current knowledge regarding ZIKV dissemination pathways.
C1 [Papa, Michelle P.; Meuren, Lana M.; Coelho, Sharton V. A.; de Oliveira Lucas, Carolina G.; Mustafa, Yasmin M.; Matassoli, Flavio Lemos; de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Rio De Janeiro, Brazil.
   [de Oliveira Lucas, Carolina G.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Imunol, Rio De Janeiro, Brazil.
   [Silveira, Paola P.; Pezzuto, Paula; Tanuri, Amilcar; de Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Frost, Paula S.; Figueiredo, Claudia P.] Univ Fed Rio de Janeiro, Fac Farm, Nucleo Neurociencias, Rio De Janeiro, Brazil.
   [Ribeiro, Milene R.; Nogueira, Mauricio L.] Fac Med Sao Jose Do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, Brazil.
   [Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Paula Neto, Heitor A.] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Lab Alvos Mol, Rio De Janeiro, Brazil.
   [Pimentel-Coelho, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Dept Virol, Rio De Janeiro, Brazil.
EM arruda@micro.ufrj.br
RI Nogueira, Mauricio L/B-7599-2012; Arruda, Luciana B/N-9086-2013;
   Pimentel-Coelho, Pedro Moreno/AAM-9106-2020; Figueiredo, Claudia
   P/F-8424-2012; Pimentel-Coelho, Pedro M/K-1994-2015; Aguiar, Renato
   S/G-3542-2015; Campanati, Loraine/V-2632-2018
OI Nogueira, Mauricio L/0000-0003-1102-2419; Pimentel-Coelho, Pedro
   Moreno/0000-0002-2414-3386; Pimentel-Coelho, Pedro
   M/0000-0002-2414-3386; Aguiar, Renato S/0000-0001-5180-3717; Campanati,
   Loraine/0000-0001-9172-1951; da Silva Frost, Paula/0000-0002-3814-999X;
   Figueiredo, Claudia/0000-0001-9467-9891
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJ-Rede ZIKA; FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, FAPERJ-Rede
   ZIKA, and FINEP. MP was the recipient of a CNPq fellowship. LM and CL
   were the recipient of a CAPES fellowship. SC was the recipient of a
   FAPERJ fellowship. MN is supported by a FAPESP grant #2013/21719-3. MN
   and MB are a CNPq Fellowship recipient.
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Chanthick C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31855
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560
   Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004
   FUJIWARA T, 1988, J BIOL CHEM, V263, P18545
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12
   JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Luethy LN, 2016, VIROLOGY, V487, P1, DOI 10.1016/j.virol.2015.09.019
   Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0
   Nikolskaia OV, 2006, J CLIN INVEST, V116, P2739, DOI [10.1172/JC127798, 10.1172/JCI27798.]
   Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tugizov SM, 2013, J VIROL, V87, P8179, DOI 10.1128/JVI.00443-13
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 62
TC 33
Z9 35
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 22
PY 2017
VL 8
AR 2557
DI 10.3389/fmicb.2017.02557
PG 17
WC Microbiology
SC Microbiology
GA FQ8DF
UT WOS:000418592400001
PM 29312238
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Puccioni-Sohler, M
   Ornelas, AMM
   de Souza, AS
   Cabral-Castro, MJ
   Ramos, JTMA
   Rosadas, C
   Salgado, MCF
   Castiglione, AA
   Ferry, F
   Peralta, JM
   Voloch, CM
   Tanuri, A
   Tovar-Moll, F
   Aguiar, RS
AF Puccioni-Sohler, Marzia
   Ornelas, Alice M. M.
   de Souza, Andrea S.
   Cabral-Castro, Mauro Jorge
   Ramos, Jessyca T. M. A.
   Rosadas, Carolina
   Salgado, Maria Cecilia F.
   Castiglione, Alexandre A.
   Ferry, Fernando
   Peralta, Jose Mauro
   Voloch, Carolina Moreira
   Tanuri, Amilcar
   Tovar-Moll, Fernanda
   Aguiar, Renato Santana
TI First report of persistent dengue-1-associated autoimmune neurological
   disturbance: neuromyelitis optica spectrum disorder
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Dengue virus; Neuromyelitis optica spectrum disorder; Magnetic resonance
   imaging; Cerebrospinal fluid
ID DENGUE; INFECTION
AB Dengue virus (DENV) causes immune-mediated diseases. Neurological involvement represents a severe condition that is rarely observed in DENV-1 infection. Neuromyelitis optica (NMO)/NMO spectrum disorders (NMOSD) are idiopathic immune-mediated demyelinating syndromes of the central nervous system. We report a 17-year-old female with oligosymptomatic DENV-1 viremia, diagnosed as NMOSD. Magnetic resonance imaging showed spinal cord and brainstem lesions. Antibody for aquaporin 4 was negative. DENV-1 RNA infection was detected by serial RT-PCR and confirmed by phylogenetic analysis in serum. Although there are some reports of NMO post-dengue infection, there are not any published accounts of NMOSD with coexistent and persistent DENV-1 infection.
C1 [Puccioni-Sohler, Marzia; Ramos, Jessyca T. M. A.; Salgado, Maria Cecilia F.; Ferry, Fernando] Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.
   [Puccioni-Sohler, Marzia; Ornelas, Alice M. M.; Cabral-Castro, Mauro Jorge; Rosadas, Carolina; Peralta, Jose Mauro; Voloch, Carolina Moreira; Tanuri, Amilcar; Tovar-Moll, Fernanda; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Puccioni-Sohler, Marzia] Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree e Guinle, Rua Mariz e Barros 775, BR-22270004 Rio de Janeiro, Brazil.
   [de Souza, Andrea S.; Tovar-Moll, Fernanda] DOr Inst Pesquisa & Educ IDOR, Rio De Janeiro, Brazil.
   [Castiglione, Alexandre A.] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
RP Puccioni-Sohler, M (corresponding author), Univ Fed Estado Rio de Janeiro UNIRIO, Rio De Janeiro, Brazil.; Puccioni-Sohler, M (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.; Puccioni-Sohler, M (corresponding author), Univ Fed Estado Rio de Janeiro, Hosp Univ Gaffree e Guinle, Rua Mariz e Barros 775, BR-22270004 Rio de Janeiro, Brazil.
EM m_puccioni@yahoo.com.br
RI Aguiar, Renato S/G-3542-2015; de Souza, Andrea Silveira/AAL-1976-2020;
   Voloch, Carolina M/F-8874-2013; Cabral-Castro, Mauro Jorge/L-8868-2016
OI Aguiar, Renato S/0000-0001-5180-3717; de Souza, Andrea
   Silveira/0000-0002-1553-2312; Voloch, Carolina M/0000-0001-5182-4366;
   Cabral-Castro, Mauro Jorge/0000-0002-1755-999X
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Edital Programa Pesquisa em Zika, Chikungunya e Dengue
   [18/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Edital Apoio Rede Zika Multicwntrico [439928/2016-8]
FX The authors thank "Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)", "Edital Programa Pesquisa em Zika, Chikungunya e
   Dengue-no. 18/2015" and "Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)", "Edital Apoio Rede Zika Multicwntrico
   (439928/2016-8)" for their financial support for this study. The authors
   also thank Dr. Carlos Senne (Senne Liquor Diagnostico, Sao Paulo) for
   the performing of paired CSF/serum oligoclonal IgG band analysis, Dr.
   Osvaldo Nascimento (Universidade Federal Fluminense, Niteroi) for the
   somatosensory evoked potential and EMG studies, Dr. Ana Cristina
   Favoreto from Hospital Municipal Jesus, Dr. Luiz Eduardo Motta Ferreira,
   and the group from Hospital Universitario Gaffree e Guinle/UNIRIO for
   their clinical assistance during the patient's hospitalization.
CR de Sousa Adriano Miranda, 2006, Journal of Infection and Chemotherapy, V12, P396, DOI 10.1007/s10156-006-0475-6
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012
   Kunishige M, 2004, NEUROLOGY, V63, P1980, DOI 10.1212/01.WNL.0000144194.29643.D0
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Machado C, 2015, J NEUROL SCI, V358, P520, DOI 10.1016/j.jns.2015.09.374
   Masuda S, 2015, J NEUROL NEUROSUR PS, V86, P1137, DOI 10.1136/jnnp-2014-308095
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Sellner J, 2010, J AUTOIMMUN, V34, P371, DOI 10.1016/j.jaut.2009.09.013
   Tran C, 2007, J INTERN MED, V261, P500, DOI 10.1111/j.1365-2796.2007.01794.x
   WHO, 2009, DENG GUID DIAGN TREA
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
NR 13
TC 2
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2017
VL 23
IS 5
BP 768
EP 771
DI 10.1007/s13365-017-0555-7
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA FK7PI
UT WOS:000413699100014
PM 28748449
DA 2020-10-22
ER

PT J
AU Barros, PO
   Dias, ASO
   Kasahara, TM
   Omelas, AMM
   Aguiar, RS
   Leon, SA
   Ruiz, A
   Marignier, R
   Araujo, ACRA
   Alvarenga, R
   Bento, CAM
AF Barros, Priscila O.
   Dias, Aleida S. O.
   Kasahara, Taissa M.
   Omelas, Alice M. M.
   Aguiar, Renato S.
   Leon, Soniza A.
   Ruiz, Anne
   Marignier, Romain
   Araujo, Ana Carolina R. A.
   Alvarenga, Regina
   Bento, Cleonice A. M.
TI Expansion of IL-6(+) Th17-like cells expressing TLRs correlates with
   microbial translocation and neurological disabilities in NMOSD patients
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Th17 phenotype; Toll-like receptor; NMOSD; CD14
ID TOLL-LIKE RECEPTORS; 4-SPECIFIC T-CELLS; NEUROMYELITIS-OPTICA; TH17
   CELLS; MULTIPLE-SCLEROSIS; DISEASE; GLYCOPROTEIN; DISTINCTION;
   MECHANISMS; SUBSETS
AB Different microbial antigens, by signaling through toll-like receptors (TLR), may contribute to Th17-mediated autoimmune diseases, such as neuromyelitis optica spectrum disorder (NMOSD). The objective of this study was to determine the proportion of different Th17-like cell subsets that express TLR in NMOSD patients. For this study, the frequency of different Th17 cell subsets expressing TLR subsets in healthy individuals (n = 20) and NMOSD patients (n = 20) was evaluated by cytometry. The peripheral levels of soluble CD14 (sCD14) and cytokines were determined by ELISA. Our results demonstrated that the proportion of peripheral CD4(+) T cells expressing TLR2, 4 and 9 was significantly higher in NMOSD samples than in healthy subjects. In NMOSD, these cells are CD28(+) PD-1(-) CD57(-) and produce elevated levels of IL-17. Among different TLRs(+) Th17-like subsets, the proportion of those that co-express IL-17 and IL-6 was significantly higher in NMOSD patients, which was positively correlated with sCD14 levels and EDSS score. By contrast, the percentage of TLRs(+) Treg17 cells (IL-10(+) IL-17(+)) was negatively related to sCD14 and the severity of NMOSD. In conclusion, the expansion of peripheral IL-6-producing TLR+ Th17-like cells in NMOSD patients was associated with both bacterial translocation and disease severity.
C1 [Barros, Priscila O.; Dias, Aleida S. O.; Kasahara, Taissa M.; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
   [Leon, Soniza A.; Araujo, Ana Carolina R. A.; Alvarenga, Regina; Bento, Cleonice A. M.] Fed Univ State Rio de Janeiro, Neurol, Rio De Janeiro, RJ, Brazil.
   [Omelas, Alice M. M.; Aguiar, Renato S.] Fed Univ State Rio de Janeiro, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Ruiz, Anne; Marignier, Romain] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, OFSEP, Serv Neurol A, F-69677 Bron, France.
   [Ruiz, Anne; Marignier, Romain] Hosp Civils Lyon, Hop Neurol Pierre Wertheimer, OFSEP, Eugene Devic EDMUS Fdn Multiple Sclerosis, F-69677 Bron, France.
   [Ruiz, Anne; Marignier, Romain] Univ Lyon 1, Lyon, France.
RP Bento, CAM (corresponding author), Fed Univ State Rio de Janeiro, Dept Microbiol & Parasitol, Frei Caneca 94, BR-20261040 Rio De Janeiro, RJ, Brazil.
EM cbento@unirio.br
RI de Oliveira Barros, Priscila/AAA-3188-2020; Aguiar, Renato
   S/G-3542-2015; de Matos Kasahara, Taissa/AAC-9399-2020
OI de Oliveira Barros, Priscila/0000-0002-6173-0416; Aguiar, Renato
   S/0000-0001-5180-3717; de Matos Kasahara, Taissa/0000-0002-1366-1049
FU Fundacao de Amparo a Pesquisa Carlos Chagas Filho (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [216324]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [302714/2013-8]
FX This work was supported by Fundacao de Amparo a Pesquisa Carlos Chagas
   Filho (FAPERJ) (216324) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) (302714/2013-8).
CR Barros PO, 2016, CLIN EXP IMMUNOL, V183, P480, DOI 10.1111/cei.12733
   Barros PO, 2013, HUM IMMUNOL, V74, P1080, DOI 10.1016/j.humimm.2013.06.016
   Chang KH, 2015, CLIN CHIM ACTA, V440, P64, DOI 10.1016/j.cca.2014.11.004
   Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005
   Cree BAC, 2016, ANN NEUROL, V80, P443, DOI 10.1002/ana.24718
   Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775
   Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452
   Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760
   Hansen BS, 2006, J NEUROIMMUNOL, V172, P94, DOI 10.1016/j.jneuroim.2005.11.006
   Jimenez-Dalmaroni MJ, 2016, AUTOIMMUN REV, V15, P1, DOI 10.1016/j.autrev.2015.08.009
   Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022
   Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565
   Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e
   Klonowska-Szymczyk A., 2014, MEDIAT INFLAMM, V2014, P1
   KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
   Leifer CA, 2016, J LEUKOCYTE BIOL, V100, P927, DOI 10.1189/jlb.2MR0316-117RR
   Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X
   Leon A, 2015, AIDS, V29, P675, DOI 10.1097/QAD.0000000000000596
   Lin J, 2016, INT J NEUROSCI, V126, P1051, DOI 10.3109/00207454.2016.1163550
   Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36
   Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917
   Marsland BJ, 2007, CURR OPIN IMMUNOL, V19, P611, DOI 10.1016/j.coi.2007.07.022
   Masuda S, 2015, J NEUROL NEUROSUR PS, V86, P1137, DOI 10.1136/jnnp-2014-308095
   da Costa DSMM, 2016, J NEUROIMMUNOL, V299, P8, DOI 10.1016/j.jneuroim.2016.08.005
   Mori M, 2011, NEUROL SCI, V32, P795, DOI 10.1007/s10072-011-0564-x
   Nyirenda MH, 2015, J IMMUNOL, V194, P5761, DOI 10.4049/jimmunol.1400472
   Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301
   Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109
   Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101
   Smyk DS, 2014, WORLD J GASTROENTERO, V20, P613, DOI 10.3748/wjg.v20.i3.613
   Thwaites R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00001
   Uzawa A, 2013, CLIN CHIM ACTA, V421, P181, DOI 10.1016/j.cca.2013.03.020
   Vaknin-Dembinsky A, 2016, MULT SCLER RELAT DIS, V6, P28, DOI 10.1016/j.msard.2015.12.004
   Varrin-Doyer M, 2012, ANN NEUROL, V72, P53, DOI 10.1002/ana.23651
   Verstrepen BE, 2016, J GEN VIROL, V97, P2599, DOI 10.1099/jgv.0.000577
   Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862
   Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
   Zeka B, 2015, ACTA NEUROPATHOL, V130, P783, DOI 10.1007/s00401-015-1501-5
NR 38
TC 6
Z9 7
U1 2
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD JUN 15
PY 2017
VL 307
BP 82
EP 90
DI 10.1016/j.jneuroim.2017.04.001
PG 9
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA EW0YX
UT WOS:000402218200015
PM 28495144
DA 2020-10-22
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Ferreira, Thales Araujo/AAA-6252-2019; Rehen, Stevens K/J-5874-2012;
   Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016; Aguiar,
   Renato S/G-3542-2015; ANDRADE, CECILIA/B-5916-2017
OI Rehen, Stevens K/0000-0003-4216-9501; Amorim, Melania
   M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717; FERREIRA,
   THALES/0000-0002-6699-5886; ANDRADE, CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 71
Z9 74
U1 0
U2 29
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-10-22
ER

PT J
AU Geddes, VEV
   Jose, DP
   Leal, FE
   Nixon, DF
   Tanuri, A
   Aguiar, RS
AF Viana Geddes, Victor Emmanuel
   Jose, Diego Pandelo
   Leal, Fabio E.
   Nixon, Douglas F.
   Tanuri, Amilcar
   Aguiar, Renato Santana
TI HTLV-1 Tax activates HIV-1 transcription in latency models
SO VIROLOGY
LA English
DT Article
DE HIV-1; Latency; HTLV-1; Tax; P-TEFb; Resting cells
ID LYMPHOTROPIC VIRUS TYPE-1; HUMAN-IMMUNODEFICIENCY-VIRUS; P-TEFB; I
   INFECTION; COINFECTION; INDIVIDUALS; REPLICATION; SUPPRESSION;
   EXPRESSION; INDUCTION
AB HIV-1 latency is a major obstacle to HIV-1 eradication. Coinfection with HTLV-1 has been associated with faster progression to AIDS. HTLV-1 encodes the transactivator Tax which can activate both HTLV-1 and HIV-1 transcription. Here, we demonstrate that Tax activates HIV transcription in latent CD4(+) T cells. Tax promotes the activation of P-TEFb, releasing CDK9 and Cyclin T1 from inactive forms, promoting transcription elongation and reactivation of latent HIV-1. Tax mutants lacking interaction with the HIV-1-LTR promoter were not able to activate P-TEFb, with no subsequent activation of latent HIV. In HIV-infected primary resting CD4(+) T cells, Tax-1 reactivated HIV-1 transcription up to five fold, confirming these findings in an ex vivo latency model. Finally, our results confirms that HTLV-1/Tax hijacks cellular partners, promoting HIV-1 transcription, and this interaction should be further investigated in HIV-1 latency studies in patients with HIV/HTLV-1 co-infection.
C1 [Viana Geddes, Victor Emmanuel; Jose, Diego Pandelo; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Av Carlos Chagas Filho 373 Predio CCS Bloco A,Sal, BR-21941902 Rio De Janeiro, Brazil.
   [Jose, Diego Pandelo] Univ Fed Triangulo Mineiro, Campus Iturama, BR-38280000 Uberaba, MG, Brazil.
   [Leal, Fabio E.] Inst Nacl Canc, Programa Oncovirol, Rio De Janeiro, Brazil.
   [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Av Carlos Chagas Filho 373 Predio CCS Bloco A,Sal, BR-21941902 Rio De Janeiro, Brazil.
EM santana@biologia.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Jose, Diego Pandelo/B-4655-2017; Nixon,
   Douglas/AAU-5734-2020
OI Aguiar, Renato S/0000-0001-5180-3717; Jose, Diego
   Pandelo/0000-0002-3243-5688; Nixon, Douglas/0000-0002-2801-1786
FU Brazilian agency CNPqNational Council for Scientific and Technological
   Development (CNPq) [405283/2013-0]; Brazilian agency FAPERJCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/111.267/2013]; CAPESCAPES [88881.130757/2016-01]
FX We thank Rodrigo Delvecchio da Cunha and Dr. Koen Bartholomeeusen for
   the support in the experiments. We also thank Dr. Kotaro Shirakawa to
   gently provide us the plasmid pEnvHIV and Dr. Jose Marcello Salabert de
   Campos for the statistical analyses. This work was supported by research
   grants from Brazilian agencies CNPq (Grant no. 405283/2013-0) and FAPERJ
   (Grant no. E-26/111.267/2013) and Victor Emmanuel Viana Geddes was
   supported by CAPES (Grant no. 88881.130757/2016-01) fellowship.
CR Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200
   Banerjee P, 2007, J VIROL, V81, P1690, DOI 10.1128/JVI.01513-06
   Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834
   Beilke MA, 2012, AIDS RES HUM RETROV, V28, P139, DOI [10.1089/AID.2011.0342, 10.1089/aid.2011.0342]
   BERAUD C, 1994, MOL CELL BIOL, V14, P1374, DOI 10.1128/MCB.14.2.1374
   Bertram S, 1996, J MED VIROL, V49, P283, DOI 10.1002/(SICI)1096-9071(199608)49:4&lt;283::AID-JMV5&gt;3.0.CO;2-#
   Blanchard A, 1997, TRENDS MICROBIOL, V5, P326, DOI 10.1016/S0966-842X(97)01089-5
   Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76
   Brauweiler A, 1997, VIROLOGY, V231, P135, DOI 10.1006/viro.1997.8509
   Brites C, 2009, AIDS REV, V11, P8
   Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11
   Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10
   Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200
   Diani E, 2015, VIROLOGY, V476, P92, DOI 10.1016/j.virol.2014.12.005
   Etzel A, 2001, J ACQ IMMUN DEF SYND, V26, P185, DOI 10.1097/00126334-200102010-00015
   Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001
   Hyun J, 2015, J VIROL, V89, P4880, DOI 10.1128/JVI.02493-14
   Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188
   Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033
   Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27
   Moriuchi H, 2000, VIROLOGY, V278, P514, DOI 10.1006/viro.2000.0684
   Mousseau G, 2012, CELL HOST MICROBE, V12, P97, DOI 10.1016/j.chom.2012.05.016
   Oo Z, 2015, J MED VIROL, V87, P790, DOI 10.1002/jmv.24070
   Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08
   Pedroso C, 2011, JAIDS-J ACQ IMM DEF, V57, pS208, DOI 10.1097/QAI.0b013e31821e9baf
   Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968
   Rockwood N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002275
   SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201
   SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875
   ZHAO TM, 1995, J VIROL, V69, P2024, DOI 10.1128/JVI.69.4.2024-2030.1995
   Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006
NR 31
TC 4
Z9 4
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD APR
PY 2017
VL 504
BP 45
EP 51
DI 10.1016/j.virol.2017.01.014
PG 7
WC Virology
SC Virology
GA EO0IO
UT WOS:000396381700005
PM 28152383
OA Bronze
DA 2020-10-22
ER

PT J
AU Garcez, PP
   Nascimento, JM
   de Vasconcelos, JM
   da Costa, RM
   Delvecchio, R
   Trindade, P
   Loiola, EC
   Higa, LM
   Cassoli, JS
   Vitoria, G
   Sequeira, PC
   Sochacki, J
   Aguiar, RS
   Fuzii, HT
   de Filippis, AMB
   Vianez, JLDG
   Tanuri, A
   Martins-de-Souza, D
   Rehen, SK
AF Garcez, Patricia P.
   Nascimento, Juliana Minardi
   de Vasconcelos, Janaina Mota
   da Costa, Rodrigo Madeiro
   Delvecchio, Rodrigo
   Trindade, Pablo
   Loiola, Erick Correia
   Higa, Luiza M.
   Cassoli, Juliana S.
   Vitoria, Gabriela
   Sequeira, Patricia C.
   Sochacki, Jaroslaw
   Aguiar, Renato S.
   Fuzii, Hellen Thais
   Bispo de Filippis, Ana M.
   Goncalves Vianez Junior, Joao Lidio da Silva
   Tanuri, Amilcar
   Martins-de-Souza, Daniel
   Rehen, Stevens K.
TI Zika virus disrupts molecular fingerprinting of human neurospheres
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; CELL-SURVIVAL; STEM-CELLS; PROTEINS; GENE;
   HEPATITIS; REPLICATION; EFFICIENT; ALIGNMENT; RCK/P54
AB Zika virus (ZIKV) has been associated with microcephaly and other brain abnormalities; however, the molecular consequences of ZIKV to human brain development are still not fully understood. Here we describe alterations in human neurospheres derived from induced pluripotent stem (iPS) cells infected with the strain of Zika virus that is circulating in Brazil. Combining proteomics and mRNA transcriptional profiling, over 500 proteins and genes associated with the Brazilian ZIKV infection were found to be differentially expressed. These genes and proteins provide an interactome map, which indicates that ZIKV controls the expression of RNA processing bodies, miRNA biogenesis and splicing factors required for self-replication. It also suggests that impairments in the molecular pathways underpinning cell cycle and neuronal differentiation are caused by ZIKV. These results point to biological mechanisms implicated in brain malformations, which are important to further the understanding of ZIKV infection and can be exploited as therapeutic potential targets to mitigate it.
C1 [Garcez, Patricia P.; Nascimento, Juliana Minardi; da Costa, Rodrigo Madeiro; Loiola, Erick Correia; Vitoria, Gabriela; Sochacki, Jaroslaw; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Nascimento, Juliana Minardi; Cassoli, Juliana S.; Martins-de-Souza, Daniel] Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
   [de Vasconcelos, Janaina Mota; Goncalves Vianez Junior, Joao Lidio da Silva] Evandro Chagas Inst, Ctr Technol Innovat, Belem, Para, Brazil.
   [Delvecchio, Rodrigo; Higa, Luiza M.; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Sequeira, Patricia C.; Bispo de Filippis, Ana M.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Fuzii, Hellen Thais] Fed Univ Para, Belem, Para, Brazil.
RP Garcez, PP; Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Garcez, PP; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Martins-de-Souza, D (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.
EM ppgarcez@icb.ufrj.br; dmsouza@unicamp.br; srehen@lance.ufrj.org
RI Martins-de-Souza, Daniel/E-7021-2010; Aguiar, Renato S/G-3542-2015;
   Garcez, Patricia/F-8026-2012; Rehen, Stevens K/J-5874-2012; Trindade,
   Pablo/D-8913-2016; Nascimento, Juliana/B-8764-2009; Madeiro,
   Rodrigo/M-6433-2017; Higa, Luiza/W-2698-2019; Vianez Junior, Joao
   Lidio/I-9547-2016; Loiola, Erick/I-4106-2016; Silva Cassoli,
   Juliana/L-3783-2013
OI Martins-de-Souza, Daniel/0000-0003-3595-5846; Aguiar, Renato
   S/0000-0001-5180-3717; Garcez, Patricia/0000-0002-9107-1335; Rehen,
   Stevens K/0000-0003-4216-9501; Trindade, Pablo/0000-0001-5953-7054;
   Nascimento, Juliana/0000-0003-3126-4984; Madeiro,
   Rodrigo/0000-0001-5646-8858; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441; Loiola, Erick/0000-0002-7926-795X; Silva
   Cassoli, Juliana/0000-0002-2174-6309
FU Brazilian Development Bank (BNDES); Funding Authority for Studies and
   Projects (FINEP); National Council of Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq); Foundation for Research Support in the State of Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ); Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [14/21035-0, 14/14881-1, 13/08711-3, 14/10068-4]; Coordination for the
   Improvement of Higher Education Personnel (CAPES)CAPES
FX The authors thank the technical support of Ismael Gomes, Dr. Renata
   Maciel for providing neural stem cells, Dr. Sandro Patroca da Silva for
   the phylogenetic and bioinformatic helpful advises and Nisha Pulimood
   Foti for English editing. Authors also thank Fabricio Pamplona and Mind
   the Graph. Funds were provided by the Brazilian Development Bank
   (BNDES); Funding Authority for Studies and Projects (FINEP); National
   Council of Scientific and Technological Development (CNPq); Foundation
   for Research Support in the State of Rio de Janeiro (FAPERJ); the Sao
   Paulo Research Foundation (FAPESP, grants 14/21035-0, 14/14881-1,
   13/08711-3 and 14/10068-4); ISD return home award and fellowships from
   the Coordination for the Improvement of Higher Education Personnel
   (CAPES).
CR Ahmed S, 2013, J IMMUNOL, V190, P2217, DOI 10.4049/jimmunol.1201630
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003
   Calvet G., 2016, LANCET INFECT DIS, P1
   Cosker KE, 2016, NAT NEUROSCI, V19, P690, DOI 10.1038/nn.4280
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang JM, 2016, STEM CELLS, P1, DOI [10.1016/j.stem.2016.04.014, DOI 10.1016/J.STEM.2016.04.014]
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Distler U., NAT METHODS
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han YW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004319
   Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huys A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067437
   Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004199
   Lowery LA, 2007, DEV DYNAM, V236, P1347, DOI 10.1002/dvdy.21132
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miyaji K, 2003, J VIRAL HEPATITIS, V10, P241, DOI 10.1046/j.1365-2893.2003.00447.x
   Mlakar J., 2016, NEW ENGL J MED, P1
   Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H., 2016, ZIKA VIRUS HUMAN PLA, DOI [10.1101/058883, DOI 10.1101/058883]
   Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455
   Tiwari KK, 2015, TOXICOL IN VITRO, V29, P1369, DOI 10.1016/j.tiv.2015.05.008
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 59
TC 41
Z9 41
U1 1
U2 36
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 23
PY 2017
VL 7
AR 40780
DI 10.1038/srep40780
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3SK
UT WOS:000392411400001
PM 28112162
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Ornelas, AMM
   Pezzuto, P
   Silveira, PP
   Melo, FO
   Ferreira, TA
   Oliveira-Szejnfeld, PS
   Leal, JI
   Amorim, MMR
   Hamilton, S
   Rawlinson, WD
   Cardoso, CC
   Nixon, DF
   Tanuri, A
   Melo, AS
   Aguiar, RS
AF Ornelas, Alice M. M.
   Pezzuto, Paula
   Silveira, Paola P.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Oliveira-Szejnfeld, Patricia S.
   Leal, Jeime I.
   Amorim, Melania M. R.
   Hamilton, Stuart
   Rawlinson, William D.
   Cardoso, Cynthia C.
   Nixon, Douglas F.
   Tanuri, Amilcar
   Melo, Adriana S.
   Aguiar, Renato S.
TI Immune activation in amniotic fluid from Zika virus-associated
   microcephaly
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID INFECTION; CYTOKINES; GROWTH; BRAIN; WOMEN
AB Recent advances in the understanding of neuropathogenesis associated with Zika virus (ZIKV) infection has led to descriptions of neonatal microcephaly cases. However, none of these reports have evaluated the humoral response during ZIKV infection. We report here polyfunctional immune activation associated with increased interferon-gamma-inducible protein 10, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), monocyte chemoattractive protein 1 (MCP-1), and granulocyte colony-stimulating factor (G-CSF) levels in the amniotic fluid of ZIKV-positive pregnant women with neonatal microcephaly. These cytokines have been associated not only with neuronal damage, but also with differentiation and proliferation of neural progenitor cells. Our results suggested that the immune activation caused by ZIKV infection in the uterine environment could also interfere with fetal development. ANN NEUROL 2017;81:152-156
C1 [Ornelas, Alice M. M.; Pezzuto, Paula; Silveira, Paola P.; Cardoso, Cynthia C.; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
   [Melo, Fabiana O.; Ferreira, Thales A.; Leal, Jeime I.; Amorim, Melania M. R.; Melo, Adriana S.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Univ Fed Sao Paulo, Fundacao Inst Ensino & Pesquisa Diagnost Imagem F, Dept Diagnost Imagem, Sao Paulo, Brazil.
   [Hamilton, Stuart; Rawlinson, William D.] Prince Wales Hosp, POWH & UNSW Res Labs, Virol Res, Randwick, NSW, Australia.
   [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM santanarnt@gmail.com
RI Aguiar, Renato S/G-3542-2015; Amorim, Melania M/C-5807-2013; Ferreira,
   Thales Araujo/AAA-6252-2019; Nixon, Douglas/AAU-5734-2020; Cardoso,
   Cynthia/K-5824-2012; Melo, Adriana S O/H-5650-2016
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Nixon, Douglas/0000-0002-2801-1786; Cardoso,
   Cynthia/0000-0003-0565-7047; FERREIRA, THALES/0000-0002-6699-5886
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CAPESCAPES; Brazilian Ministry of Education (CAPES)CAPES
FX This work was funded by Consellho Nacional de Desenvolvimento e Pesquisa
   (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ).; We thank CAPES for student's fellowship. A.M.M.O. has been
   sponsored by a Ph.D. scholarship from the Brazilian Ministry of
   Education (CAPES) and this work is part of her requirements for
   obtaining a Ph.D. degree by the Graduate Program in Genetics at the
   Federal University of rio de janeiro, Brazil.
CR Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748
   Breton J, 2011, J NEUROL NEUROPHYSIO, pS4, DOI DOI 10.4172/2155-9562.S4-001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chow SSW, 2008, CYTOKINE, V44, P78, DOI 10.1016/j.cyto.2008.06.009
   Fortunato SJ, 1998, AM J REPROD IMMUNOL, V39, P16
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0
   Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006
   Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022
   Miceli M, 2016, PROTEOMICS, V16, P674, DOI 10.1002/pmic.201500223
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onis M., 2007, WHO CHILD GROWTH STA
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Suzuki Y, 2006, FETAL DIAGN THER, V21, P45, DOI 10.1159/000089047
   Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3
   Wallner Stephanie, 2015, Front Cell Dev Biol, V3, P48, DOI 10.3389/fcell.2015.00048
   Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x
NR 20
TC 21
Z9 21
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2017
VL 81
IS 1
BP 152
EP 156
DI 10.1002/ana.24839
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ9QV
UT WOS:000393562300015
PM 27977881
DA 2020-10-22
ER

PT J
AU Melo, ASD
   Aguiar, RS
   Amorim, MMR
   Arruda, MB
   Melo, FD
   Ribeiro, STC
   Batista, AGM
   Ferreira, T
   dos Santos, MP
   Sampaio, VV
   Moura, SRM
   Rabello, LP
   Gonzaga, CE
   Malinger, G
   Ximenes, R
   de Oliveira-Szejnfeld, PS
   Tovar-Moll, F
   Chimelli, L
   Silveira, PP
   Delvechio, R
   Higa, L
   Campanati, L
   Nogueira, RMR
   Filippis, AMB
   Szejnfeld, J
   Voloch, CM
   Ferreira, OC
   Brindeiro, RM
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Aguiar, Renato Santana
   Ramos Amorim, Melania Maria
   Arruda, Monica B.
   Melo, Fabiana de Oliveira
   Clementino Ribeiro, Suelem Tais
   Medeiros Batista, Alba Gean
   Ferreira, Thales
   dos Santos, Mayra Pereira
   Sampaio, Virginia Vilar
   Martins Moura, Sarah Rogeria
   Rabello, Luciana Portela
   Gonzaga, Clarissa Emanuelle
   Malinger, Gustavo
   Ximenes, Renato
   de Oliveira-Szejnfeld, Patricia Soares
   Tovar-Moll, Fernanda
   Chimelli, Leila
   Silveira, Paola Paz
   Delvechio, Rodrigo
   Higa, Luiza
   Campanati, Loraine
   Nogueira, Rita M. R.
   Bispo Filippis, Ana Maria
   Szejnfeld, Jacob
   Voloch, Carolina Moreira
   Ferreira, Orlando C., Jr.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Congenital Zika Virus Infection Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; DIAGNOSTIC-APPROACH; TRANSMISSION; CHILDREN
AB IMPORTANCE Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy. To our knowledge, most reports to date have focused on select aspects of the maternal or fetal infection and fetal effects.
   OBJECTIVE To describe the prenatal evolution and perinatal outcomes of 11 neonates who had developmental abnormalities and neurological damage associated with ZIKV infection in Brazil.
   DESIGN, SETTING, AND PARTICIPANTS We observed 11 infants with congenital ZIKV infection from gestation to 6 monthus in the state of Paraba, Brazil. Ten of 11 women included in this study presented with symptoms of ZIKV infection during the first half of pregnancy, and all 11 had laboratory evidence of the infection in several tissues by serology or polymerase chain reaction. Brain damage was confirmed through intrauterine ultrasonography and was complemented by magnetic resonance imaging. Histopathological analysis was performed on the placenta and brain tissue from infants who died. The ZIKV genome was investigated in several tissues and sequenced for further phylogenetic analysis.
   MAIN OUTCOMES AND MEASURES Description of the major lesions caused by ZIKV congenital infection.
   RESULTS Of the 11 infants, 7 (63.6%) were female, and the median (SD) maternal age at delivery was 25 (6) years. Three of 11 neonates died, giving a perinatal mortality rate of 27.3%. The median (SD) cephalic perimeter at birth was 31 (3) cm, a value lower than the limit to consider a microcephaly case. In all patients, neurological impairments were identified, including microcephaly, a reduction in cerebral volume, ventriculomegaly, cerebellar hypoplasia, lissencephaly with hydrocephalus, and fetal akinesia deformation sequence (ie, arthrogryposis). Results of limited testing for other causes of microcephaly, such as genetic disorders and viral and bacterial infections, were negative, and the ZIKV genome was found in both maternal and neonatal tissues (eg, amniotic fluid, cord blood, placenta, and brain). Phylogenetic analyses showed an intrahost virus variation with some polymorphisms in envelope genes associated with different tissues.
   CONCLUSIONS AND RELEVANCE Combined findings from clinical, laboratory, imaging, and pathological examinations provided a more complete picture of the severe damage and developmental abnormalities caused by ZIKV infection than has been previously reported. The term congenital Zika syndrome is preferable to refer to these cases, as microcephaly is just one of the clinical signs of this congenital malformation disorder.
C1 [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira; Clementino Ribeiro, Suelem Tais; dos Santos, Mayra Pereira] Inst Saude Elpidio de Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Clementino Ribeiro, Suelem Tais; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela; Gonzaga, Clarissa Emanuelle] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Aguiar, Renato Santana; Arruda, Monica B.; Silveira, Paola Paz; Delvechio, Rodrigo; Higa, Luiza; Voloch, Carolina Moreira; Ferreira, Orlando C., Jr.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ramos Amorim, Melania Maria; Ferreira, Thales] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ximenes, Renato] Fundacao Med Fetal Latino Amer, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fundacao Inst Pesquisa & Ensino Diagnost Imagem, Sao Paulo, Brazil.
   [Tovar-Moll, Fernanda; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.; Bispo Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco Sala 121, BR-21941902 Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Amorim, Melania M/C-5807-2013; Campanati, Loraine/V-2632-2018; Ferreira,
   Thales Araujo/AAA-6252-2019; Voloch, Carolina M/F-8874-2013; Higa,
   Luiza/W-2698-2019; Aguiar, Renato S/G-3542-2015; Melo, Adriana S
   O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; Campanati,
   Loraine/0000-0001-9172-1951; Voloch, Carolina M/0000-0001-5182-4366;
   Aguiar, Renato S/0000-0001-5180-3717; Malinger,
   Gustavo/0000-0003-0864-206X
FU Consellho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Prefeitura Municipal
   de Campina Grande
FX This study was supported by Consellho Nacional de Desenvolvimento e
   Pesquisa, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and
   Prefeitura Municipal de Campina Grande.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M., 2014, EURO SURVEILL, V19
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Kouame N, 2013, Diagn Interv Imaging, V94, P433, DOI 10.1016/j.diii.2013.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002
   Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 33
TC 183
Z9 184
U1 0
U2 47
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1407
EP 1416
DI 10.1001/jamaneurol.2016.3720
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200011
PM 27695855
OA Bronze
DA 2020-10-22
ER

PT J
AU Delvecchio, R
   Higa, LM
   Pezzuto, P
   Valadao, AL
   Garcez, PP
   Monteiro, FL
   Loiola, EC
   Dias, AA
   Silva, FJM
   Aliota, MT
   Caine, EA
   Osorio, JE
   Bellio, M
   O'Connor, DH
   Rehen, S
   de Aguiar, RS
   Savarino, A
   Campanati, L
   Tanuri, A
AF Delvecchio, Rodrigo
   Higa, Luiza M.
   Pezzuto, Paula
   Valadao, Ana Luiza
   Garcez, Patricia P.
   Monteiro, Fabio L.
   Loiola, Erick C.
   Dias, Andre A.
   Silva, Fabio J. M.
   Aliota, Matthew T.
   Caine, Elizabeth A.
   Osorio, Jorge E.
   Bellio, Maria
   O'Connor, David H.
   Rehen, Stevens
   de Aguiar, Renato Santana
   Savarino, Andrea
   Campanati, Loraine
   Tanuri, Amilcar
TI Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus
   Infection in Different Cell Models
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; chloroquine; antiviral; microcephaly; neural stem cell
ID SEXUAL TRANSMISSION; MECHANISM; PREGNANCY; ENTRY; DRUG; REPLICATION;
   MICRONESIA; ORGANOIDS; EXPOSURE; MALARIA
AB Zika virus (ZIKV) infection in utero might lead to microcephaly and other congenital defects. Since no specific therapy is available thus far, there is an urgent need for the discovery of agents capable of inhibiting its viral replication and deleterious effects. Chloroquine is widely used as an antimalarial drug, anti-inflammatory agent, and it also shows antiviral activity against several viruses. Here we show that chloroquine exhibits antiviral activity against ZIKV in Vero cells, human brain microvascular endothelial cells, human neural stem cells, and mouse neurospheres. We demonstrate that chloroquine reduces the number of ZIKV-infected cells in vitro, and inhibits virus production and cell death promoted by ZIKV infection without cytotoxic effects. In addition, chloroquine treatment partially reveres morphological changes induced by ZIKV infection in mouse neurospheres.
C1 [Delvecchio, Rodrigo; Higa, Luiza M.; Pezzuto, Paula; Valadao, Ana Luiza; Monteiro, Fabio L.; de Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Silva, Fabio J. M.; Rehen, Stevens; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Loiola, Erick C.; Rehen, Stevens] DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.
   [Dias, Andre A.; Bellio, Maria] Univ Fed Rio de Janeiro, Dept Immunol, BR-21941902 Rio De Janeiro, Brazil.
   [Aliota, Matthew T.; Caine, Elizabeth A.; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Savarino, Andrea] Ist Super Sanita, Deptartment Infect Dis, 299 Viale Regina Elena, I-00161 Rome, Italy.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.; Campanati, L (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.
EM digodelvecchio@gmail.com; luizahiga@gmail.com; paulapezzuto81@gmail.com;
   analuvaladao@gmail.com; ppgarcez@gmail.com; fabiolimonte@gmail.com;
   erickloiola@lance-ufrj.org; aadias2005@yahoo.com.br;
   fabiojms@icb.ufrj.br; mtaliota@wisc.edu; eacaine@wisc.edu;
   jorge.osorio@wisc.edu; mariabellioufrj@gmail.com; dhoconno@wisc.edu;
   srehen@lance-ufrj.org; santanarnt@gmail.com; ansavari@yahoo.com;
   lcampanati@gmail.com; atanuri@biologia.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Rehen, Stevens K/J-5874-2012; Higa,
   Luiza/W-2698-2019; Garcez, Patricia/F-8026-2012; Campanati,
   Loraine/V-2632-2018; Loiola, Erick/I-4106-2016; BELLIO,
   MARIA/N-8525-2018
OI Aguiar, Renato S/0000-0001-5180-3717; Rehen, Stevens
   K/0000-0003-4216-9501; Garcez, Patricia/0000-0002-9107-1335; Campanati,
   Loraine/0000-0001-9172-1951; Aliota, Matthew/0000-0002-6902-9149;
   Pezzuto, Paula/0000-0001-9570-8244; o'connor, david/0000-0003-2139-470X;
   Lima Monteiro, Fabio Luis/0000-0002-9107-6865; Savarino,
   Andrea/0000-0003-0983-3693; Loiola, Erick/0000-0002-7926-795X; BELLIO,
   MARIA/0000-0002-3360-2740
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Departamento de Doencas Sexualmente Transmissiveis, AIDS e Hepatites
   Virais do Ministerio da Saude do Brasil
FX This work was supported by Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), and Departamento de Doencas Sexualmente
   Transmissiveis, AIDS e Hepatites Virais do Ministerio da Saude do
   Brasil. The authors acknowledge Manoel Itamar for providing technical
   support.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Brasil P., 2016, ENGL J MED, DOI [10.1056/NEJMoa160241226943629, DOI 10.1056/NEJMOA160241226943629]
   Browning D., 2014, PHARM CHLOROQUINE HY, V35, P63
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campanati L., 2016, BIORXIV, V1, P25
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diaz-Griffero F, 2002, J VIROL, V76, P12866, DOI 10.1128/JVI.76.24.12866-12876.2002
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Farias K. J. S., 2013, WORLD J, V2013, DOI [10.1155/2013/28273423431254, DOI 10.1155/2013/28273423431254]
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   GonzalezDunia D, 1998, J VIROL, V72, P783, DOI 10.1128/JVI.72.1.783-788.1998
   Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001
   Helal GK, 2016, J MED VIROL, V88, P2170, DOI 10.1002/jmv.24575
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   MACKENZIE AH, 1983, AM J MED, V75, P40, DOI 10.1016/0002-9343(83)91269-X
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo A. S., 2016, JAMA NEUROL, V1, DOI [10.1001/jamaneurol.2016.372027695855, DOI 10.1001/JAMANEUROL.2016.372027695855]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39
   PARKE AL, 1988, J RHEUMATOL, V15, P607
   Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Savarino A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0178-0
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001
   Tricou V., 2010, PLOS NEGLECT TROP D, V4, DOI [10.1371/journal.pntd.000078520706626, DOI 10.1371/JOURNAL.PNTD.000078520706626]
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   WOLFE MS, 1985, BRIT MED J, V290, P1466, DOI 10.1136/bmj.290.6480.1466
   World Health Organization, 2016, ZIK VIR MICR GUILL B
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
NR 56
TC 107
Z9 112
U1 1
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2016
VL 8
IS 12
AR 322
DI 10.3390/v8120322
PG 15
WC Virology
SC Virology
GA EI4SW
UT WOS:000392484600002
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Silveira, P
   Goncalves, G
   Barbizan, T
   Rabay, AF
   Pianowski, L
   O'Connor, D
   Aguiar, R
   Tanuri, A
AF Silveira, Paola
   Goncalves, Gabriel
   Barbizan, Thais
   Rabay, Ana Flavia
   Pianowski, Luis
   O'Connor, David
   Aguiar, Renato
   Tanuri, Amilcar
TI THS, a Potential Candidate for Prevention Strategies, Reduces HIV and
   SIV Infection via CD4 Receptor Modulation
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT Conference on HIV Research for Prevention (HIV R4P)
CY OCT 17-20, 2016
CL Chicago, IL
C1 [Silveira, Paola; Goncalves, Gabriel; Aguiar, Renato; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Barbizan, Thais; Rabay, Ana Flavia; Pianowski, Luis] Kyolab, Valinhos, SP, Brazil.
   [O'Connor, David] Univ Wisconsin, Madison, WI 53706 USA.
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT
PY 2016
VL 32
SU 1
MA P08.13
BP 238
EP 238
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA EA6YH
UT WOS:000386774600437
DA 2020-10-22
ER

PT J
AU de Oliveira-Szejnfeld, PS
   Levine, D
   Melo, ASD
   Amorim, MMR
   Batista, AGM
   Chimelli, L
   Tanuri, A
   Aguiar, RS
   Malinger, G
   Ximenes, R
   Robertson, R
   Szejnfeld, J
   Tovar-Moll, F
AF de Oliveira-Szejnfeld, Patricia Soares
   Levine, Deborah
   de Oliveira Melo, Adriana Suely
   Ramos Amorim, Melania Maria
   Batista, Alba Gean M.
   Chimelli, Leila
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Malinger, Gustavo
   Ximenes, Renato
   Robertson, Richard
   Szejnfeld, Jacob
   Tovar-Moll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can
   Expect to See Prenatally and Postnatally
SO RADIOLOGY
LA English
DT Article
ID INFECTION; ULTRASOUND; OUTBREAK; GROWTH; BRAZIL
AB Purpose: To document the imaging findings associated with congenital Zika virus infection as found in the Instituto de Pesquisa in Campina Grande State Paraiba (IPESQ) in northeastern Brazil, where the congenital infection has been particularly severe.
   Materials and Methods: From June 2015 to May 2016, 438 patients were referred to the IPESQ for rash occurring during pregnancy or for suspected fetal central nervous system abnormality. Patients who underwent imaging at IPESQ were included, as well as those with documented Zika virus infection in fluid or tissue (n = 17, confirmed infection cohort) or those with brain findings suspicious for Zika virus infection, with intracranial calcifications (n = 28, presumed infection cohort). Imaging examinations included 12 fetal magnetic resonance (MR) examinations, 42 postnatal brain computed tomographic examinations, and 11 postnatal brain MR examinations. Images were reviewed by four radiologists, with final opinion achieved by means of consensus.
   Results: Brain abnormalities seen in confirmed (n = 17) and presumed (n = 28) congenital Zika virus infections were similar, with ventriculomegaly in 16 of 17 (94%) and 27 of 28 (96%) infections, respectively; abnormalities of the corpus callosum in 16 of 17 (94%) and 22 of 28 (78%) infections, respectively; and cortical migrational abnormalities in 16 of 17 (94%) and 28 of 28 (100%) infections, respectively. Although most fetuses underwent at least one examination that showed head circumference below the 5th percentile, head circumference could be normal in the presence of severe ventriculomegaly (seen in three fetuses). Intracranial calcifications were most commonly seen at the gray matter-white matter junction, in 15 of 17 (88%) and 28 of 28 (100%) confirmed and presumed infections, respectively. The basal ganglia and/or thalamus were also commonly involved with calcifications in 11 of 17 (65%) and 18 of 28 (64%) infections, respectively. The skull frequently had a collapsed appearance with overlapping sutures and redundant skin folds and, occasionally, intracranial herniation of orbital fat and clot in the confluence of sinuses.
   Conclusion: The spectrum of findings associated with congenital Zika virus infection in the IPESQ in northeastern Brazil is illustrated to aid the radiologist in identifying Zika virus infection at imaging. (C) RSNA, 2016
C1 [de Oliveira-Szejnfeld, Patricia Soares; Ximenes, Renato; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Batista, Alba Gean M.] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Div Ultrasound Obstet & Gynecol, Tel Aviv Sourasky Med Ctr,Lis Matern Hosp, Tel Aviv, Israel.
   [Ximenes, Renato] Fetal Med Fdn Latinamerica FMFLA, Centrus Fetal Med, Campinas, SP, Brazil.
   [Robertson, Richard] Boston Childrens Hosp, Boston, MA USA.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Melo, Adriana S O/H-5650-2016; Aguiar, Renato S/G-3542-2015; Amorim,
   Melania M/C-5807-2013
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Robertson, Richard/0000-0001-8811-4405; Malinger,
   Gustavo/0000-0003-0864-206X
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: Medline
CR [Anonymous], 2016, HEAD CIRC FOR AG
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Brazilian Ministry of Health, 2016, MIN SAUD CONF 1656 C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo A, JAMA NEUROL IN PRESS
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 32
TC 124
Z9 130
U1 0
U2 13
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD OCT
PY 2016
VL 281
IS 1
BP 203
EP 218
DI 10.1148/radiol.2016161584
PG 16
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG8NJ
UT WOS:000391313600023
PM 27552432
OA Bronze
DA 2020-10-22
ER

PT J
AU Galliez, RM
   Spitz, M
   Rafful, PP
   Cagy, M
   Escosteguy, C
   Germano, CSB
   Sasse, E
   Goncalves, AL
   Silveira, PP
   Pezzuto, P
   Ornelas, AMD
   Tanuri, A
   Aguiar, RS
   Moll, FT
AF Galliez, Rafael Mello
   Spitz, Mariana
   Rafful, Patricia Piazza
   Cagy, Marcelo
   Escosteguy, Claudia
   Brito Germano, Caroline Sposito
   Sasse, Elisa
   Goncalves, Alessandro Luis
   Silveira, Paola Paz
   Pezzuto, Paula
   de Magalhaes Ornelas, Alice Maria
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Moll, Fernanda Tovar
TI Zika Virus Causing Encephalomyelitis Associated With Immunoactivation
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE encephalomyelitis; neurological manifestations; proinflammatory
   cytokines; Zika virus
ID JAPANESE ENCEPHALITIS
AB Brazil has experienced a Zika virus (ZIKV) outbreak with increased incidence of congenital malformations and neurological manifestations. We describe a case of a 26-year-old Brazilian Caucasian man infected with ZIKV and diagnosed with encephalomyelitis. Brain and spinal cord images showed hyperintense lesions on T2 and fluid-attenuated inversion recovery (FLAIR), and levels of proinflammatory cytokines in the cerebrospinal fluid showed a remarkable increase of interleukin (IL)-6 and IL-8. The observed pattern suggests immune activation during the acute phase, along with the neurological impairment, with normalization in the recovery phase. This is the first longitudinal report of ZIKV infection causing encephalomyelitis with documented immune activation.
C1 [Galliez, Rafael Mello] Inst Estadual Infectol Sao Sebastiao, Rio De Janeiro, Brazil.
   [Galliez, Rafael Mello] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Spitz, Mariana; Cagy, Marcelo; Brito Germano, Caroline Sposito; Sasse, Elisa] Hosp Fed Servidores Estado, Neurol Serv, Rio De Janeiro, Brazil.
   [Escosteguy, Claudia] Hosp Fed Servidores Estado, Epidemiol Serv, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza; Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; Moll, Fernanda Tovar] Dor Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rafful, Patricia Piazza] Univ Fed Rio de Janeiro, Radiol Dept, BR-21941 Rio De Janeiro, Brazil.
   [Goncalves, Alessandro Luis; Silveira, Paola Paz; Pezzuto, Paula; de Magalhaes Ornelas, Alice Maria; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Genet Dept, Inst Biol, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941 Rio De Janeiro, Brazil.
   [Moll, Fernanda Tovar] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, BR-21941 Rio De Janeiro, Brazil.
RP Moll, FT (corresponding author), Rua Diniz Cordeiro 30, BR-22281100 Botafogo, RJ, Brazil.
EM fernanda.tovarmoll@idor.org
RI Galliez, Rafael Mello/AAA-2724-2020; Escosteguy, Claudia
   Caminha/D-1043-2010; Aguiar, Renato S/G-3542-2015
OI Galliez, Rafael Mello/0000-0003-0348-8374; Escosteguy, Claudia
   Caminha/0000-0003-0273-6911; Aguiar, Renato S/0000-0001-5180-3717
FU Brazilian Council for Development of Science and Technology; CAPES
   FoundationCAPES; Brazilian Ministry of Education; Rio de Janeiro
   Foundation; D'Or Institute for Research and Education
FX This work was funded by different grants from the Brazilian Council for
   Development of Science and Technology, the CAPES Foundation, Brazilian
   Ministry of Education, the Rio de Janeiro Foundation for the Support of
   Science, and intramural grants from D'Or Institute for Research and
   Education.
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Jeha LE, 2003, NEUROLOGY, V61, P55, DOI 10.1212/01.WNL.0000073617.08185.0A
   Kalita J, 2000, J NEUROL SCI, V174, P3, DOI 10.1016/S0022-510X(99)00318-4
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nandan VA, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/487659
   Thabet FI, 2013, PEDIATR NEUROL, V48, P393, DOI 10.1016/j.pediatrneurol.2012.12.017
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
NR 9
TC 15
Z9 16
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD FAL
PY 2016
VL 3
IS 4
DI 10.1093/ofid/ofw203
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0ZI
UT WOS:000388572800009
PM 28053996
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Valadao, ALC
   Aguiar, RS
   de Arruda, LB
AF Valadao, Ana L. C.
   Aguiar, Renato S.
   de Arruda, Luciana B.
TI Interplay between Inflammation and Cellular Stress Triggered by
   Flaviviridae Viruses
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus; innate immune response; ER stress; reactive oxygen species;
   stress granules
ID HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN
   RESPONSE; PATTERN-RECOGNITION RECEPTORS; IRF3 TRANSCRIPTION FACTOR;
   INNATE IMMUNE-RESPONSES; BETA GENE-EXPRESSION; TOLL-LIKE RECEPTOR-3;
   SPECK-LIKE PROTEIN; FACTOR-KAPPA-B
AB The Flaviviridae family comprises several human pathogens, including Dengue, Zika, Yellow Fever, West Nile, Japanese Encephalitis viruses, and Hepatitis C Virus. Those are enveloped, single-stranded positive sense RNA viruses, which replicate mostly in intracellular compartments associated to endoplasmic reticulum (ER) and Golgi complex. Virus replication results in abundant viral RNAs and proteins, which are recognized by cellular mechanisms evolved to prevent virus infection, resulting in inflammation and stress responses. Virus RNA molecules are sensed by Toll-like receptors (TLRs), RIG-I-like receptors (RIG-I and MDA5) and RNA-dependent protein kinases (PKR), inducing the production of inflammatory mediators and interferons. Simultaneously, the synthesis of virus RNA and proteins are distinguished in different compartments such as mitochondria, ER and cytoplasmic granules, triggering intracellular stress pathways, including oxidative stress, unfolded protein response pathway, and stress granules assembly. Here, we review the new findings that connect the inflammatory pathways to cellular stress sensors and the strategies of Flaviviridae members to counteract these cellular mechanisms and escape immune response.
C1 [Valadao, Ana L. C.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
RP de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
EM arruda@micro.ufrj.br
RI Arruda, Luciana B/N-9086-2013; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU CAPESCAPES; CAPES/PVE-Program; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, and FAPERJ.
   AV is the recipient of a FAPERJ fellowship.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Asdonk T, 2012, BIOCHEM BIOPH RES CO, V420, P66, DOI 10.1016/j.bbrc.2012.02.116
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888
   Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005
   Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004
   Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673
   Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Chakrabarti A, 2012, J VIROL, V86, P11311, DOI 10.1128/JVI.00270-12
   Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082
   Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50
   Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953
   Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Daito T, 2014, GASTROENTEROLOGY, V147, P463, DOI 10.1053/j.gastro.2014.04.035
   Dang SS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-424
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004
   Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948
   Eksioglu EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021186
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Finnen RL, 2012, J VIROL, V86, P8119, DOI 10.1128/JVI.00313-12
   Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004
   Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019
   Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010
   Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652
   Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352
   He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833
   He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926
   Iglesias NG, 2009, VIRAL GENOME REPLICATION, P41, DOI 10.1007/b135974_3
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Ishikawa H, 2008, NATURE, V456, P274, DOI 10.1038/nature07432
   Ivanov AV, 2015, VIRUSES-BASEL, V7, P2745, DOI 10.3390/v7062745
   Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Jain B, 2014, MICROB PATHOGENESIS, V69-70, P45, DOI 10.1016/j.micpath.2014.03.004
   Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006
   Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251
   Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221
   Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kim HJ, 2015, AM J RESP CELL MOL, V53, P525, DOI 10.1165/rcmb.2014-0334OC
   Kim SK, 2015, PUBLIC MANAG REV, V17, P328, DOI 10.1080/14719037.2013.822530
   Klassen P, 2004, NUTRITION, V20, P542, DOI 10.1016/j.nut.2004.03.016
   Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2
   Langereis MA, 2013, J VIROL, V87, P6314, DOI 10.1128/JVI.03213-12
   Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527
   Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390
   Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7
   Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690
   Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008
   Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7
   Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007
   Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108
   Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210
   Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782
   Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007
   Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328
   Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823
   Mottola G, 2002, VIROLOGY, V293, P31, DOI 10.1006/viro.2001.1229
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Nazmi A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00347
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031
   Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008
   Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7
   Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x
   Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pesne V, 2015, J VIROL, V89, P5462, DOI 10.1128/JVI.03197-14
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415
   Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09
   Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Qin CF, 2011, MOL BIOL REP, V38, P3867, DOI 10.1007/s11033-010-0502-7
   Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11
   Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017
   Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0
   SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Sen D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00250
   Seronello S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027436
   Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Sou SN, 2012, BIOCHEM BIOPH RES CO, V420, P473, DOI 10.1016/j.bbrc.2012.03.030
   Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930
   Soundravally R, 2008, ACTA TROP, V106, P156, DOI 10.1016/j.actatropica.2008.03.001
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054
   Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520
   Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492
   Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078
   Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002
   Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372
   Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387
   Tsai WC, 2014, ANNU REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819
   Valiente-Echeverria F, 2012, VIRUS RES, V169, P430, DOI 10.1016/j.virusres.2012.06.004
   Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009
   Vasallo C, 2015, VIRUS RES, V209, P100, DOI 10.1016/j.virusres.2015.03.013
   von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x
   White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001
   Williams KL, 2009, ANN NY ACAD SCI, V1171, pE12, DOI 10.1111/j.1749-6632.2009.05057.x
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291
   Xu Z, 1998, J INTERF CYTOK RES, V18, P609, DOI 10.1089/jir.1998.18.609
   Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1
   Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552
   Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012
   Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09
   Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2
   Zhou RB, 2011, NATURE, V475, DOI 10.1038/nature10156
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
   Zou J, 2013, IMMUNITY, V38, P717, DOI 10.1016/j.immuni.2012.12.007
NR 209
TC 24
Z9 25
U1 1
U2 24
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 25
PY 2016
VL 7
AR 1233
DI 10.3389/fmicb.2016.01233
PG 19
WC Microbiology
SC Microbiology
GA DT9VS
UT WOS:000381851000001
PM 27610098
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Calvet, G
   Aguiar, RS
   Melo, ASO
   Sampaio, SA
   de Filippis, I
   Fabri, A
   Araujo, ESM
   de Sequeira, PC
   de Mendonca, MCL
   de Oliveira, L
   Tschoeke, DA
   Schrago, CG
   Thompson, FL
   Brasil, P
   dos Santos, FB
   Nogueira, RMR
   Tanurit, A
   Filippis, AMB
AF Calvet, Guilherme
   Aguiar, Renato S.
   Melo, Adriana S. O.
   Sampaio, Simone A.
   de Filippis, Ivano
   Fabri, Allison
   Araujo, Eliane S. M.
   de Sequeira, Patricia C.
   de Mendonca, Marcos C. L.
   de Oliveira, Louisi
   Tschoeke, Diogo A.
   Schrago, Carlos G.
   Thompson, Fabiano L.
   Brasil, Patricia
   dos Santos, Flavia B.
   Nogueira, Rita M. R.
   Tanurit, Amilcar
   de Filippis, Ana M. B.
TI Detection and sequencing of Zika virus from amniotic fluid of fetuses
   with microcephaly in Brazil: a case study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; INFECTION; OUTBREAK; FEVER
AB Background The incidence of microcephaly in Brazil in 2015 was 20 times higher than in previous years. Congenital microcephaly is associated with genetic factors and several causative agents. Epidemiological data suggest that microcephaly cases in Brazil might be associated with the introduction of Zika virus. We aimed to detect and sequence the Zika virus genome in amniotic fluid samples of two pregnant women in Brazil whose fetuses were diagnosed with microcephaly.
   Methods In this case study, amniotic fluid samples from two pregnant women from the state of Paraiba in Brazil whose fetuses had been diagnosed with microcephaly were obtained, on the recommendation of the Brazilian health authorities, by ultrasound-guided transabdominal amniocentesis at 28 weeks' gestation. The women had presented at 18 weeks' and 10 weeks' gestation, respectively, with clinical manifestations that could have been symptoms of Zika virus infection, including fever, myalgia, and rash. After the amniotic fluid samples were centrifuged, DNA and RNA were extracted from the purified virus particles before the viral genome was identified by quantitative reverse transcription PCR and viral metagenomic next-generation sequencing. Phylogenetic reconstruction and investigation of recombination events were done by comparing the Brazilian Zika virus genome with sequences from other Zika strains and from flaviviruses that occur in similar regions in Brazil.
   Findings We detected the Zika virus genome in the amniotic fluid of both pregnant women. The virus was not detected in their urine or serum. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, Treponema pallidum, and parvovirus B19 were all negative. After sequencing of the complete genome of the Brazilian Zika virus isolated from patient 1, phylogenetic analyses showed that the virus shares 97-100% of its genomic identity with lineages isolated during an outbreak in French Polynesia in 2013, and that in both envelope and NS 5 genomic regions, it clustered with sequences from North and South America, southeast Asia, and the Pacific. After assessing the possibility of recombination events between the Zika virus and other flaviviruses, we ruled out the hypothesis that the Brazilian Zika virus genome is a recombinant strain with other mosquito-borne flaviviruses.
   Interpretation These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil. Moreover, our results suggest that the virus can cross the placental barrier. As a result, Zika virus should be considered as a potential infectious agent for human fetuses. Pathogenesis studies that confirm the tropism of Zika virus for neuronal cells are warranted.
C1 [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, BR-21040900 Rio De Janeiro, Brazil.
   [Sampaio, Simone A.; Fabri, Allison; Araujo, Eliane S. M.; de Sequeira, Patricia C.; de Mendonca, Marcos C. L.; dos Santos, Flavia B.; Nogueira, Rita M. R.; de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Nacl Controle & Qualidade, BR-21040900 Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; de Oliveira, Louisi; Schrago, Carlos G.; Tanurit, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Tschoeke, Diogo A.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Melo, Adriana S. O.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestaotecnol CT2, Rio de Janeiro, Brazil.
RP Filippis, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
EM abispo@ioc.fiocruz.br
RI Calvet, GA/G-6959-2013; Melo, Adriana S O/H-5650-2016; Aguiar, Renato
   S/G-3542-2015; Tschoeke, Diogo A/F-9913-2019; Schrago,
   Carlos/E-4612-2012; amsalu, ribka/G-8780-2019; de Filippis,
   Ivano/X-8759-2019
OI Calvet, GA/0000-0002-3545-5238; Aguiar, Renato S/0000-0001-5180-3717;
   Tschoeke, Diogo A/0000-0001-8134-4259; Schrago,
   Carlos/0000-0001-6257-8906; de Filippis, Ivano/0000-0003-0610-8648
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
FX Consellho Nacional de Desenvolvimento e Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, 2016, MINIST SAFICLE INVES
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Lanari M, 2012, EARLY HUM DEV, V88, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 561
Z9 583
U1 8
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 653
EP 660
DI 10.1016/S1473-3099(16)00095-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500044
PM 26897108
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU Mishra, M
   Varghese, RK
   Verma, A
   Das, S
   Aguiar, RS
   Tanuri, A
   Mahadevan, A
   Shankar, SK
   Satishchandra, P
   Ranga, U
AF Mishra, Mamata
   Varghese, Rebu K.
   Verma, Anjali
   Das, Sutanuka
   Aguiar, Renato Santana
   Tanuri, Amilcar
   Mahadevan, Anita
   Shankar, Susarla K.
   Satishchandra, Parthasarathy
   Ranga, Udaykumar
TI Genetic diversity and proviral DNA load in different neural compartments
   of HIV-1 subtype C infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE HIV-1; Subtype C; HIV-associated dementia; Proviral load
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CLADE-SPECIFIC DIFFERENCES;
   HIV-1-ASSOCIATED DEMENTIA; NONDEMENTED PATIENTS; CORECEPTOR USAGE; LOOP
   SEQUENCES; VIRAL LOAD; TYPE-1 DNA; RNA LEVELS; BRAIN
AB In India, the low prevalence of HIV-associated dementia (HAD) in the Human immunodeficiency virus type 1 (HIV-1) subtype C infection is quite paradoxical given the high-rate of macrophage infiltration into the brain. Whether the direct viral burden in individual brain compartments could be associated with the variability of the neurologic manifestations is controversial. To understand this paradox, we examined the proviral DNA load in nine different brain regions and three different peripheral tissues derived from ten human subjects at autopsy. Using a highly sensitive TaqMan probe-based real-time PCR, we determined the proviral load in multiple samples processed in parallel from each site. Unlike previously published reports, the present analysis identified uniform proviral distribution among the brain compartments examined without preferential accumulation of the DNA in any one of them. The overall viral DNA burden in the brain tissues was very low, approximately 1 viral integration per 1000 cells or less. In a subset of the tissue samples tested, the HIV DNA mostly existed in a free unintegrated form. The V3-V5 envelope sequences, demonstrated a brain-specific compartmentalization in four of the ten subjects and a phylogenetic overlap between the neural and non-neural compartments in three other subjects. The envelope sequences phylogenetically belonged to subtype C and the majority of them were R5 tropic. To the best of our knowledge, the present study represents the first analysis of the proviral burden in subtype C postmortem human brain tissues. Future studies should determine the presence of the viral antigens, the viral transcripts, and the proviral DNA, in parallel, in different brain compartments to shed more light on the significance of the viral burden on neurologic consequences of HIV infection.
C1 [Mishra, Mamata; Varghese, Rebu K.; Verma, Anjali; Das, Sutanuka; Ranga, Udaykumar] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Bangalore 560012, Karnataka, India.
   [Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Mahadevan, Anita; Shankar, Susarla K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore, Karnataka, India.
   [Satishchandra, Parthasarathy] Natl Inst ofMental Hlth & Neuro Sci, Dept Neurol, Bangalore, Karnataka, India.
RP Ranga, U (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, HIV AIDS Lab, Bangalore 560012, Karnataka, India.
EM udaykumar@jncasr.ac.in
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU Department of Science and Technology, India under the Indo-Brazil
   Research program [DST/INT/Brazil/RPO-02/2009(i)]; JNCASRDepartment of
   Science & Technology (India); Council of Science and Industrial Research
   fellowship from the Government of India
FX This study was supported by grants from the Department of Science and
   Technology, India under the Indo-Brazil Research program
   (DST/INT/Brazil/RPO-02/2009(i)) and intramural grants from JNCASR to UR.
   MM was supported by a post-doctoral fellowship and SD by a student
   fellowship from JNCASR. AV is a recipient of the Council of Science and
   Industrial Research fellowship from the Government of India.
CR ACHIM CL, 1994, J NEUROPATH EXP NEUR, V53, P284, DOI 10.1097/00005072-199405000-00010
   Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895
   Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195
   An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005
   An SF, 1996, ANN NEUROL, V40, P611, DOI 10.1002/ana.410400411
   Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
   Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158
   BELL JE, 1993, J INFECT DIS, V168, P818, DOI 10.1093/infdis/168.4.818
   BOCKSTAHLER LE, 1995, CLIN DIAGN VIROL, V3, P61, DOI 10.1016/0928-0197(94)00023-N
   BREW BJ, 1995, ANN NEUROL, V38, P563, DOI 10.1002/ana.410380404
   Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016
   Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa
   Chan LG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000662
   Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005
   Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003
   Das Gupta J, 2007, J NEUROVIROL, V13, P195, DOI 10.1080/13550280701258407
   Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6
   Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114
   Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857
   Fujimura RK, 1997, J ACQ IMMUN DEF SYND, V16, P146, DOI 10.1097/00042560-199711010-00002
   Gartner S, 2002, J NEUROVIROL, V8, P69, DOI 10.1080/13550280290049525
   GLASS JD, 1993, NEUROLOGY, V43, P2230, DOI 10.1212/WNL.43.11.2230
   GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510
   Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06
   Gonzalez RG, 2000, AIDS, V14, P2841, DOI 10.1097/00002030-200012220-00005
   Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527
   Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001
   Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171
   Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231
   Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006
   Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003
   Johnson RT, 1996, ANN NEUROL, V39, P392, DOI 10.1002/ana.410390319
   Kumar AM, 2007, J NEUROVIROL, V13, P210, DOI 10.1080/13550280701327038
   Lamers SL, 2011, INFECT GENET EVOL, V11, P31, DOI 10.1016/j.meegid.2010.10.016
   Lazarini F, 1997, J NEUROVIROL, V3, P299, DOI 10.3109/13550289709029471
   Liu YL, 2000, J NEUROVIROL, V6, pS70
   Mahadevan A, 2007, J NEUROPATH EXP NEUR, V66, P799, DOI 10.1097/NEN.0b013e3181461d3e
   Muniyandi Karthigaipriya, 2012, Indian J Psychiatry, V54, P149, DOI 10.4103/0019-5545.99534
   Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141
   Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003
   Pace MJ, 2011, VIROLOGY, V411, P344, DOI 10.1016/j.virol.2010.12.041
   PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0
   Persidsky Y, 2000, J LEUKOCYTE BIOL, V68, P413
   Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200
   Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004
   Rao VR, 2008, J NEUROSCI, V28, P10010, DOI 10.1523/JNEUROSCI.2955-08.2008
   Riedel D, 2006, J NEUROVIROL, V12, P34, DOI 10.1080/13550280500516500
   Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615
   SAINI S, 2014, INT J NUTR PHARM NEU, V4, P252, DOI DOI 10.4103/2231-0738.139408
   Satishchandra P, 2000, INDIAN J MED RES, V111, P14
   Shankar SK, 2005, INDIAN J MED RES, V121, P468
   SHAW GM, 1985, SCIENCE, V227, P177, DOI 10.1126/science.2981429
   Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89
   Singh R, 2011, ANN INDIAN ACAD NEUR, V14, P172, DOI 10.4103/0972-2327.85878
   STEVENSON M, 1990, J VIROL, V64, P2421, DOI 10.1128/JVI.64.5.2421-2425.1990
   Teo I, 1997, J VIROL, V71, P2928, DOI 10.1128/JVI.71.4.2928-2933.1997
   Wadia R S, 2001, J Assoc Physicians India, V49, P343
   White D A, 1995, J Int Neuropsychol Soc, V1, P304
   WILEY CA, 1994, ADV NEUROIMMUNOL, V4, P319, DOI 10.1016/S0960-5428(06)80272-X
   Wiley CA, 1998, BRAIN PATHOL, V8, P277
   Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13
   Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047
   Zhou L, 2013, INFECT DIS REP, V5, P38, DOI 10.4081/idr.2013.s1.e8
   Zink MC, 1999, J VIROL, V73, P10480, DOI 10.1128/JVI.73.12.10480-10488.1999
NR 64
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD AUG
PY 2015
VL 21
IS 4
BP 399
EP 414
DI 10.1007/s13365-015-0328-0
PG 16
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA CN3OL
UT WOS:000358336100007
PM 25750071
DA 2020-10-22
ER

PT J
AU Valadao, ALC
   Abreu, CM
   Dias, JZ
   Arantes, P
   Verli, H
   Tanuri, A
   de Aguiar, RS
AF Chaves Valadao, Ana Luiza
   Abreu, Celina Monteiro
   Dias, Juliana Zanatta
   Arantes, Pablo
   Verli, Hugo
   Tanuri, Amilcar
   de Aguiar, Renato Santana
TI Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by
   Interfering with Reverse Transcriptase Activity
SO MOLECULES
LA English
DT Article
DE HIV-1; emetine; Reverse Transcriptase; PBMC; resistance
ID IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; IN-VITRO; RNASE-H;
   IDENTIFICATION; MICROBICIDES; PROPHYLAXIS; MECHANISM; DOMAINS
AB Ipecac alkaloids are secondary metabolites produced in the medicinal plant Psychotria ipecacuanha. Emetine is the main alkaloid of ipecac and one of the active compounds in syrup of Ipecac with emetic property. Here we evaluated emetine's potential as an antiviral agent against Human Immunodeficiency Virus. We performed in vitro Reverse Transcriptase (RT) Assay and Natural Endogenous Reverse Transcriptase Activity Assay (NERT) to evaluate HIV RT inhibition. Emetine molecular docking on HIV-1 RT was also analyzed. Phenotypic assays were performed in non-lymphocytic and in Peripheral Blood Mononuclear Cells (PBMC) with HIV-1 wild-type and HIV-harboring RT-resistant mutation to Nucleoside Reverse Transcriptase Inhibitors (M184V). Our results showed that HIV-1 RT was blocked in the presence of emetine in both models: in vitro reactions with isolated HIV-1 RT and intravirion, measured by NERT. Emetine revealed a strong potential of inhibiting HIV-1 replication in both cellular models, reaching 80% of reduction in HIV-1 infection, with low cytotoxic effect. Emetine also blocked HIV-1 infection of RT M184V mutant. These results suggest that emetine is able to penetrate in intact HIV particles, and bind and block reverse transcription reaction, suggesting that it can be used as anti-HIV microbicide. Taken together, our findings provide additional pharmacological information on the potential therapeutic effects of emetine.
C1 [Chaves Valadao, Ana Luiza; Abreu, Celina Monteiro; Dias, Juliana Zanatta; Tanuri, Amilcar; de Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Lab Virol Mol, Dept Genet, Inst Biol, BR-21941902 Rio De Janeiro, Brazil.
   [Arantes, Pablo; Verli, Hugo] Univ Fed Rio Grande do Sul, Grp Bioinformat Estrutural, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
RP Valadao, ALC (corresponding author), Univ Fed Rio de Janeiro, Lab Virol Mol, Dept Genet, Inst Biol, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM analu.valadao@gmail.com; celydion@gmail.com; juzdias@gmail.com;
   pablitoarantes@gmail.com; hverli@cbiot.ufrgs.br;
   atanuri@biologia.ufrj.br; santana@biologia.ufrj.br
RI Abreu, Celina Monteiro/AAT-7447-2020; Aguiar, Renato S/G-3542-2015;
   Verli, Hugo/G-8703-2012
OI Aguiar, Renato S/0000-0001-5180-3717; Verli, Hugo/0000-0002-4796-8620
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); MCT by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), MEC, Brasilia, DF, Brazil; Fundacao de Amparo a
   Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Foundation for Research
   Support of the State of Rio Grande do Sul (FAPERGS)
FX The following reagents were obtained through the NIH AIDS Research and
   Reference Reagent Program, Division of AIDS, NIAID, NIH: 3TC
   (lamivudine), GHOST cells from Vineet N. Kewal Ramani and Dan R.
   Littman, and MT-4 cells from Douglas Richman. The authors thank Paula
   Pezzuto for the help with FACS. This work was supported by Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), MCT by
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   MEC, Brasilia, DF, Brazil and by Fundacao de Amparo a Pesquisa do Estado
   do Rio Grande do Sul (FAPERGS).
CR Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200
   Aguiar RS, 2007, ANTIMICROB AGENTS CH, V51, P638, DOI 10.1128/AAC.00749-06
   [Anonymous], 2014, GAP REP 2014 PEOPL L
   Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524
   BELLER BM, 1968, CIRC RES, V22, P501, DOI 10.1161/01.RES.22.4.501
   Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657
   BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231
   Bunge K, 2012, JAIDS-J ACQ IMM DEF, V60, P337, DOI 10.1097/QAI.0b013e3182575914
   Celum Connie L, 2011, Top Antivir Med, V19, P181
   De Clercq E, 2000, MED RES REV, V20, P323, DOI 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A
   DeLano WL, PYMOL MOL GRAPHICS S
   Deng L, 2007, J VIROL, V81, P13392, DOI 10.1128/JVI.00770-07
   Domingo E, 1997, J NUTR, V127, pS958, DOI 10.1093/jn/127.5.958S
   Dornadula G, 1997, VIROLOGY, V227, P260, DOI 10.1006/viro.1996.8317
   ERIKSSON BFH, 1989, ANTIMICROB AGENTS CH, V33, P663, DOI 10.1128/AAC.33.5.663
   Esteves AIS, 2011, MAR DRUGS, V9, P139, DOI 10.3390/md9010139
   Garg S, 2003, AIDS PATIENT CARE ST, V17, P377, DOI 10.1089/108729103322277402
   Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x
   Harrigan PR, 2010, CLIN INFECT DIS, V50, P1286, DOI 10.1086/651685
   Ilina T, 2008, ADV PHARMACOL, V56, P121, DOI 10.1016/S1054-3589(07)56005-9
   JANOT MM, 1953, ALKALOIDS-CHEM BIOL, V3, P363
   Johnson Victoria A, 2011, Top Antivir Med, V19, P156
   Karim QA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-67
   Karim QA, 2011, CONTEMP CLIN TRIALS, V32, P333, DOI 10.1016/j.cct.2011.01.005
   Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748
   Larsson DE, 2006, ANTICANCER RES, V26, P4125
   Larsson DE, 2009, CANCER CHEMOTH PHARM, V65, P5, DOI 10.1007/s00280-009-0997-6
   LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x
   Lengruber RB, 2011, J ANTIMICROB CHEMOTH, V66, P702, DOI 10.1093/jac/dkr005
   MAASS G, 1993, ANTIMICROB AGENTS CH, V37, P2612, DOI 10.1128/AAC.37.12.2612
   Mehrotra PK, 2004, CONTRACEPTION, V69, P379, DOI 10.1016/j.contraception.2003.12.011
   Sierra RMY, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-104
   Moller M, 2007, ONCOL REP, V18, P737
   Monini P, 2004, NAT REV CANCER, V4, P861, DOI 10.1038/nrc1479
   Morner A, 1999, J VIROL, V73, P2343
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Naswa Smriti, 2011, Indian J Sex Transm Dis AIDS, V32, P1, DOI 10.4103/0253-7184.81246
   Nomura T, 2010, PLANT SIGNAL BEHAV, V5, P875, DOI [10.4161/psb.5.7.11901, 10.1074/jbc.M109.086157]
   O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Panel O.T.C., 1980, FED REGISTER, V45, P82014
   Parniak MA, 2001, AIDS, V15, pS56, DOI 10.1097/00002030-200102001-00079
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998
   POWELL SJ, 1971, B NEW YORK ACAD MED, V47, P469
   PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924
   Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071
   Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Seger D, 2004, J TOXICOL-CLIN TOXIC, V42, P133, DOI 10.1081/CLT-120037421
   Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p
   Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959
   TAN GT, 1991, J BIOL CHEM, V266, P23529
   Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711
   TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653
   VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504
   WHO, 2012, HIV DRUG RES REP 201
   WIEGREBE W, 1984, J NAT PROD, V47, P397, DOI 10.1021/np50033a001
   Yin Low JS, 2009, J ANTIVIR ANTIRETROV, V1, P62, DOI DOI 10.4172/JAA.1000009
   Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519
NR 63
TC 17
Z9 18
U1 0
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD JUN
PY 2015
VL 20
IS 6
BP 11474
EP 11489
DI 10.3390/molecules200611474
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA CM8ZE
UT WOS:000357992700120
PM 26111177
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU de Carvalho, JV
   de Castro, RO
   da Silva, EZM
   Silveira, PP
   da Silva-Januario, ME
   Arruda, E
   Jamur, MC
   Oliver, C
   Aguiar, RS
   Dasilva, LLP
AF de Carvalho, Julianne V.
   de Castro, Rodrigo O.
   da Silva, Elaine Z. M.
   Silveira, Paola P.
   da Silva-Januario, Mara E.
   Arruda, Eurico
   Jamur, Maria C.
   Oliver, Constance
   Aguiar, Renato S.
   daSilva, Luis L. P.
TI Nef Neutralizes the Ability of Exosomes from CD4(+) T Cells to Act as
   Decoys during HIV-1 Infection
SO PLOS ONE
LA English
DT Article
ID VIRUS TYPE-1 NEF; COMPLEX CLASS-I; LONG-TERM SURVIVOR; DOWN-REGULATION;
   SOLUBLE CD4; MHC-I; INTRACELLULAR TRAFFICKING; MULTIVESICULAR BODIES;
   REDUCED SENSITIVITY; CYTOPLASMIC DOMAIN
AB Nef is an HIV-1 accessory protein that promotes viral replication and pathogenesis. A key function of Nef is to ensure sustained depletion of CD4 and MHC-I molecules in infected cells by inducing targeting of these proteins to multivesicular bodies (MVBs), and ultimately to lysosomes for degradation. Nef also affects cellular secretory routes promoting its own secretion via exosomes. To better understand the effects of Nef on the exocytic pathway, we investigated whether this viral factor modifies the composition of exosomes released by T lymphocytes. We showed that both CD4 and MHC-I molecules are secreted in exosomes from T cells and that the expression of Nef reduces the amount of these proteins in exosomes. To investigate the functional role for this novel activity of Nef, we performed in vitro HIV-1 infection assays in the presence of distinct populations of exosomes. We demonstrated that exosomes released by CD4(+) T cells, but not CD4(-) T cells, efficiently inhibit HIV-1 infection in vitro. Because CD4 is the main receptor for HIV-1 infection, these results suggest that CD4 molecules displayed on the surface of exosomes can bind to envelope proteins of HIV-1 hindering virus interaction with target cells and infection. Importantly, CD4-depleted exosomes released by CD4(+) T cells expressing Nef have a reduced capacity to inhibit HIV-1 infection in vitro. These results provide evidence that Nef promotes HIV-1 infection by reducing the expression of CD4 in exosomes from infected cells, besides the original role of Nef in reducing the CD4 levels at the cell surface.
C1 [de Carvalho, Julianne V.; de Castro, Rodrigo O.; da Silva, Elaine Z. M.; da Silva-Januario, Mara E.; Arruda, Eurico; Jamur, Maria C.; Oliver, Constance; daSilva, Luis L. P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil.
   [Silveira, Paola P.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
RP Dasilva, LLP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, BR-14049 Ribeirao Preto, Brazil.
EM lldasilva@fmrp.usp.br
RI Silveira, Patricia P/A-7139-2011; Arruda, Eurico/E-4101-2012; daSilva,
   Luis LP/AAD-5657-2019; Da Silva, Elaine Z/O-5535-2015; Aguiar, Renato
   S/G-3542-2015; daSilva, Luis LP/A-9949-2010
OI daSilva, Luis LP/0000-0003-3558-0087; Da Silva, Elaine
   Z/0000-0002-2749-6275; Aguiar, Renato S/0000-0001-5180-3717; daSilva,
   Luis LP/0000-0003-3558-0087
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2009/50650-6]; Brazilian National Council
   for Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [470707/2009-7];
   Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das
   Clinicas, FMRP-USP; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX The work in this article was supported by the Sao Paulo Research
   Foundation (FAPESP), through a Young Investigators grant (nr.
   2009/50650-6) (http://www.fapesp.br/en/), by the Brazilian National
   Council for Scientific and Technological Development (CNPq) project nr.
   470707/2009-7 (http://www.cnpq.br) and by the Fundacao de Apoio ao
   Ensino, Pesquisa e Assistencia do Hospital das Clinicas, FMRP-USP to
   LLPdS, JVC and EZMS thank FAPESP for a doctoral fellowship. ROC was
   supported by a postdoctoral training grant from FAPESP. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200
   Amorim NA, 2014, J BIOL CHEM, V289, P27744, DOI 10.1074/jbc.M114.560193
   ANDERSON SJ, 1994, J VIROL, V68, P3092, DOI 10.1128/JVI.68.5.3092-3101.1994
   Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200
   Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002
   BENSON RE, 1993, J EXP MED, V177, P1561, DOI 10.1084/jem.177.6.1561
   Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009
   Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5
   Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014
   Bruno CJ, 2010, J ANTIMICROB CHEMOTH, V65, P1839, DOI 10.1093/jac/dkq261
   Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x
   Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267
   Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049
   Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08
   Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951
   Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929
   Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33
   DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574
   daSilva LLP, 2009, J VIROL, V83, P6578, DOI 10.1128/JVI.00548-09
   DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988
   Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010
   Dustin ML, 2014, MOL BIOL CELL, V25, P1699, DOI 10.1091/mbc.E13-11-0636
   Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x
   FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906
   FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539
   Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84
   Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964
   Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041
   Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360
   HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081
   Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004
   Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002
   Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973
   KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I
   KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405
   KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011
   Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084
   Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440
   Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821
   Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X
   LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383
   Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x
   Leonard JA, 2011, J VIROL, V85, P6867, DOI 10.1128/JVI.00229-11
   Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218
   Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200
   Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996
   Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   Melikyan GB, 2014, CURR OPIN VIROL, V4, P1, DOI 10.1016/j.coviro.2013.09.004
   MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101
   MOORE JP, 1991, J VIROL, V65, P1133, DOI 10.1128/JVI.65.3.1133-1140.1991
   Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009
   Naslund TI, 2014, AIDS, V28, P171, DOI 10.1097/QAD.0000000000000159
   Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07
   ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993
   Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5
   Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   RHEE SS, 1994, J VIROL, V68, P5156, DOI 10.1128/JVI.68.8.5156-5163.1994
   Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05
   Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031
   Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873
   SANFRIDSON A, 1994, J BIOL CHEM, V269, P3917
   Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131
   Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x
   SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993
   Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211
   Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534
   Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567
   Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200
   Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11
   Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616
NR 74
TC 31
Z9 32
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2014
VL 9
IS 11
AR e113691
DI 10.1371/journal.pone.0113691
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AU9GL
UT WOS:000345899700054
PM 25423108
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Silveira, P
   Orlandini, R
   Cunha, R
   Barbizan, T
   Pianowski, L
   Da Silva, L
   Tanuri, A
   Aguiar, R
AF Silveira, Paola
   Orlandini, Rodrigo
   Cunha, Rodrigo
   Barbizan, Thais
   Pianowski, Luis
   Da Silva, Luis
   Tanuri, Amilcar
   Aguiar, Renato
TI Jatropha sp Extracts Induces CD4 Internalization and Inhibits HIV-1
   Entry
SO AIDS RESEARCH AND HUMAN RETROVIRUSES
LA English
DT Meeting Abstract
CT Symposium on HIV Research for Prevention (HIV R4P)
CY OCT 28-31, 2014
CL Cape Town, SOUTH AFRICA
C1 [Silveira, Paola; Cunha, Rodrigo; Tanuri, Amilcar; Aguiar, Renato] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Orlandini, Rodrigo; Da Silva, Luis] Univ Fed Sao Paulo, Ribeirao Preto, Brazil.
   [Barbizan, Thais; Pianowski, Luis] Kyolab Labs, Valinhos, Brazil.
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0889-2229
EI 1931-8405
J9 AIDS RES HUM RETROV
JI Aids Res. Hum. Retrovir.
PD OCT 1
PY 2014
VL 30
SU 1
MA P15.03
BP A142
EP A142
DI 10.1089/aid.2014.5285.abstract
PG 1
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AT2OO
UT WOS:000344774401164
DA 2020-10-22
ER

PT J
AU Higa, LM
   Curi, BM
   Aguiar, RS
   Cardoso, CC
   De Lorenzi, AG
   Sena, SLF
   Zingali, RB
   Da Poian, AT
AF Higa, Luiza M.
   Curi, Bruno M.
   Aguiar, Renato S.
   Cardoso, Cynthia C.
   De Lorenzi, Andre G.
   Sena, Silvia L. F.
   Zingali, Russolina B.
   Da Poian, Andrea T.
TI Modulation of alpha-Enolase Post-Translational Modifications by Dengue
   Virus: Increased Secretion of the Basic Isoforms in Infected Hepatic
   Cells
SO PLOS ONE
LA English
DT Article
ID ALZHEIMERS-DISEASE BRAIN; PLASMINOGEN-BINDING; PROTEOMIC ANALYSIS;
   GLYCOLYTIC ENZYME; IDENTIFICATION; FIBRINOLYSIS; COAGULATION; PROTEINS;
   PATHOGENESIS; ACTIVATION
AB Hepatic cells are major sites of dengue virus (DENV) replication and liver injury constitutes a characteristic of severe forms of dengue. The role of hepatic cells in dengue pathogenesis is not well established, but since hepatocytes are the major source of plasma proteins, changes in protein secretion by these cells during infection might contribute to disease progression. Previously, we showed that DENV infection alters the secretion pattern of hepatic HepG2 cells, with alpha-enolase appearing as one of the major proteins secreted in higher levels by infected cells. ELISA analysis demonstrated that DENV infection modulates alpha-enolase secretion in HepG2 cells in a dose-dependent manner, but has no effect on its gene expression and on the intracellular content of the protein as assessed by PCR and western blot analyses, respectively. Two-dimensional western blots showed that both intracellular and secreted forms of alpha-enolase appear as five spots, revealing alpha-enolase isoforms with similar molecular weights but distinct isoeletric points. Remarkably, quantification of each spot content revealed that DENV infection shifts the isoform distribution pattern of secreted alpha-enolase towards the basic isoforms, whereas the intracellular protein remains unaltered, suggesting that post-translational modifications might be involved in alpha-enolase secretion by infected cells. These findings provide new insights into the mechanisms underlying alpha-enolase secretion by hepatic cells and its relationship with the role of liver in dengue pathogenesis. In addition, preliminary results obtained with plasma samples from DENV-infected patients suggest an association between plasma levels of alpha-enolase and disease severity. Since alpha-enolase binds plasminogen and modulates its activation, it is plausible to speculate the association of the increase in alpha-enolase secretion by infected hepatic cells with the haemostatic dysfunction observed in dengue patients including the promotion of fibrinolysis and vascular permeability alterations.
C1 [Higa, Luiza M.; Curi, Bruno M.; Zingali, Russolina B.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; Cardoso, Cynthia C.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [De Lorenzi, Andre G.; Sena, Silvia L. F.] Hosp Naval Marcilio Dias, Clin Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
EM dapoian@bioqmed.ufrj.br
RI Da Poian, Andrea T./V-1699-2019; Cardoso, Cynthia/K-5824-2012; Aguiar,
   Renato S/G-3542-2015; Higa, Luiza/W-2698-2019
OI Cardoso, Cynthia/0000-0003-0565-7047; Aguiar, Renato
   S/0000-0001-5180-3717; Da Poian, Andrea/0000-0002-3969-704X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [550114/2010-6, 550137/2010-6]; Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/102.919/2011, E-26/110.636/2012]; National Institute of
   Science and Technology in Dengue (INCT-Dengue); International Research
   Staff Exchange Scheme (FP7-PEOPLE IRSES); project MEMPEPACROSS
   [FP7-HEALTH-F3-2008-223414]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, http://www.cnpq.br/, grant numbers
   550114/2010-6 and 550137/2010-6); Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/,
   grant numbers E-26/102.919/2011 and E-26/110.636/2012); National
   Institute of Science and Technology in Dengue (INCT-Dengue,
   http://www.icb.ufmg.br/inctemdengue/); and International Research Staff
   Exchange Scheme (FP7-PEOPLE IRSES), project MEMPEPACROSS (grant number
   FP7-HEALTH-F3-2008-223414). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AARONSON RM, 1995, J BIOL CHEM, V270, P27752, DOI 10.1074/jbc.270.46.27752
   Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x
   Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x
   Cappello P, 2009, INT J CANCER, V125, P639, DOI 10.1002/ijc.24355
   Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435
   Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x
   Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x
   Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003
   Diaz-Ramos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050477
   Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795
   Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0
   FUNAHARA Y, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P346
   Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002
   Gitlits VM, 2001, J INVEST MED, V49, P138, DOI 10.2310/6650.2001.34040
   Guabiraba R, 2013, EUR J IMMUNOL, V43, P1529, DOI 10.1002/eji.201243229
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015
   Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354
   Huang YH, 2001, J MED VIROL, V63, P247, DOI 10.1002/1096-9071(200103)63:3&lt;247::AID-JMV1008&gt;3.0.CO;2-F
   IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0
   ISARANGKURA P B, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P331
   Jang B, 2012, BIOCHEM J, V445, P183, DOI 10.1042/BJ20120025
   Jin X, 2008, BIOCHEM BIOPH RES CO, V371, P804, DOI 10.1016/j.bbrc.2008.04.166
   Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845
   Krishnamurti C, 2001, AM J TROP MED HYG, V65, P840, DOI 10.4269/ajtmh.2001.65.840
   Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A
   Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291
   Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814
   Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Miura N, 2012, EUKARYOT CELL, V11, P1075, DOI 10.1128/EC.00075-12
   Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#
   Newman SF, 2007, J NEUROSCI RES, V85, P1506, DOI 10.1002/jnr.21275
   Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Orsi FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-350
   Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910
   Patramool S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-138
   Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658
   Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200
   Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919
   Pontillo A., 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/870214
   REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x
   Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025
   Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09
   Sosothikul D, 2007, THROMB HAEMOSTASIS, V97, P627, DOI 10.1160/TH06-02-0094
   SRICHAIKUL T, 1977, AM J TROP MED HYG, V26, P525, DOI 10.4269/ajtmh.1977.26.525
   Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004
   Thepparit C, 2004, INTERVIROLOGY, V47, P78, DOI 10.1159/000077830
   Tomaino B, 2011, J PROTEOME RES, V10, P105, DOI 10.1021/pr100213b
   Tsai ST, 2010, EUR J CANCER, V46, P1712, DOI 10.1016/j.ejca.2010.03.018
   van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137
   van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x
   WHO, 2009, DENG GUID DIAGN TREA
   WHO, 2011, COMPR GUID PREV CONT
   Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837
   Yang Hong-bo, 2011, Chinese Medical Sciences Journal, V26, P152
   Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u
   Zhou WD, 2010, J PROTEOME RES, V9, P2929, DOI 10.1021/pr901109w
NR 73
TC 9
Z9 10
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2014
VL 9
IS 8
AR e88314
DI 10.1371/journal.pone.0088314
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO2EE
UT WOS:000341127500001
PM 25171719
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Jose, DP
   Bartholomeeusen, K
   da Cunha, RD
   Abreu, CM
   Glinski, J
   da Costa, TBF
   Rabay, AFMB
   Pianowski, LF
   Dudycz, LW
   Ranga, U
   Peterlin, BM
   Pianowski, LF
   Tanuri, A
   Aguiar, RS
AF Jose, Diego Pandelo
   Bartholomeeusen, Koen
   da Cunha, Rodrigo Delvecchio
   Abreu, Celina Monteiro
   Glinski, Jan
   Ferreira da Costa, Thais Barbizan
   Mello Bacchi Rabay, Ana Flavia
   Pianowski Filho, Luiz Francisco
   Dudycz, Lech W.
   Ranga, Udaykumar
   Peterlin, Boris Matija
   Pianowski, Luiz Francisco
   Tanuri, Amilcar
   Aguiar, Renato Santana
TI Reactivation of latent HIV-1 by new semi-synthetic ingenol esters
SO VIROLOGY
LA English
DT Article
DE HIV; Latency; Ingenol; PKC; NF-kappa B; Resting cells; P-TEFb
ID PROTEIN-KINASE-C; NF-KAPPA-B; P-TEFB; SUBTYPE C; DEACETYLASE INHIBITORS;
   GENE-EXPRESSION; T-LYMPHOCYTES; ACTIVATION; TRANSCRIPTION; REPLICATION
AB The ability of HIV to establish long-lived latent infection is mainly due to transcriptional silencing of viral genome in resting memory T lymphocytes. Here, we show that new semi-synthetic ingenol esters reactivate latent HIV reservoirs. Amongst the tested compounds, 3-caproyl-ingenol (ING B) was more potent in reactivating latent HIV than known activators such as SAHA, ingenol 3,20-dibenzoate, TNF-alpha, PMA and HMBA. ING B activated PKC isoforms followed by NF-kappa B nuclear translocation. As virus reactivation is dependent on intact NF-kappa B binding sites in the LTR promoter region ING B, we have shown that. ING B was able to reactivate virus transcription in primary HIV-infected resting cells up to 12 fold and up to 25 fold in combination with SAHA. Additionally, ING B promoted up-regulation of P-TEFb subunits CDK9/Cyclin TI. The role of ING B on promoting both transcription initiation and elongation makes this compound a strong candidate for an anti-HIV latency drug combined with suppressive HAART. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jose, Diego Pandelo; da Cunha, Rodrigo Delvecchio; Abreu, Celina Monteiro; Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.
   [Bartholomeeusen, Koen; Peterlin, Boris Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Glinski, Jan] PlantaAnalytica LLC, Danbury, CT 06810 USA.
   [Ferreira da Costa, Thais Barbizan; Mello Bacchi Rabay, Ana Flavia; Pianowski Filho, Luiz Francisco; Pianowski, Luiz Francisco] Kyolab Labs, BR-13273105 Sao Paulo, Brazil.
   [Dudycz, Lech W.] Lex Co Res Labs, Shirley, MA 01464 USA.
   [Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bengaluru 560064, India.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Av Carlos Chagas Filho 373 Predio CCS Bloco A, BR-21941971 Rio de Janeiro, RJ, Brazil.
EM santana@biologia.ufrj.br
RI Abreu, Celina Monteiro/AAT-7447-2020; Aguiar, Renato S/G-3542-2015;
   bartholomeeusen, koen/J-1843-2015; Jose, Diego Pandelo/B-4655-2017
OI Aguiar, Renato S/0000-0001-5180-3717; bartholomeeusen,
   koen/0000-0001-9576-2400; Jose, Diego Pandelo/0000-0002-3243-5688
FU Brazilian agencie CNPqNational Council for Scientific and Technological
   Development (CNPq) [480861/2011-0, 405283/2013-0]; Brazilian agencie
   FAPERJ [E-26/111.267/2013]; CNPqNational Council for Scientific and
   Technological Development (CNPq); DST, IndiaDepartment of Science &
   Technology (India)
FX We thank Dr. Morgan Huse and Dr. Kotaro Shirakawa to gently provide the
   human PKC-GFP plasmids (alpha, delta and gamma) and pEnvHIV,
   respectively. We also thank Dr. Ana Lucia Moraes Giannini for English
   review. This work was supported by research grants from Brazilian
   agencies CNPq (Grant nos. 480861/2011-0, 405283/2013-0) and FAPERJ
   (Grant no. E-26/111.267/2013) and Diego Pandelo Jose was supported by
   CNPq fellowship. We acknowledge funding support to UR from DST, India
   toward the Indo-Brazil collaboration.
CR Aditya Suruchi, 2013, Indian Dermatol Online J, V4, P246, DOI 10.4103/2229-5178.115538
   Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286
   Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191
   Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158
   Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834
   Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489
   Burnett JC, 2010, J VIROL, V84, P5958, DOI 10.1128/JVI.00161-10
   Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10
   Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146
   Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37
   Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200
   Dahabieh MS, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-17
   Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005
   Dong Q, 2000, J LAB CLIN MED, V136, P333, DOI 10.1067/mlc.2000.110104
   Ersvaer E, 2010, TOXINS, V2, P174, DOI 10.3390/toxins2010174
   Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295
   Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11
   Fujiwara M, 1998, ARCH VIROL, V143, P2003, DOI 10.1007/s007050050436
   Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171
   Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001
   Gonzalez E, 2001, J IMMUNOL, V166, P4560, DOI 10.4049/jimmunol.166.7.4560
   Hong Kee-Jong, 2011, Osong Public Health Res Perspect, V2, P109, DOI 10.1016/j.phrp.2011.07.001
   Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060
   Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639
   Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69
   Jassbi AR, 2006, PHYTOCHEMISTRY, V67, P1977, DOI 10.1016/j.phytochem.2006.06.030
   Johnston R, 2010, AIDS RES HUM RETROV, V26, P943, DOI 10.1089/aid.2010.0087
   JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.biochem.63.1.717
   Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188
   Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916
   Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26
   Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X
   Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068
   Lee WY, 2010, J BIOL CHEM, V285, P23889, DOI 10.1074/jbc.M109.041962
   Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303
   Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200
   Maioli E, 2004, ENDOCR-RELAT CANCER, V11, P161
   Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008
   McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347
   Mochly-Rosen D, 1998, FASEB J, V12, P35
   Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185
   Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197
   Olsnes AM, 2009, BRIT J HAEMATOL, V145, P761, DOI 10.1111/j.1365-2141.2009.07691.x
   Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000
   Racke FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051059
   Remoli AL, 2012, CYTOKINE GROWTH F R, V23, P159, DOI 10.1016/j.cytogfr.2012.05.003
   Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093
   Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706
   Roof P, 2002, VIROLOGY, V296, P77, DOI 10.1006/viro.2001.1397
   Rossenkhan R, 2013, J VIROL, V87, P5732, DOI 10.1128/JVI.03297-12
   Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x
   Sahu GK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-400
   Salatino A, 2007, J BRAZIL CHEM SOC, V18, P11, DOI 10.1590/S0103-50532007000100002
   Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07
   Song XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072331
   Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097
   Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007
   Strair RK, 2002, CLIN CANCER RES, V8, P2512
   Torgerson TR, 1998, J IMMUNOL, V161, P6084
   Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09
   Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67
   van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004
   Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854
   Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900
   Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200
   Wu CL, 2005, CELL MOL IMMUNOL, V2, P197
   Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199
   Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981
NR 68
TC 51
Z9 53
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD AUG
PY 2014
VL 462
BP 328
EP 339
DI 10.1016/j.virol.2014.05.033
PG 12
WC Virology
SC Virology
GA AM9TY
UT WOS:000340225100035
PM 25014309
OA Green Accepted, Bronze
DA 2020-10-22
ER

PT J
AU Schachter, J
   Valadao, ALC
   Aguiar, RS
   Barreto-de-Souza, V
   Rossi, AD
   Arantes, PR
   Verli, H
   Quintana, PG
   Heise, N
   Tanuri, A
   Bou-Habib, DC
   Persechini, PM
AF Schachter, Julieta
   Chaves Valadao, Ana Luiza
   Aguiar, Renato Santana
   Barreto-de-Souza, Victor
   Rossi, Atila Duque
   Arantes, Pablo Ricardo
   Verli, Hugo
   Quintana, Paula Gabriela
   Heise, Norton
   Tanuri, Amilcar
   Bou-Habib, Dumith Chequer
   Persechini, Pedro Muanis
TI 2 ',3 '-Dialdehyde of ATP, ADP, and Adenosine Inhibit HIV-1 Reverse
   Transcriptase and HIV-1 Replication
SO CURRENT HIV RESEARCH
LA English
DT Article
DE HIV-1; macrophage; oxidized adenosine; oxidized ADP; oxidized ATP;
   reverse transcriptase
ID IMMUNODEFICIENCY-VIRUS TYPE-1; OXIDIZED ATP; MOLECULAR-MECHANISM; P2X(7)
   RECEPTOR; ACTIVATION; DIALDEHYDE; BINDING; INVOLVEMENT; EXPRESSION;
   VIRIONS
AB The 2'3'-dialdehyde of ATP or oxidized ATP (oATP) is a compound known for specifically making covalent bonds with the nucleotide-binding site of several ATP-binding enzymes and receptors. We investigated the effects of oATP and other oxidized purines on HIV-1 infection and we found that this compound inhibits HIV-1 and SIV infection by blocking early steps of virus replication. oATP, oxidized ADP (oADP), and oxidized Adenosine (oADO) impact the natural activity of endogenous reverse transcriptase enzyme (RT) in cell free virus particles and are able to inhibit viral replication in different cell types when added to the cell cultures either before or after infection. We used UFLC-UV to show that both oADO and oATP can be detected in the cell after being added in the extracellular medium. oATP also suppresses RT activity and replication of the HIV-1 resistant variants M184V and T215Y. We conclude that oATP, oADP and oADO display anti HIV-1 activity that is at in least in part due to inhibitory activity on HIV-1 RT.
C1 [Schachter, Julieta; Quintana, Paula Gabriela; Heise, Norton; Persechini, Pedro Muanis] Univ Fed Rio de Janeiro, IBCCF, Polo De Xerem, RJ, Brazil.
   [Schachter, Julieta; Persechini, Pedro Muanis] INPeTAm, Conselho Nacl Desenvolvimento Cient & Tecnol, Rio De Janeiro, RJ, Brazil.
   [Chaves Valadao, Ana Luiza; Aguiar, Renato Santana; Rossi, Atila Duque; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Barreto-de-Souza, Victor; Bou-Habib, Dumith Chequer] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Sobre Timo, Rio De Janeiro, RJ, Brazil.
   [Arantes, Pablo Ricardo; Verli, Hugo] Univ Fed Rio de Janeiro, Ctr Biotecnol, Rio De Janeiro, RJ, Brazil.
RP Schachter, J (corresponding author), Univ Fed Rio de Janeiro, IBCCF, Polo De Xerem, RJ, Brazil.
EM julieta@biof.ufrj.br
RI Rossi, Atila Duque/AAV-6079-2020; Heise, Norton/I-4098-2013; Aguiar,
   Renato S/G-3542-2015; Verli, Hugo/G-8703-2012
OI Rossi, Atila Duque/0000-0001-6235-8807; Aguiar, Renato
   S/0000-0001-5180-3717; Verli, Hugo/0000-0002-4796-8620; Heise,
   Norton/0000-0003-0154-7406
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Programa de Nucleos de
   Excelencia (PRONEX-CNPq); POM/IOC (Fiocruz); Coordenacao de
   Aperfeicoamento de Pessoal do Ensino Superior (CAPES)CAPES; Instituto
   Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao
   Amazonica, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brasil
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Nucleos de
   Excelencia (PRONEX-CNPq), POM/IOC (Fiocruz), Coordenacao de
   Aperfeicoamento de Pessoal do Ensino Superior (CAPES), and Instituto
   Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao
   Amazonica, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico/MCT (INCT-INPeTAm/CNPq/MCT), Brasil.
CR Adamson CS, 2010, ANTIVIR RES, V85, P119, DOI 10.1016/j.antiviral.2009.09.009
   Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200
   Aguiar RS, 2007, ANTIMICROB AGENTS CH, V51, P638, DOI 10.1128/AAC.00749-06
   Anderson KS, 2002, BBA-MOL BASIS DIS, V1587, P296, DOI 10.1016/S0925-4439(02)00092-3
   BALZARINI J, 1988, BIOCHEM PHARMACOL, V37, P2847, DOI 10.1016/0006-2952(88)90049-4
   Barat C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-30
   Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657
   BERNIKOV LR, 1990, EUR J BIOCHEM, V194, P413, DOI 10.1111/j.1432-1033.1990.tb15634.x
   Borkow G, 1997, J VIROL, V71, P3023, DOI 10.1128/JVI.71.4.3023-3030.1997
   BOSTROM B, 1988, CANCER RES, V48, P5933
   Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001
   Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06
   Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007
   COATES JAV, 1992, ANTIMICROB AGENTS CH, V36, P733, DOI 10.1128/AAC.36.4.733
   COOMBER DWJ, 1994, INT J PARASITOL, V24, P357, DOI 10.1016/0020-7519(94)90083-3
   De Clercq E, 2002, BBA-MOL BASIS DIS, V1587, P258, DOI 10.1016/S0925-4439(02)00089-3
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Dell'Antonio G, 2002, NEUROSCI LETT, V327, P87, DOI 10.1016/S0304-3940(02)00385-3
   Di Virgilio F, 2003, BRIT J PHARMACOL, V140, P441, DOI 10.1038/sj.bjp.0705469
   Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021
   EASTERBROOKSMITH SB, 1976, EUR J BIOCHEM, V62, P125, DOI 10.1111/j.1432-1033.1976.tb10105.x
   Fang KM, 2011, J NEUROSCI RES, V89, P199, DOI 10.1002/jnr.22538
   FOURNIER M, 1987, EUR J BIOCHEM, V167, P533, DOI 10.1111/j.1432-1033.1987.tb13370.x
   FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333
   Garforth SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002074
   Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9
   Giroud C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-71
   Hattori F, 2012, EUR J PHARM
   Hazleton JE, 2012, J IMMUNOL, V188, P4488, DOI 10.4049/jimmunol.1102482
   Henke W, 1998, BBA-BIOENERGETICS, V1363, P209, DOI 10.1016/S0005-2728(97)00103-5
   Hull Mark W, 2011, Curr HIV/AIDS Rep, V8, P85, DOI 10.1007/s11904-011-0076-6
   JOHNSON MA, 1988, J BIOL CHEM, V263, P15354
   Johnson Victoria A, 2010, Top HIV Med, V18, P156
   KOCHETKOV SN, 1977, EUR J BIOCHEM, V81, P111, DOI 10.1111/j.1432-1033.1977.tb11932.x
   LIPFORD JR, 1994, J ACQ IMMUN DEF SYND, V7, P1215
   LOWE P, 1979, Biochemical Society Transactions, V7, P1131
   Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4
   MIGNACO J, 1990, BIOCHIM BIOPHYS ACTA, V1039, P305, DOI 10.1016/0167-4838(90)90263-F
   Moayeri M, 2006, INFECT IMMUN, V74, P3707, DOI 10.1128/IAI.00051-06
   Morner A, 1999, J VIROL, V73, P2343
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   MURGIA M, 1993, J BIOL CHEM, V268, P8199
   Regis EG, 2010, VIROLOGY, V399, P31, DOI 10.1016/j.virol.2009.12.018
   Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436
   Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805
   Shiota M, 2012, J UROLOGY, V188, P300, DOI 10.1016/j.juro.2012.02.2553
   Souza TML, 2011, BLOOD, V117, P2944, DOI 10.1182/blood-2010-05-287193
   Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p
   *UNAIDS, 2011, GLOBAL HIV AIDS RESP
   Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082
   WESTCOTT KR, 1980, J BIOL CHEM, V255, P8767
   Yokoyama M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008867
   Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519
NR 56
TC 2
Z9 2
U1 0
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-162X
EI 1873-4251
J9 CURR HIV RES
JI Curr. HIV Res.
PY 2014
VL 12
IS 5
BP 347
EP 358
DI 10.2174/1570162X12666140826105824
PG 12
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA AY3FD
UT WOS:000347469000005
PM 25174839
DA 2020-10-22
ER

PT J
AU Cunha, RD
   Abreu, CM
   Gonzalez, LMF
   Nijhuis, M
   de Jong, D
   Aguiar, RS
   Afonso, AO
   Brindeiro, RM
   Tanuri, A
AF Cunha, Rodrigo D.
   Abreu, Celina M.
   Gonzalez, Luis M. F.
   Nijhuis, Monique
   de Jong, Dorien
   Aguiar, Renato S.
   Afonso, Adriana O.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition
   in HIV-1 RT of Subtypes B and C
SO PLOS ONE
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL
   THERAPY; VIROLOGICAL RESPONSE; REPLICATION CAPACITY; EXPERIENCED
   PATIENTS; NAIVE PATIENTS; NUCLEOSIDE; PROTEASE; FAILURE
AB Background: HIV-1 subtype B is the most prevalent in developed countries and, consequently, it has been extensively studied. On the other hand, subtype C is the most prevalent worldwide and therefore is a reasonable target for future studies. Here we evaluate the acquisition of resistance and the viability of HIV-1 subtype B and C RT clones from different isolates that were subjected to in vitro selection pressure with zidovudine (ZDV) and lamivudine (3TC).
   Methods/Principal Findings: MT4 cells were infected with chimeric virus pseudotyped with RT from subtype B and C clones, which were previously subjected to serial passage with increasing concentrations of ZDV and 3TC. The samples collected after each passage were analyzed for the presence of resistance mutations and VL. No differences were found between subtypes B and C in viral load and resistance mutations when these viruses were selected with 3TC. However, the route of mutations and the time to rebound of subtype B and C virus were different when subjected to ZDV treatment. In order to confirm the role of the mutations detected, other clones were generated and subjected to in vitro selection. RT subtype B virus isolates tended to acquire different ZDV resistance mutations (Q151M and D67N or T215Y, D67D/N and F214L) compared to subtype C (D67N, K70R, T215I or T215F).
   Conclusions/Significance: This study suggests that different subtypes have a tendency to react differently to antiretroviral drug selection in vitro. Consequently, the acquisition of resistance in patients undergoing antiretroviral therapy can be dependent on the subtypes composing the viral population.
C1 [Cunha, Rodrigo D.; Abreu, Celina M.; Gonzalez, Luis M. F.; Aguiar, Renato S.; Afonso, Adriana O.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil.
   [Nijhuis, Monique; de Jong, Dorien] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Abreu, Celina Monteiro/AAT-7447-2020; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU Brazilian AIDS Program; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX This work was sponsored by Brazilian AIDS Program and CNPq. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aguiar RS, 2006, J GEN VIROL, V87, P2669, DOI 10.1099/vir.0.82046-0
   Armstrong KL, 2009, J VIROL, V83, P4051, DOI 10.1128/JVI.02645-08
   Boucher CAB, 1996, ANTIMICROB AGENTS CH, V40, P2404, DOI 10.1128/AAC.40.10.2404
   Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Puertas MC, 2009, J VIROL, V83, P7434, DOI 10.1128/JVI.00487-09
   Carmona R, 2005, J CLIN VIROL, V32, P248, DOI 10.1016/j.jcv.2004.11.009
   Ceccherini-Silberstein F, 2007, J INFECT DIS, V196, P1180, DOI 10.1086/521678
   Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791
   Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483
   Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003
   Hu ZX, 2006, J VIROL, V80, P7020, DOI 10.1128/JVI.02747-05
   Johnson Victoria A, 2011, Top Antivir Med, V19, P156
   Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112
   Marcelin AG, 2005, ANTIMICROB AGENTS CH, V49, P1739, DOI 10.1128/AAC.49.5.1739-1744.2005
   Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550
   Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109
   Melikian GL, 2012, ANTIMICROB AGENTS CH, V56, P2305, DOI 10.1128/AAC.05487-11
   Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784
   Munerato P, 2010, AIDS RES HUM RETROV, V26, P265, DOI [10.1089/aid.2008.0288, 10.1089/aid.2009.0288]
   Novitsky V, 2007, AIDS RES HUM RETROV, V23, P868, DOI 10.1089/aid.2006.0298
   Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P708, DOI 10.1128/AAC.01109-08
   O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000
   Pellegrin I, 1999, AIDS, V13, P1705, DOI 10.1097/00002030-199909100-00014
   Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871
   Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34
   Rezende LF, 1998, J VIROL, V72, P2890, DOI 10.1128/JVI.72.4.2890-2895.1998
   Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103
   Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004
   Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d
   Santos AF, 2010, VIRUSES-BASEL, V2, P503, DOI 10.3390/v2020503
   Sturmer M, 2003, ANTIMICROB AGENTS CH, V47, P54, DOI 10.1128/AAC.47.1.54-61.2003
   Svicher V, 2006, J VIROL, V80, P7186, DOI 10.1128/JVI.02084-05
   van Maarseveen NM, 2006, J VIROL METHODS, V133, P185, DOI 10.1016/j.jviromet.2005.11.008
   Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012
   Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282
   Wyl V Von, 2010, J INFEC DIS, V201, P000
NR 37
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2012
VL 7
IS 10
AR e46622
DI 10.1371/journal.pone.0046622
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015NU
UT WOS:000309454000064
PM 23056372
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Souza, TML
   Rodrigues, DQ
   Passaes, CPB
   Barreto-de-Souza, V
   Aguiar, RS
   Temerozo, JR
   Morgado, MG
   Fontes, CFL
   Araujo, EG
   Bou-Habib, DC
AF Souza, Thiago Moreno L.
   Rodrigues, Diego Q.
   Passaes, Caroline P. B.
   Barreto-de-Souza, Victor
   Aguiar, Renato S.
   Temerozo, Jairo R.
   Morgado, Mariza G.
   Fontes, Carlos Frederico L.
   Araujo, Elizabeth G.
   Bou-Habib, Dumith Chequer
TI The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1
   transcription and replication in human primary macrophages
SO BLOOD
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; NEUROTROPHIC FACTOR; NONNEURONAL CELLS;
   PROTEIN GP120; MAST-CELLS; IN-VITRO; EXPRESSION; INFECTION; LYMPHOCYTES;
   MONOCYTES
AB Macrophages infected with HIV-1 sustain viral replication for long periods of time, functioning as viral reservoirs. Therefore, recognition of factors that maintain macrophage survival and influence HIV-1 replication is critical to understanding the mechanisms that regulate the HIV-1 replicative cycle. Because HIV-1-infected macrophages release the nerve growth factor (NGF), and NGF neutralization reduces viral production, we further analyzed how this molecule affects HIV-1 replication. In the present study, we show that NGF stimulates HIV-1 replication in primary macrophages by signaling through its high-affinity receptor Tropomyosin-related Kinase A (TrKA), and with the involvement of reticular calcium, protein kinase C, extracellular signal-regulated kinase, p38 kinase, and nuclear factor-kappa B. NGF-induced enhancement of HIV-1 replication occurred during the late events of the HIV-1-replicative cycle, with a concomitant increase in viral transcription and production. In addition, NGF reduced the synthesis of the cellular HIV-1 restriction factor APOBEC3G and also overrode its interferon-gamma-induced up-regulation, allowing the production of a well-fitted virus. Because NGF-TrKA signaling is a crucial event for macrophage survival, it is possible that NGF-induced HIV-1 replication plays a role in the maintenance of HIV-1 reservoirs. Our study may contribute to the understanding of the immunopathogenesis of HIV-1 infection and provide insights about approaches aimed at limiting viral replication in HIV-1 reservoirs. (Blood. 2011;117(10):2944-2952)
C1 [Souza, Thiago Moreno L.; Rodrigues, Diego Q.; Barreto-de-Souza, Victor; Temerozo, Jairo R.; Bou-Habib, Dumith Chequer] Oswaldo Cruz Inst Fiocruz, Lab Thymus Res, Rio De Janeiro, Brazil.
   [Souza, Thiago Moreno L.] Oswaldo Cruz Inst Fiocruz, Lab Resp Viruses & Measles, Rio De Janeiro, Brazil.
   [Souza, Thiago Moreno L.; Fontes, Carlos Frederico L.] Univ Fed Rio de Janeiro, Inst Med Biochem, Lab Prot Struct & Regulat, Rio De Janeiro, Brazil.
   [Passaes, Caroline P. B.; Morgado, Mariza G.] Oswaldo Cruz Inst Fiocruz, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Mol Virol, Rio De Janeiro, Brazil.
   [Araujo, Elizabeth G.] Univ Fed Fluminense, Hertha Meyer Lab Tissue Culture, Niteroi, RJ, Brazil.
RP Souza, TML (corresponding author), Fundacao Oswald Cruz, Av Brasil L365, BR-21045900 Rio De Janeiro, Brazil.
EM tmoreno@ioc.fiocruz.br; Dumith@ioc.fiocruz.br
RI Temerozo, Jairo Ramos/K-4894-2012; Passaes, Caroline/AAH-3392-2020;
   Souza, Thiago Moreno L./G-2900-2012; Fontes, C.F.L. or
   Fontes/G-2343-2014; Aguiar, Renato S/G-3542-2015
OI Temerozo, Jairo Ramos/0000-0002-8092-2149; Passaes,
   Caroline/0000-0002-0813-2521; Souza, Thiago Moreno
   L./0000-0003-2212-3899; Fontes, C.F.L. or Fontes/0000-0002-9384-0898;
   Aguiar, Renato S/0000-0001-5180-3717; Araujo,
   Elizabeth/0000-0001-6583-6237
FU PAPES/Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This study was supported by grants from PAPES/Fiocruz, CNPq, and Faperj.
CR AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995
   Alfano Massimo, 2008, Curr HIV/AIDS Rep, V5, P27, DOI 10.1007/s11904-008-0005-5
   Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1
   Boven LA, 1999, J NEUROIMMUNOL, V97, P154, DOI 10.1016/S0165-5728(99)00044-2
   Calcaterra S, 2001, J INFECTION, V43, P239, DOI 10.1053/jinf.2001.0875
   Copeland KFT, 2005, MINI-REV MED CHEM, V5, P1093, DOI 10.2174/138955705774933383
   Corasaniti MT, 1998, BIOCHEM PHARMACOL, V56, P153, DOI 10.1016/S0006-2952(98)00044-6
   DAVIES AM, 1994, J NEUROBIOL, V25, P1334, DOI 10.1002/neu.480251103
   Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x
   EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P5423, DOI 10.1073/pnas.90.12.5423
   EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P10984, DOI 10.1073/pnas.90.23.10984
   ENSOLI F, 1994, VIROLOGY, V200, P668, DOI 10.1006/viro.1994.1230
   Fabbro A, 2004, BRIT J PHARMACOL, V142, P425, DOI 10.1038/sj.bjp.0705813
   Garaci E, 1999, P NATL ACAD SCI USA, V96, P14013, DOI 10.1073/pnas.96.24.14013
   Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540
   HATTORI A, 1993, J BIOL CHEM, V268, P2577
   Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133
   Kinoshita SM, 2008, P NATL ACAD SCI USA, V105, P15022, DOI 10.1073/pnas.0807269105
   Kumar R, 2002, J VIROL METHODS, V105, P233, DOI 10.1016/S0166-0934(02)00105-2
   LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206
   Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412
   LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0
   Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185
   MATSUDA H, 1991, J EXP MED, V174, P7, DOI 10.1084/jem.174.1.7
   Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010
   Nosheny RL, 2005, NEUROTOX RES, V8, P187, DOI 10.1007/BF03033829
   Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857
   OTTEN U, 1979, NATURE, V282, P413, DOI 10.1038/282413a0
   OTTEN U, 1989, P NATL ACAD SCI USA, V86, P10059, DOI 10.1073/pnas.86.24.10059
   Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998
   Ramirez SH, 2001, J NEUROCHEM, V78, P874, DOI 10.1046/j.1471-4159.2001.00467.x
   Recio JA, 1997, J BIOL CHEM, V272, P26807, DOI 10.1074/jbc.272.43.26807
   Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706
   Samah B, 2009, J NEUROVIROL, V15, P71, DOI 10.1080/13550280802482575
   Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668
   Skaper SD, 2008, CNS NEUROL DISORD-DR, V7, P46, DOI 10.2174/187152708783885174
   Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903
   STEINER P, 1991, AM J PHYSIOL, V261, pF792
   Sterneck E, 1998, J NEUROCHEM, V70, P2424
   Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853
   Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200
   Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438
   Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134
   Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192
   THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E
   THORPE LW, 1987, J NEUROSCI RES, V17, P128, DOI 10.1002/jnr.490170206
   TOOSSI Z, 1993, J EXP MED, V177, P1511, DOI 10.1084/jem.177.5.1511
   Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020
   Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814
   WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x
NR 50
TC 15
Z9 15
U1 0
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD MAR 10
PY 2011
VL 117
IS 10
BP 2944
EP 2952
DI 10.1182/blood-2010-05-287193
PG 9
WC Hematology
SC Hematology
GA 732SJ
UT WOS:000288209600032
PM 21217078
DA 2020-10-22
ER

PT J
AU da Costa, LJ
   dos Santos, AL
   Mandic, R
   Shaw, K
   de Aguiar, RS
   Tanuri, A
   Luciw, PA
   Peterlin, BM
AF da Costa, Luciana Jesus
   dos Santos, Adriana Lopes
   Mandic, Robert
   Shaw, Karen
   de Aguiar, Renato Santana
   Tanuri, Amilcar
   Luciw, Paul A.
   Peterlin, B. Matija
TI Interactions between SIVNef, SIVGagPol and Alix correlate with viral
   replication and progression to AIDS in rhesus macaques
SO VIROLOGY
LA English
DT Article
DE SIV; HIV; Nef; Monkey infection; Pathogenesis; Disease progression;
   GagPol; Alix
ID HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 NEF PROTEIN; FUSION INHIBITOR T-20;
   HIV-1 NEF; DOWN-REGULATION; FACILITATE EGRESS; V-ATPASE; INFECTIVITY;
   EXPRESSION; GENE
AB Infection with Simian Immunodeficiency Virus (SIV) leads to high viral loads and progression to Simian AIDS (SAIDS) in rhesus macaques. The viral accessory protein Nef is required for this phenotype in monkeys as well as in HIV-infected humans. Previously, we determined that HIVNef binds HIVGagPol and Alix for optimal viral replication in cells. In this study, we demonstrated that these interactions could correlate with high viral loads leading to SAIDS in the infected host. By infecting rhesus macaques with a Mutant SIVmac239, where sequences in the nef gene that are required for these interactions were Mutated, we observed robust viral replication and disease in two Out Of four monkeys, where they reverted to the wild type genotype and phenotype. These two rhesus macaques also died of SAIDS. Two other monkeys did not progress to disease and continued to harbor mutant nef sequences. We conclude that interactions between Nef, GagPol and Alix contribute to optimal viral replication and progression to disease in the infected host. (C) 2009 Elsevier Inc. All rights reserved.
C1 [da Costa, Luciana Jesus] Univ Fed Rio de Janeiro, IMPPG, Dept Virol, Lab Genet & Imunol Infeccoes Virais, BR-21941590 Rio De Janeiro, Brazil.
   [da Costa, Luciana Jesus; dos Santos, Adriana Lopes; de Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, IB, Dept Genet, BR-21941590 Rio De Janeiro, Brazil.
   [Mandic, Robert] Univ Hosp Giessen & Marburg, Dept Otorhinolaryngol Head & Neck Surg, Marburg, Germany.
   [Shaw, Karen; Luciw, Paul A.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.
   [de Aguiar, Renato Santana; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA.
   [de Aguiar, Renato Santana; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
RP da Costa, LJ (corresponding author), Univ Fed Rio de Janeiro, IMPPG, Dept Virol, Lab Genet & Imunol Infeccoes Virais, CCS Bloco 1,Ss-048,Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM ljcosta@micro.ufrj.br; matija.peterlin@ucsf.edu
RI Aguiar, Renato S/G-3542-2015; Santos, Adriana Lopes dos/J-6960-2019;
   Santos, Adriana Lopes dos/B-7252-2018; Mandic, Robert/Y-4324-2019;
   Costa, Luciana J/B-7878-2013
OI Aguiar, Renato S/0000-0001-5180-3717; Santos, Adriana Lopes
   dos/0000-0002-0736-4937; Santos, Adriana Lopes dos/0000-0002-0736-4937; 
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50 GM082250, P50 GM082250-02] Funding Source:
   Medline
CR Beissinger M, 1996, EUR J BIOCHEM, V237, P383, DOI 10.1111/j.1432-1033.1996.0383k.x
   Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0
   Brenner M, 2006, J VIROL, V80, P4469, DOI 10.1128/JVI.80.9.4469-4481.2006
   Brugger B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-70
   Chakrabarti LA, 2003, J VIROL, V77, P1245, DOI 10.1128/JVI.77.2.1245-1256.2003
   Costa LJ, 2004, J VIROL, V78, P5311, DOI 10.1128/JVI.78.10.5311-5323.2004
   Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33
   DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917
   DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988
   Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000
   Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035
   Geyer M, 2002, MOL BIOL CELL, V13, P2045, DOI 10.1091/mbc.02-02-0026
   Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141
   GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995
   HIGGINS JR, 1992, J MED PRIMATOL, V21, P265
   Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002
   KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003
   KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I
   KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992
   Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999
   KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405
   Lafrate AJ, 2000, J VIROL, V74, P9836, DOI 10.1128/JVI.74.21.9836-9844.2000
   Leiherer A, 2009, VIROLOGY, V387, P200, DOI 10.1016/j.virol.2009.01.042
   Lock M, 1999, EMBO J, V18, P2722, DOI 10.1093/emboj/18.10.2722
   Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07
   Mandic R, 2001, MOL BIOL CELL, V12, P463, DOI 10.1091/mbc.12.2.463
   MARTHAS ML, 1993, J VIROL, V67, P6047, DOI 10.1128/JVI.67.10.6047-6055.1993
   Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313
   MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101
   Miller Michael D., 1994, Trends in Microbiology, V2, P294, DOI 10.1016/0966-842X(94)90007-8
   Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07
   Munch J, 2002, J VIROL, V76, P12360, DOI 10.1128/JVI.76.23.12360-12364.2002
   Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996
   Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998
   SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x
   Sandrin V, 2006, J BIOL CHEM, V281, P528, DOI 10.1074/jbc.M506070200
   Sawai ET, 2000, J VIROL, V74, P2038, DOI 10.1128/JVI.74.4.2038-2045.2000
   Schiavoni I, 2004, J BIOL CHEM, V279, P22996, DOI 10.1074/jbc.M312453200
   Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338
   Shacklett BL, 2002, J VIROL, V76, P11365, DOI 10.1128/JVI.76.22.11365-11378.2002
   Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6
   Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498
   Wagner R, 2000, HUM GENE THER, V11, P2403, DOI 10.1089/104303400750038507
   Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002
   Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240
   Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319
   Zheng YH, 2003, P NATL ACAD SCI USA, V100, P8460, DOI 10.1073/pnas.1437453100
   Zhou J, 2004, J VIROL, V78, P922, DOI 10.1128/JVI.78.2.922-929.2004
NR 48
TC 8
Z9 8
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV 10
PY 2009
VL 394
IS 1
BP 47
EP 56
DI 10.1016/j.virol.2009.08.024
PG 10
WC Virology
SC Virology
GA 515AI
UT WOS:000271438000007
PM 19748111
OA Green Accepted
DA 2020-10-22
ER

PT J
AU da Silva, RFCF
   Abreu, CM
   Branco, EC
   Bule, E
   Stakteas, S
   Aguiar, RS
   Brindeiro, PA
   Martins, AN
   Arruda, MB
   Brindeiro, RD
   da Silva, FG
   Serrano, D
   Costa, LJ
   Tanuri, A
AF Ferreira da Silva, R. F. C.
   Abreu, C. M.
   Branco, E. C.
   Bule, E.
   Stakteas, S.
   Aguiar, R. S.
   Brindeiro, P. A.
   Martins, A. N.
   Arruda, M. B.
   Brindeiro, R. de Moraes
   da Silva, F. G.
   Serrano, D.
   Costa, L. J.
   Tanuri, A.
TI Evaluation of primary resistance in human immunodeficiency virus type-1
   (HIV-1) circulating in Angola and Mozambique based on an HIV Drug
   Resistance Threshold Survey (HIVDR-TS)
SO ANTIVIRAL THERAPY
LA English
DT Meeting Abstract
CT 18th International HIV Drug Resistance Workshop
CY JUN 09-13, 2009
CL Ft Myers, FL
C1 [Ferreira da Silva, R. F. C.; Branco, E. C.; da Silva, F. G.] Minist Saude, Inst Nacl Saude Publ Angola, Luanda, Angola.
   [Abreu, C. M.; Aguiar, R. S.; Brindeiro, P. A.; Martins, A. N.; Arruda, M. B.; Brindeiro, R. de Moraes; Tanuri, A.] Univ Fed Rio de Janeiro, Lab Virol Mol Anim, IB, BR-21941 Rio De Janeiro, Brazil.
   [Bule, E.; Stakteas, S.] Minist Saude MISAU, Dept Nacl Saude, Maputo, Mozambique.
   [Serrano, D.] Minist Saude, Inst Nacl Luta Contra SIDA, Luanda, Angola.
   [Costa, L. J.] Univ Fed Rio de Janeiro, IMPPG, Lab Genet & Imunol Infeccoes Virais, BR-21941 Rio De Janeiro, Brazil.
RI Abreu, Celina Monteiro/AAT-7447-2020; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2009
VL 14
IS 4
MA 170
BP A193
EP A193
PG 1
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA 471FA
UT WOS:000268039900187
DA 2020-10-22
ER

PT J
AU Aguiar, RS
   Peterlin, BM
AF Aguiar, Renato S.
   Peterlin, B. Matija
TI APOBEC3 proteins and reverse transcription
SO VIRUS RESEARCH
LA English
DT Review
DE HIV; APOBEC3; cytidine deaminase; restriction factors; reverse
   transcription; Vif; retroelements
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; POLYNUCLEOTIDE
   (DEOXY)CYTIDINE DEAMINASES; RESTRICTS HIV-1 INFECTION; EDITING ENZYME
   APOBEC3G; E3 UBIQUITIN LIGASE; TYPE-1 VIF PROTEIN; CYTIDINE DEAMINASE;
   ANTIVIRAL ACTIVITY; DENDRITIC CELLS
AB The ability of members of the APOBEC3 (A3) family of proteins to confer intrinsic immunity to retroviral infection was recognized in several studies. More specifically, A3 proteins are cytidine deaminases (CDAs) that cause hypermutations of nascent retroviral genomes by deamination of cytidine residues. Although A3 proteins can restrict the replication of HIV, this inhibition is overcome by the viral infectivity factor (Vif). Inhibitory effects of APOBEC proteins are not limited to HIV but extend to other viruses and endogenous mobile genetic elements that share a reverse transcription process analogous to that of exogenous retroviruses. In sharp contrast, another conundrum of A3 proteins is that they inhibit viral replication even in the absence of CDA activity and recent advances have defined the inhibition of reverse transcriptase (RT) catalyzed DNA elongation reactions by A3 proteins. Together, these proteins provide strong and immediate intracellular immunity against incoming pathogens and restrict the movement of mobile genetic elements protecting the genome. Published by Elsevier B.V.
C1 [Aguiar, Renato S.; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.
RP Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, 533 Parnassus Ave U422, San Francisco, CA 94143 USA.
EM matija.peterlin@ucsf.edu
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50 GM082250-01, P50 GM082250] Funding Source:
   Medline
CR Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055
   Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200
   Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027
   Ancuta P, 2006, J IMMUNOL, V176, P5760, DOI 10.4049/jimmunol.176.10.5760
   Arts EJ, 1996, ADV VIRUS RES, V46, P97, DOI 10.1016/S0065-3527(08)60071-8
   Bennett RP, 2006, BIOCHEM BIOPH RES CO, V350, P214, DOI 10.1016/j.bbrc.2006.09.032
   Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06
   Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658
   Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057
   Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019
   Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103
   Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416
   Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101
   Bourara K, 2007, PLOS PATHOG, V3, P1477, DOI 10.1371/journal.ppat.0030153
   Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100
   BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601
   Caride E, 2002, J CLIN VIROL, V23, P179, DOI 10.1016/S1386-6532(01)00218-9
   Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086
   Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031
   Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103
   Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493
   Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026
   Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006
   da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062
   Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06
   Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013
   Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006
   Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768
   Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740
   Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005
   Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051
   Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5
   Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581
   Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054
   Eto T, 2003, P NATL ACAD SCI USA, V100, P12895, DOI 10.1073/pnas.2135587100
   Franca R, 2006, MED SCI MONITOR, V12, pRA92
   Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06
   Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06
   Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200
   Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9
   Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489
   Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0
   Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101
   Hill MS, 2006, AIDS RES HUM RETROV, V22, P541, DOI 10.1089/aid.2006.22.541
   Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004
   Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200
   Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038
   Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750
   Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718
   Jost S, 2007, J VIROL, V81, P10588, DOI 10.1128/JVI.02489-06
   Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006
   Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003
   Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152
   Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670
   Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1
   Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19
   Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101
   Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005
   Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181
   Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004
   Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200
   Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155
   Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998
   Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200
   Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lee GS, 2004, MOL CELL, V16, P505, DOI 10.1016/S1097-2765(04)00682-3
   Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010
   Lehmann DM, 2007, BBA-MOL CELL RES, V1773, P408, DOI 10.1016/j.bbamcr.2006.11.019
   Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925
   Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050
   Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005
   Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004
   Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004
   Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06
   Madani N, 2000, J VIROL, V74, P5982, DOI 10.1128/JVI.74.13.5982-5987.2000
   Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998
   Mahieux R, 2005, J GEN VIROL, V86, P2489, DOI 10.1099/vir.0.80973-0
   Malim MH, 2006, CR BIOL, V329, P871, DOI 10.1016/j.crvi.2006.01.012
   Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709
   Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200
   Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4
   Matsumoto T, 2006, FEBS LETT, V580, P731, DOI 10.1016/j.febslet.2005.12.081
   Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07
   Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200
   Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07
   Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200
   Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005
   Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07
   Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340
   Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200
   Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011
   Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068
   Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06
   Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06
   OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006
   Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540
   Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1
   Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512
   Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763
   Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671
   Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519
   Prak ETL, 2000, NAT REV GENET, V1, P134
   Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492
   Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011
   Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608
   Ribeiro AC, 2005, J VIROL, V79, P823, DOI 10.1128/JVI.79.2.823-833.2005
   Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994
   Rose KM, 2005, AIDS RES HUM RETROV, V21, P611, DOI 10.1089/aid.2005.21.611
   Rose KM, 2004, J BIOL CHEM, V279, P41744, DOI 10.1074/jbc.M406760200
   Sakuma R, 2007, GENE THER, V14, P185, DOI 10.1038/sj.gt.3302852
   Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530
   Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32
   Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37
   Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275
   Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777
   Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005
   Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101
   Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102
   Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200
   Shirakawa K, 2006, VIROLOGY, V344, P263, DOI 10.1016/j.virol.2005.10.028
   Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987
   Smith HC, 2004, TRENDS GENET, V20, P224, DOI 10.1016/j.tig.2004.03.012
   Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015
   Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200
   STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x
   Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8
   Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200
   Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505
   TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591
   Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135
   VARTANIAN JP, 1991, J VIROL, V65, P1779, DOI 10.1128/JVI.65.4.1779-1788.1991
   Vartanian JP, 2002, J GEN VIROL, V83, P801, DOI 10.1099/0022-1317-83-4-801
   Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4
   Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200
   Wichroski MJ, 2006, PLOS PATHOG, V2, P374, DOI 10.1371/journal.ppat.0020041
   Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200
   Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246
   Wurtzer S, 2006, J VIROL, V80, P3679, DOI 10.1128/JVI.80.7.3679-3683.2006
   Xiao ZX, 2007, FASEB J, V21, P217, DOI 10.1096/fj.06-6773com
   Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002
   Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101
   Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893
   Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200
   Ying SC, 2007, ACTA BIOCH BIOPH SIN, V39, P297, DOI 10.1111/j.1745-7270.2007.00275.x
   Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200
   Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758
   Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591
   ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L
   Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707
   Zhang W, 2008, CELL MICROBIOL, V10, P112, DOI 10.1111/j.1462-5822.2007.01020.x
   Zheng YH, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-25
   Zheng YH, 2005, IMMUNOL LETT, V97, P225, DOI 10.1016/j.imlet.2004.11.026
   Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004
NR 158
TC 38
Z9 38
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUN
PY 2008
VL 134
IS 1-2
BP 74
EP 85
DI 10.1016/j.virusres.2007.12.022
PG 12
WC Virology
SC Virology
GA 307BF
UT WOS:000256291900006
PM 18262674
DA 2020-10-22
ER

PT J
AU Aguiar, RS
   Lovsin, N
   Tanuri, A
   Peterlin, BM
AF Aguiar, Renato S.
   Lovsin, Nika
   Tanuri, Amilcar
   Peterlin, B. Matija
TI Vpr.A3A chimera inhibits HIV replication
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; POTENT
   INHIBITORS; ENZYME APOBEC3G; PROTEINS; VPR; RETROTRANSPOSITION;
   INFECTION; DNA; HYPERMUTATION
AB Several APOBEC3 proteins (A3F and A3G), that are cytidine deaminases restrict human immunodeficiency virus (HIV) replication in the absence of the viral infectivity factor (Vif) protein. However, Vif leads to their degradation and counteracts their effects. Another member, A3A, restricts some retrotransposons and another virus but not HIV. Wereasoned that this failure was due to the lack of appropriate targeting. Thus, we fused A3A to another viral protein, Vpr, which binds p6 in Gag and is incorporated into viral cores. Indeed, the Vpr. A3A chimera but not A3A was found abundantly in the viral core. It also restricted potently the replication of HIV and simian immunodeficiency virus in the presence and absence of Vif. Because we identified a high frequency of G to Amutations in viral cDNAs, this antiviral activity was mediated by DNA editing. Interestingly, our fusion protein did not restrict murine leukemia virus, which does not incorporate Vpr. Thus, by targeting appropriately a potent single domain cytidine deaminase, we rendered HIV and simian immunodeficiency virus restriction resistant to Vif.
C1 [Aguiar, Renato S.; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Lovsin, Nika] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21944970 Rio De Janeiro, Brazil.
RP Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, 533 Parnassus Ave,U422, San Francisco, CA 94143 USA.
EM matija.peterlin@ucsf.edu
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50 GM082250, P50 GM082250-01] Funding Source:
   Medline
CR Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057
   Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103
   Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416
   Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031
   Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003
   Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493
   Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33
   Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005
   Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238
   Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123
   Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06
   Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61
   Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9
   Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489
   Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101
   Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004
   Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200
   Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101
   Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005
   KONDO E, 1995, J VIROL, V69, P2759, DOI 10.1128/JVI.69.5.2759-2764.1995
   Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200
   Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11
   Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010
   Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4
   Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07
   Morner A, 1999, J VIROL, V73, P2343
   Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200
   Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068
   Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06
   Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540
   Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512
   Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400
   Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777
   Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102
   Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945
   Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939
   Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297
   Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113
   WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995
   Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988
   Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101
   Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200
   Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591
   Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035
   Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004
NR 47
TC 50
Z9 50
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 1
PY 2008
VL 283
IS 5
BP 2518
EP 2525
DI 10.1074/jbc.M706436200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 254XW
UT WOS:000252622300008
PM 18057006
OA Bronze
DA 2020-10-22
ER

PT J
AU Gonzalez, LMF
   Pinto, AFN
   Martins, AN
   Aguiar, RS
   Afonso, AO
   Brindeiro, RM
   Tanuri, A
AF Gonzalez, L. M. F.
   Pinto, A. F. N.
   Martins, A. N.
   Aguiar, R. S.
   Afonso, A. O.
   Brindeiro, R. M.
   Tanuri, A.
TI Silent mutations at reverse transcriptase codons 65 and 66 in B and C
   strains found in Brazil are very strongly associated with treatment and
   these signatures can impact on zidovudine mutation acquisition in vitro
SO ANTIVIRAL THERAPY
LA English
DT Meeting Abstract
CT 17th International HIV Drug Resistance Workshop
CY JUN 10-14, 2008
CL Sitges, SPAIN
C1 [Gonzalez, L. M. F.; Pinto, A. F. N.; Martins, A. N.; Aguiar, R. S.; Afonso, A. O.; Brindeiro, R. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, Brazil.
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 1
Z9 1
U1 0
U2 0
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PY 2008
VL 13
IS 4
BP A63
EP A63
PG 1
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA 323EY
UT WOS:000257428100076
DA 2020-10-22
ER

PT J
AU Aguiar, RS
   Costa, LJ
   Pereira, HS
   Brindeiro, RM
   Tanuri, A
AF Aguiar, Renato S.
   Costa, Luciana J.
   Pereira, Helena S.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Development of a new methodology for screening of human immunodeficiency
   virus type 1 microbicides based on real-time PCR quantification
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID HIV-1 REVERSE-TRANSCRIPTASE; NONNUCLEOSIDE INHIBITOR; LANGERHANS CELLS;
   DEXTRAN SULFATE; INFECTION; MECHANISM; BINDING; REPLICATION;
   CONSTRUCTION; NONOXYNOL-9
AB Potential topical retrovirucides or vaginal microbicides against human immunodeficiency virus type I (HIV-1) include normucleoside reverse transcriptase inhibitors (NNRTIs). To be successful, such agents have to be highly active against cell-free virions. In the present study, we developed a new real-time PCR-based assay to measure the natural endogenous reverse transcription (NERT) activity directly on intact HIV-1 particles in the presence of reverse transcriptase (RT) inhibitors. We further evaluated the permeability to nevirapine (NVP) and efavirenz (EFV) and their retention within nascent viral particles. We also demonstrated the NVP and EFV inhibitory effects on NERT activity and the impact of resistance mutations measured directly by this new strategy. Furthermore, the results showed a clear correlation between NERT activity and classical infectivity assays. The 50% inhibitory concentrations (IC(50)s) of NVP and EFV were demonstrated to be up to 100-fold higher for cell-free than for cell-associated virions, suggesting that cell-free virions are less permeable to these drugs. Our results suggest that NVP and EFV penetrate both the envelope and the capsid of HIV-1 particles and readily inactivate cell-free virions. However, the characteristics of these NNRTIs, such as lower permeability and lower retention during washing procedures, in cell-free virions reduce their efficacies as microbicides. Here, we demonstrate the usefulness of the NERT real-time PCR as an assay for screening novel antiretroviral compounds with unique mechanisms of action.
C1 Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, BR-21944970 Rio De Janeiro, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, CCS Bloco A2,Sala 121,Cidade Univ, BR-21944970 Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Costa, Luciana J/B-7878-2013; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Pereira,
   Helena/0000-0002-0316-3732
CR ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986
   *ALL MICR DEV, 2004, ALL MICR DEV WEEKL N
   BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132
   Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124
   BOONE LR, 1981, J VIROL, V37, P117, DOI 10.1128/JVI.37.1.117-126.1981
   Borkow G, 1997, J VIROL, V71, P3023, DOI 10.1128/JVI.71.4.3023-3030.1997
   DECLERCO E, 1992, P NATL ACAD SCI USA, V89, P5286, DOI 10.1073/pnas.89.12.5286
   ELIAS CJ, 1994, AIDS, V8, P1, DOI 10.1097/00002030-199401000-00002
   HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081
   Hooker CW, 2001, J VIROL, V75, P3095, DOI 10.1128/JVI.75.7.3095-3104.2001
   Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491
   Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100
   KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992
   Maga G, 2000, ANTIMICROB AGENTS CH, V44, P1186, DOI 10.1128/AAC.44.5.1186-1194.2000
   MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480
   Motakis D, 2002, ANTIMICROB AGENTS CH, V46, P1851, DOI 10.1128/AAC.46.6.1851-1856.2002
   Neurath AR, 1996, NAT MED, V2, P230, DOI 10.1038/nm0296-230
   NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010
   O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000
   PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990
   Pomerantz RJ, 2003, NAT MED, V9, P867, DOI 10.1038/nm0703-867
   POTTS M, 1994, AM J PUBLIC HEALTH, V84, P890, DOI 10.2105/AJPH.84.6.890
   RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994
   Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673
   RODDY RE, 1993, INT J STD AIDS, V4, P165, DOI 10.1177/095646249300400308
   Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321
   STEIN ZA, 1990, AM J PUBLIC HEALTH, V80, P460, DOI 10.2105/AJPH.80.4.460
   Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959
   SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144
   Tanuri A, 2000, VIROLOGY, V268, P79, DOI 10.1006/viro.1999.0145
   *WHO, 2004, AIDS EP UPD
   WU JC, 1991, BIOCHEMISTRY-US, V30, P2022, DOI 10.1021/bi00222a003
   YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602
   Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519
   ZHANG L, 1996, TERRA NOVA ABSTR S, V1, P70
NR 37
TC 7
Z9 7
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2007
VL 51
IS 2
BP 638
EP 644
DI 10.1128/AAC.00749-06
PG 7
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 131WB
UT WOS:000243900600033
PM 17116672
OA Bronze, Green Published
DA 2020-10-22
ER

PT J
AU Aguiar, RS
   Pereira, HS
   Costa, LJ
   Brindeiro, RM
   Tanuri, A
AF Aguiar, Renato S.
   Pereira, Helena S.
   Costa, Luciana J.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Gag-Pol bearing a reverse transcriptase drug-resistant mutation
   influences viral genomic RNA incorporation into human immunodeficiency
   virus type 1 particles
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID NUCLEOCAPSID PROTEIN; RECOMBINATION; TRANSLATION; ELEMENTS; CELLS;
   ENCAPSIDATION; CONSTRUCTION; NEVIRAPINE; EFFICIENT; PR55(GAG)
AB The unspliced human immunodeficiency virus type 1 (HIV-1) RNA is both the messenger for Gag and Gag-Pol and the viral genomic RNA (vRNA) that is packaged into the virion. Although Gag alone is sufficient for the incorporation of vRNA into virus particles, Gag-Pol molecules play an important role in vRNA dimerization and virion maturation. Here, a cis model for vRNA packaging was demonstrated, in which nascent Gag-Pol molecules were preferentially co-encapsulated with their cognate RNA used as the template. Genome-incorporation frequencies were evaluated for two distinct HIV-1 proviral clones differing in their ability to respond to nevirapine (NVP) treatment in one round of infection. It was shown that, under NVP selection, there was a twofold-higher incorporation of vRNAs and integration of provirus genome carrying NVP resistance when compared with the wild-type counterpart. Although cis incorporation has been already demonstrated for Gag, the novelty of these findings is that newly acquired resistant mutations in Gag-Pol will select their specific genomic RNA during virus replication, thus rapidly increasing the chance of the emergence of resistant viruses during the course of anti-retroviral treatment.
C1 Univ Fed Rio de Janeiro, Inst Biol, Mol Virol Lab, BR-21944970 Rio De Janeiro, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Mol Virol Lab, CCS Bloco A2 Sala 121,Cidade Univ,Ilha Fundao 219, BR-21944970 Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Costa, Luciana J/B-7878-2013; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717; Pereira,
   Helena/0000-0002-0316-3732
CR ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990
   Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6
   Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177
   BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995
   BERKOWITZ RD, 1994, VIROLOGY, V202, P233, DOI 10.1006/viro.1994.1339
   Butsch M, 2000, J VIROL, V74, P11531, DOI 10.1128/JVI.74.24.11531-11537.2000
   Caride E, 2000, VIROLOGY, V275, P107, DOI 10.1006/viro.2000.0487
   Cen Shan, 2004, Retrovirology, V1, P33, DOI 10.1186/1742-4690-1-33
   Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002
   Dang Q, 2004, P NATL ACAD SCI USA, V101, P632, DOI 10.1073/pnas.0307636100
   DORFMAN T, 1993, J VIROL, V67, P6159, DOI 10.1128/JVI.67.10.6159-6169.1993
   GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X
   GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993
   Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001
   Halwani R, 2003, J VIROL, V77, P3973, DOI 10.1128/JVI.77.7.3973-3984.2003
   Hill MK, 2001, J VIROL, V75, P6835, DOI 10.1128/JVI.75.15.6835-6840.2001
   Hooker CW, 2003, J CLIN VIROL, V26, P229, DOI 10.1016/S1386-6532(02)00121-X
   Hooker CW, 2001, J VIROL, V75, P3095, DOI 10.1128/JVI.75.7.3095-3104.2001
   Iglesias-Ussel MD, 2002, J GEN VIROL, V83, P93, DOI 10.1099/0022-1317-83-1-93
   JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0
   Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a
   Kaye JF, 1999, J VIROL, V73, P3023, DOI 10.1128/JVI.73.4.3023-3031.1999
   Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002
   Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101
   Liang C, 2004, AIDS RES HUM RETROV, V20, P203, DOI 10.1089/088922204773004923
   Liang C, 2002, AIDS RES HUM RETROV, V18, P1117, DOI 10.1089/088922202320567851
   McBride MS, 1997, J VIROL, V71, P4544, DOI 10.1128/JVI.71.6.4544-4554.1997
   MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072
   PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990
   Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x
   Poon DTK, 1996, J VIROL, V70, P6607, DOI 10.1128/JVI.70.10.6607-6616.1996
   Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283
   Provitera P, 2001, BIOCHEMISTRY-US, V40, P5565, DOI 10.1021/bi002040l
   RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994
   Shehu-Xhilaga M, 2002, J VIROL, V76, P4331, DOI 10.1128/JVI.76.9.4331-4340.2002
   Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001
   Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270
   Tanuri A, 2000, VIROLOGY, V268, P79, DOI 10.1006/viro.1999.0145
   Zhang H, 1996, P NATL ACAD SCI USA, V93, P12519, DOI 10.1073/pnas.93.22.12519
   ZHANG YQ, 1995, J VIROL, V69, P5716, DOI 10.1128/JVI.69.9.5716-5722.1995
   Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002
NR 41
TC 2
Z9 2
U1 0
U2 0
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD SEP
PY 2006
VL 87
BP 2669
EP 2677
DI 10.1099/vir.0.82046-0
PN 9
PG 9
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 076EN
UT WOS:000239939900026
PM 16894207
OA Bronze
DA 2020-10-22
ER

PT J
AU Costa, LJ
   Chen, N
   Lopes, A
   Aguiar, RS
   Tanuri, A
   Plemenitas, A
   Peterlin, BM
AF Costa, Luciana J.
   Chen, Nan
   Lopes, Adriana
   Aguiar, Renato S.
   Tanuri, Amilcar
   Plemenitas, Ana
   Peterlin, B. Matija
TI Interactions between Nef and AIP I proliferate multivesicular bodies and
   facilitate egress of HIV-I
SO RETROVIROLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-BANK COHORT; CELL-SURFACE CD4;
   TYPE-1 NEF; T-CELLS; DOWN-REGULATION; LIPID RAFTS; MHC-I; PROTEIN;
   REPLICATION
AB Background: Nef is an accessory protein of primate lentiviruses, HIV-1, HIV-2 and SIV. Besides removing CD4 and MHC class I from the surface and activating cellular signaling cascades, Nef also binds GagPol during late stages of the viral replicative cycle. In this report, we investigated further the ability of Nef to facilitate the replication of HIV-1.
   Results: To this end, first the release of new viral particles was much lower in the absence of Nef in a T cell line. Since the same results were obtained in the absence of the viral envelope using pseudo-typed viruses, this phenomenon was independent of CD4 and enhanced infectivity. Next, we found that Nef not only possesses a consensus motif for but also binds AIP1 in vitro and in vivo. AIP1 is the critical intermediate in the formation of multivesicular bodies (MVBs), which play an important role in the budding and release of viruses from infected cells. Indeed, Nef proliferated MVBs in cells, but only when its AIP1-binding site was intact. Finally, these functions of Nef were reproduced in primary macrophages, where the wild type but not mutant Nef proteins led to increased release of new viral particles from infected cells.
   Conclusion: We conclude that by binding GagPol and AIP1, Nef not only proliferates MVBs but also contributes to the egress of viral particles from infected cells.
C1 Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA.
   Univ Fed Rio de Janeiro, Dep Genet, Mol Virol Lab, Rio De Janeiro, Brazil.
   Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia.
RP Peterlin, BM (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA.
EM ljcosta@biologia.ufrj.br; nan.chen@ucsf.edu; matija.peterlin@ucsf.edu;
   matija.peterlin@ucsf.edu; matija.peterlin@ucsf.edu;
   ana.plemenitas@mf.uni-lj.si; matija.peterlin@ucsf.edu
RI Santos, Adriana Lopes dos/J-6960-2019; Costa, Luciana J/B-7878-2013;
   Santos, Adriana Lopes dos/B-7252-2018; Aguiar, Renato S/G-3542-2015
OI Santos, Adriana Lopes dos/0000-0002-0736-4937; Santos, Adriana Lopes
   dos/0000-0002-0736-4937; Aguiar, Renato S/0000-0001-5180-3717
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI051165] Funding Source: Medline
CR ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986
   Akari H, 1999, J GEN VIROL, V80, P2945, DOI 10.1099/0022-1317-80-11-2945
   Alexander L, 1997, J VIROL, V71, P6094, DOI 10.1128/JVI.71.8.6094-6099.1997
   Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004
   ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3
   Anastassopoulou CG, 2005, CURR HIV RES, V3, P113, DOI 10.2174/1570162053506946
   Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6
   Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5
   BLOM J, 1993, APMIS, V101, P672, DOI 10.1111/j.1699-0463.1993.tb00164.x
   Brenner M, 2006, J VIROL, V80, P4469, DOI 10.1128/JVI.80.9.4469-4481.2006
   Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9
   Cavrois M, 2004, VIROLOGY, V328, P36, DOI 10.1016/j.virol.2004.07.015
   Choi J, 2005, J VIROL, V79, P11194, DOI 10.1128/JVI.79.17.11194-11204.2005
   Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005
   Costa LJ, 2004, J VIROL, V78, P5311, DOI 10.1128/JVI.78.10.5311-5323.2004
   Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277
   DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917
   DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988
   DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H
   Dyer WB, 1997, AIDS, V11, P1565, DOI 10.1097/00002030-199713000-00004
   Fackler OT, 2001, J VIROL, V75, P6601, DOI 10.1128/JVI.75.14.6601-6608.2001
   Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8
   Fackler OT, 2001, CURR BIOL, V11, P1294, DOI 10.1016/S0960-9822(01)00373-6
   Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2
   GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428
   Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8
   Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360
   KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405
   Kuiken Carla, 2003, AIDS Reviews, V5, P52
   Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X
   Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1
   Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900
   Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365
   Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5
   Lundquist CA, 2002, J VIROL, V76, P4625, DOI 10.1128/JVI.76.9.4625-4633.2002
   Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100
   Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313
   MILLS HA, 1979, J PLANT NUTR, V1, P101, DOI 10.1080/01904167909362704
   Mobius W, 2003, TRAFFIC, V4, P222
   Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350
   ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988
   Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996
   Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008
   Persson B, 2000, EXS, V88, P215
   Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1
   Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x
   Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8
   Sandrin V, 2006, J BIOL CHEM, V281, P528, DOI 10.1074/jbc.M506070200
   Sanfridson A, 1997, P NATL ACAD SCI USA, V94, P873, DOI 10.1073/pnas.94.3.873
   SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026
   Sawai ET, 2000, J VIROL, V74, P2038, DOI 10.1128/JVI.74.4.2038-2045.2000
   Schiavoni I, 2004, J BIOL CHEM, V279, P22996, DOI 10.1074/jbc.M312453200
   Schibeci SD, 2000, AIDS, V14, P1701, DOI 10.1097/00002030-200008180-00003
   Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102
   Shapira-Nahor O, 2002, VIROLOGY, V303, P138, DOI 10.1006/viro.2002.1643
   Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3
   Sol-Foulon N, 2004, J BIOL CHEM, V279, P31398, DOI 10.1074/jbc.M401621200
   SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115
   Stange A, 2005, J VIROL, V79, P5466, DOI 10.1128/JVI.79.9.5466-5476.2005
   Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6
   Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200
   Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498
   Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211
   van 't Wout AB, 2005, J VIROL, V79, P10053, DOI 10.1128/JVI.79.15.10053-10058.2005
   Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200
   Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5
   VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198
   von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1
   Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394
   Welker R, 1996, VIROLOGY, V219, P228, DOI 10.1006/viro.1996.0240
   Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8
   Zheng YH, 2003, P NATL ACAD SCI USA, V100, P8460, DOI 10.1073/pnas.1437453100
NR 72
TC 47
Z9 49
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD JUN 9
PY 2006
VL 3
AR 33
DI 10.1186/1742-4690-3-33
PG 13
WC Virology
SC Virology
GA 070FB
UT WOS:000239504600001
PM 16764724
OA DOAJ Gold, Green Published
DA 2020-10-22
ER

PT J
AU Gonzalez, LMF
   Aguiar, RS
   Afonso, A
   Brindeiro, PA
   Arruda, MB
   Soares, MA
   Brindeiro, RM
   Tanuri, A
AF Gonzalez, LMF
   Aguiar, RS
   Afonso, A
   Brindeiro, PA
   Arruda, MB
   Soares, MA
   Brindeiro, RM
   Tanuri, A
TI Biological characterization of human immunodeficiency virus type 1
   subtype C protease carrying indinavir drug-resistance mutations
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL THERAPY; IN-VITRO; NUCLEOSIDE
   ANALOGS; HIV-1-INFECTED PATIENTS; ZIDOVUDINE RESISTANCE; PHENOTYPIC
   RESISTANCE; REPLICATIVE FITNESS; HIV-1 INFECTION; INHIBITORS
AB Human immunodeficiency virus type 1 subtype C isolates belong to one of the most prevalent strains circulating worldwide and are responsible for the majority of new infections in the sub-Saharan region and other highly populated areas of the globe. In this work, the impact of drug-resistance mutations in the protease gene of subtype C viruses was analysed and compared with that of subtype B counterparts. A series of recombinant subtype C and B viruses was constructed carrying indinavir (IDV)-resistance mutations (M46V, 154V, V82A and L90M) and their susceptibility to six FDA-approved protease inhibitor compounds (amprenavir, indinavir, lopinavir, ritonavir, sacluinavir and nelfinavir) was determined. A different impact of these mutations was found when nelfinavir and lopinavir were tested. The IDV drug-resistance mutations in the subtype C protease backbone were retained for a long period in culture without selective pressure when compared with those in subtype B counterparts in washout experiments.
C1 Univ Fed Rio de Janeiro, Mol Virol Lab, Inst Biol, CCS, BR-21944970 Rio De Janeiro, Brazil.
RP Tanuri, A (corresponding author), CDC, Global AIDS Program Lab Act, NCHSTP, 1600 Clifton Rd MS A12, Atlanta, GA 30333 USA.
EM atanuri@biologia.ufrj.br
RI Soares, Marcelo A/G-5662-2010; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
CR Boden D, 1998, ANTIMICROB AGENTS CH, V42, P2775, DOI 10.1128/AAC.42.11.2775
   Calazans A, 2005, J INFECT DIS, V191, P1961, DOI 10.1086/430002
   Cane PA, 2001, J CLIN MICROBIOL, V39, P2652, DOI 10.1128/JCM.39.7.2652-2654.2001
   Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146
   Carrion G, 2004, AIDS RES HUM RETROV, V20, P1022, DOI 10.1089/aid.2004.20.1022
   Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996
   CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0
   Dumans AT, 2004, J INFECT DIS, V189, P1232, DOI 10.1086/382483
   Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698
   Gonzalez LMF, 2004, ANTIMICROB AGENTS CH, V48, P3552, DOI 10.1128/AAC.48.9.3552-3555.2004
   Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003
   Goudsmit J, 1997, J VIROL, V71, P4479, DOI 10.1128/JVI.71.6.4479-4484.1997
   Goudsmit J, 1996, J VIROL, V70, P5662, DOI 10.1128/JVI.70.8.5662-5664.1996
   Grossman Z, 2004, ANTIMICROB AGENTS CH, V48, P2159, DOI 10.1128/AAC.48.6.2159-2165.2004
   Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35
   Haas DW, 2003, AIDS, V17, P1339, DOI 10.1097/00002030-200306130-00008
   Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101
   Harrigan PR, 1998, J VIROL, V72, P3773, DOI 10.1128/JVI.72.5.3773-3778.1998
   Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010
   Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269
   Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417
   Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996
   Julg B, 2005, INFECTION, V33, P299, DOI 10.1007/s15010-005-6405-1
   Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112
   Kantor R, 2001, NUCLEIC ACIDS RES, V29, P296, DOI 10.1093/nar/29.1.296
   Kantor Rami, 2003, AIDS Reviews, V5, P25
   Kijak G H, 2003, HIV Med, V4, P72, DOI 10.1046/j.1468-1293.2003.00131.x
   LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804
   LILLEHOJ EP, 1988, J VIROL, V62, P3053, DOI 10.1128/JVI.62.8.3053-3058.1988
   Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002
   Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999
   MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995
   Miller V, 2000, AIDS, V14, P2857, DOI 10.1097/00002030-200012220-00007
   Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760
   Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013
   Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637
   Picchio GR, 2000, J ACQ IMMUN DEF SYND, V25, P289, DOI 10.1097/00126334-200012010-00001
   Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004
   Piliero PJ, 2002, EXPERT OPIN INV DRUG, V11, P1295, DOI 10.1517/13543784.11.9.1295
   Puchhammer-Stockl E, 1998, CLIN DIAGN VIROL, V9, P25, DOI 10.1016/S0928-0197(97)10014-9
   ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230
   ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0
   Ruiz L, 1998, J ACQ IMMUN DEF SYND, V19, P19, DOI 10.1097/00042560-199809010-00003
   Sanne I, 2003, JAIDS-J ACQ IMM DEF, V32, P18, DOI 10.1097/00126334-200301010-00004
   Schmidt B, 2000, AIDS, V14, P1731, DOI 10.1097/00002030-200008180-00007
   Schmidt Barbara, 2002, AIDS Reviews, V4, P148
   Schmit JC, 1996, J INFECT DIS, V174, P962, DOI 10.1093/infdis/174.5.962
   Shafer RW, 1999, J VIROL, V73, P6197, DOI 10.1128/JVI.73.7.6197-6202.1999
   Sharma PL, 1997, J VIROL, V71, P8846, DOI 10.1128/JVI.71.11.8846-8851.1997
   Sonnerborg A, 1997, AIDS RES HUM RETROV, V13, P343, DOI 10.1089/aid.1997.13.343
   Weber J, 2003, JAIDS-J ACQ IMM DEF, V33, P448, DOI 10.1097/00126334-200308010-00005
   Ziermann R, 2000, J VIROL, V74, P4414, DOI 10.1128/JVI.74.9.4414-4419.2000
NR 52
TC 7
Z9 7
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 0022-1317
J9 J GEN VIROL
JI J. Gen. Virol.
PD MAY
PY 2006
VL 87
BP 1303
EP 1309
DI 10.1099/vir.0.81517-0
PN 5
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 037OC
UT WOS:000237155300028
PM 16603533
OA Bronze
DA 2020-10-22
ER

PT J
AU Gonzalez, LMF
   Brindeiro, RM
   Aguiar, RS
   Pereira, HS
   Abreu, CM
   Soares, MA
   Tanuri, A
AF Gonzalez, LMF
   Brindeiro, RM
   Aguiar, RS
   Pereira, HS
   Abreu, CM
   Soares, MA
   Tanuri, A
TI Impact of nelfinavir resistance mutations on in vitro phenotype,
   fitness, and replication capacity of human immunodeficiency virus type 1
   with subtype B and C proteases
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; INHIBITORS; INFECTION;
   SELECTION; PATTERNS; NAIVE; HIV-1; GENE
AB Human immunodeficiency virus type 1 subtype B and C proteases were manipulated to contain 90M, 88D, or 89L, and their in vitro biological properties were studied. We showed that D30N has significantly more impact in subtype C than in subtype B counterparts, accounting for the reported low prevalence of this mutation in patients failing nelfinavir-based regimens.
C1 Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, BR-21944970 Rio De Janeiro, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, CCS,Bloco A,Cidade Univ, BR-21944970 Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Abreu, Celina Monteiro/AAT-7447-2020;
   Soares, Marcelo A/G-5662-2010
OI Aguiar, Renato S/0000-0001-5180-3717; Pereira,
   Helena/0000-0002-0316-3732
CR ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986
   Ariyoshi K, 2003, JAIDS-J ACQ IMM DEF, V33, P336, DOI 10.1097/00126334-200307010-00007
   Cane PA, 2001, J CLIN MICROBIOL, V39, P2652, DOI 10.1128/JCM.39.7.2652-2654.2001
   Cote HCF, 2001, J VIROL, V75, P589, DOI 10.1128/JVI.75.2.589-594.2001
   Gallego O, 2003, J CLIN MICROBIOL, V41, P1245, DOI 10.1128/JCM.41.3.1245-1247.2003
   Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698
   Gonzalez LMF, 2003, ANTIMICROB AGENTS CH, V47, P2817, DOI 10.1128/AAC.47.9.2817-2822.2003
   Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269
   Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417
   HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991
   MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995
   Nicastri E, 2003, J MED VIROL, V69, P1, DOI 10.1002/jmv.10269
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637
   Perrin V, 2003, J VIROL, V77, P10172, DOI 10.1128/JVI.77.18.10172-10175.2003
   Peters S, 2001, J VIROL, V75, P9644, DOI 10.1128/JVI.75.20.9644-9653.2001
   Puchhammer-Stockl E, 1998, CLIN DIAGN VIROL, V9, P25, DOI 10.1016/S0928-0197(97)10014-9
   SCHINAZI RF, 2000, INT ANTIVIRAL NEWS, V8, P65
   Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003
   Ziermann R, 2000, J VIROL, V74, P4414, DOI 10.1128/JVI.74.9.4414-4419.2000
NR 20
TC 40
Z9 41
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2004
VL 48
IS 9
BP 3552
EP 3555
DI 10.1128/AAC.48.9.3552-3555.2004
PG 4
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 850PV
UT WOS:000223625800049
PM 15328124
OA Green Published, Bronze
DA 2020-10-22
ER

PT J
AU Gonzalez, LMF
   Brindeiro, RM
   Aguiar, RS
   Pereira, HS
   Abreu, CM
   Soares, MA
   Tanuri, A
AF Gonzalez, LMF
   Brindeiro, RM
   Aguiar, RS
   Pereira, HS
   Abreu, CM
   Soares, MA
   Tanuri, A
TI Impact of nelfinavir resistance mutations on in vitro phenotype, fitness
   and replication capacity of HIV-1 with subtype B and C proteases
SO ANTIVIRAL THERAPY
LA English
DT Meeting Abstract
CT 13th International HIV Drug Resistance Workshop
CY JUN 08-12, 2004
CL Tenerife, SPAIN
C1 Fed Univ Rio De Janeiro, Dept Genet, Rio De Janeiro, RJ, Brazil.
RI Abreu, Celina Monteiro/AAT-7447-2020; Soares, Marcelo A/G-5662-2010;
   Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 1
Z9 1
U1 0
U2 0
PU INT MEDICAL PRESS LTD
PI LONDON
PA 2-4 IDOL LANE, LONDON EC3R 5DD, ENGLAND
SN 1359-6535
J9 ANTIVIR THER
JI Antivir. Ther.
PD AUG
PY 2004
VL 9
IS 4
BP U57
EP U57
PG 1
WC Infectious Diseases; Pharmacology & Pharmacy; Virology
SC Infectious Diseases; Pharmacology & Pharmacy; Virology
GA 960TH
UT WOS:000231615600080
DA 2020-10-22
ER

PT J
AU Smith, P
   Wang, FF
   Wilkinson, K
   Shipp, M
   Aguiar, R
AF Smith, P
   Wang, FF
   Wilkinson, K
   Shipp, M
   Aguiar, R
TI The phosphodiesterase PDE4B controls cell proliferation and apoptosis in
   DLB-CL via the PI3K/AKT pathway: Novel opportunities for clinical
   intervention.
SO BLOOD
LA English
DT Meeting Abstract
CT 45th Annual Meeting and Exhibition of the American-Society-of-Hematology
CY DEC 06-09, 2003
CL San Diego, CA
SP Amer Soc Hematol
C1 Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
RI Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 1
Z9 1
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2003
VL 102
IS 11
MA 79
BP 25A
EP 26A
PN 1
PG 2
WC Hematology
SC Hematology
GA 742UP
UT WOS:000186536700080
DA 2020-10-22
ER

PT J
AU Savage, KJ
   Monti, S
   Kutok, J
   Cattoretti, G
   Neuberg, D
   Laval, L
   Kurtin, P
   Del Chin, P
   Ladd, C
   Feuerhake, F
   Aguiar, R
   Li, SG
   Salles, G
   Berger, F
   Jing, W
   Pinkus, GS
   Habermann, T
   Dalla-Favera, R
   Harris, NL
   Aster, JC
   Golub, TR
   Shipp, MA
AF Savage, KJ
   Monti, S
   Kutok, J
   Cattoretti, G
   Neuberg, D
   Laval, L
   Kurtin, P
   Del Chin, P
   Ladd, C
   Feuerhake, F
   Aguiar, R
   Li, SG
   Salles, G
   Berger, F
   Jing, W
   Pinkus, GS
   Habermann, T
   Dalla-Favera, R
   Harris, NL
   Aster, JC
   Golub, TR
   Shipp, MA
TI The molecular signature of mediastinal large B-cell lymphoma differs
   from that of other diffuse large B-cell lymphomas and shares features
   with classical Hodgkin's lymphoma.
SO BLOOD
LA English
DT Meeting Abstract
CT 45th Annual Meeting of the American-Society-of-Hematology
CY DEC 06-09, 2003
CL SAN DIEGO, CALIFORNIA
SP Amer Soc Hematol
C1 Dana Farber Canc Inst, Boston, MA 02115 USA.
   MIT, Ctr Genome Res, Cambridge, MA USA.
   Brigham & Womens Hosp, Boston, MA 02115 USA.
   Columbia Univ, Inst Canc Genet, New York, NY USA.
   Massachusetts Gen Hosp, Boston, MA 02114 USA.
   Mayo Clin, Rochester, MN USA.
   Ctr Hosp Lyon Sud, Lyon, France.
   Mayo Clin, Div Hematol, Rochester, MN USA.
   Mayo Clin, Dept Med, Rochester, MN USA.
RI Salles, Gilles/Z-2336-2019; Aguiar, Renato S/G-3542-2015
OI Aguiar, Renato S/0000-0001-5180-3717
NR 0
TC 10
Z9 11
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2003
VL 102
IS 11
MA 622
BP 179A
EP 179A
PN 1
PG 1
WC Hematology
SC Hematology
GA 742UP
UT WOS:000186536700622
DA 2020-10-22
ER

PT J
AU Macedo, AM
   Pimenta, JR
   de Aguiar, RS
   Melo, AIR
   Chiari, E
   Zingales, B
   Pena, SDJ
   Oliveira, RP
AF Macedo, AM
   Pimenta, JR
   de Aguiar, RS
   Melo, AIR
   Chiari, E
   Zingales, B
   Pena, SDJ
   Oliveira, RP
TI Usefulness of microsatellite typing in population genetic studies of
   Trypanosoma cruzi
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Trypanosoma cruzi; microsatellites; genetic typing; rDNA classification;
   phylogenetic inference
ID RELEVANT PHYLOGENETIC SUBDIVISIONS; RIBOSOMAL-RNA; EPIDEMIOLOGY;
   SEQUENCES; LINEAGES; STRAINS
AB Through microsatellite analysis of 53 monoclonal populations of Trypanosoma cruzi, we found a remarkable degree of genetic polymorphism with no single multilocus genotype being observed more than once. The microsatellite profile proved to be stable during 70 generations of the CL Brener clone in culture. The microsatellite profiling presented also high diagnostic sensitivity since DNA amplifications could be achieved with less than 100 fg DNA, corresponding to half parasite total DNA content. Based on these technical attributes the microsatellite assay turns out to be an important tool for direct typing T. cruzi in biological samples. By using this approach we were able to type T. cruzi in feces of artificially infected bugs and in single cells sorted by FAGS. The microsatellites have shown to be excellent markers for T. cruzi phylogenetic reconstruction. We used maximum parsimony based on the minimum number of mutational steps to build an unrooted Wagner network, which confirms previous conclusions based on the analysis of the D7 domain of the LSU rDNA gene that T. cruzi is composed by two major groups. We also obtained evidence that strains belonging to rRNA group 2 are subdivided into two genetically distant clusters, and that one of these clusters is more related to rRNA group 1/2. These results suggest different origins for these strains.
C1 Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-30161970 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Parasitol, BR-30161970 Belo Horizonte, MG, Brazil.
   Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
   Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, MG, Brazil.
RP Macedo, AM (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, Caixa Postal 486, BR-30161970 Belo Horizonte, MG, Brazil.
RI Oliveira, Riva/J-8408-2013; Aguiar, Renato S/G-3542-2015
OI Oliveira, Riva/0000-0002-4917-7646; Aguiar, Renato
   S/0000-0001-5180-3717; de Paula Oliveira, Riva/0000-0002-6092-6142
CR AZAMBUJA P, 1997, MOL BIOL INSECT DIS, P56, DOI DOI 10.1007/978-94-009-1535-0_6
   Brisse S, 1998, PARASITOL TODAY, V14, P178, DOI 10.1016/S0169-4758(98)01225-3
   Felsenstein J, 1993, PHYLIP PHYLOGENY INF
   GARCIA ES, 1997, MOL BIOL INSECT DIS, P147
   Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191
   MACEDO AM, 1992, MOL BIOCHEM PARASIT, V55, P147, DOI 10.1016/0166-6851(92)90135-7
   Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4
   Momen H, 1999, MEM I OSWALDO CRUZ, V94, P181, DOI 10.1590/S0074-02761999000700025
   Oliveira RP, 1999, MEM I OSWALDO CRUZ, V94, P65, DOI 10.1590/S0074-02761999000700006
   Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776
   Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7
   Souto RP, 1998, PARASITOL TODAY, V14, P207, DOI 10.1016/S0169-4758(98)01229-0
   Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0
   Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1
   Zingales B, 1999, MEM I OSWALDO CRUZ, V94, P159, DOI 10.1590/S0074-02761999000700020
NR 15
TC 50
Z9 50
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2001
VL 96
IS 3
BP 407
EP 413
DI 10.1590/S0074-02762001000300023
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 417BX
UT WOS:000167816500024
PM 11313654
OA DOAJ Gold
DA 2020-10-22
ER

EF